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The first aim of this study was to examine and assess the sensitivity and utility 
of a number of different measuring techniques for the detection of nitric oxide 
(NO). The systems examined did not measure NO directly. Instead, some of 
the systems employed measured nitrite, the major in vitro breakdown product 
of NO: these were the Griess reaction, chemiluminescence detection coupled 
to two reducing systems, i.e. 1,1 '-dimethylferrocene/acetonitrile reflux and 
sodium iodide/glacial acetic acid reflux and lastly fluorometric detection. The 
Griess reaction was the least sensitive with a threshold detection limit of 300 
pmol, but a large number of samples could be assayed each day. The
1,1 '-dimethylferrocene/acetonitrile system produced chemiluminescence 
signals that were difficult to discern from background noise and was 
abandoned. The sodium iodide/glacial acetic acid reflux system did, however, 
produce good chemiluminescence signals, giving a threshold sensitivity of 100 
pmol. This technique was slow, however, permitting only small numbers of 
samples to be assayed each day. The fluorometric detection system for nitrite 
had a similar sensitivity of around 120 pmol but as each sample was stable for 
around 10 min only small numbers of samples could be assayed each day. 
Thus, if samples contained large amounts of nitrite, the less sensitive Griess 
reaction (300 pmol) was by far the easiest system to use. A stronger reducing 
system, involving vanadium chloride/hydrochloric acid was tested which when 
combined with chemiluminescence could measure both of the breakdown 
products of NO, i.e. nitrite and nitrate. This system had a high sensitivity of 
around 200 pmol but in addition to being able to handle only small numbers of 
samples, it was much less selective since many 'false' positive signals were 
generated by constituents of tissue culture medium.
Having assessed the suitability of the above detection systems, the second 
aim of this study was to use them in conjunction with other techniques to 
examine the expression of iNOS in different preparations. Expression of 
iNOS in J774.2 murine macrophages was seen after incubation with
iv
lipopolysaccharide (LPS; 1 - 1000 ng mM) or interferon-y (IFN-y; 1 - 100 u 
mM). In contrast, LPS (1 - 1000 ng mM) failed to stimulate expression of iNOS 
in bovine aortic endothelial cells (BAEC) in culture.
:
:
.INFollowing an overnight incubation at 37°C in Krebs solution, phenylephrine 
(PE; 1 nM - 10 pM)-induced contraction of endothelium-denuded rings of rat 
aorta was depressed. This depression was prevented by including polymixin B 
(30 pg mM) during the incubation suggesting it resulted from LPS 
contaminating the Krebs solution. This depression was likely to have resulted 
from production of NO by iNOS as it could be reversed by the addition of 
l-NAME (1 mM), an inhibitor of NOS, methylene blue (10 pM), an inhibitor of 
soluble guanylate cyclase or haemoglobin (10 pM), which binds and 
inactivates NO. The effects of generators of superoxide anion, which destroy 
NO, were also examined. The intracellular generator of superoxide anion, LY 
83583 (0.1 - 1 pM), reversed the depression but the extracellular generator, 
hypoxanthine (100 pM)/xanthine oxidase(16 mu ml"''), had no effect. These
data suggest that NO is generated and acts within the same smooth muscle 
cells.
': ir
In contrast to rat aorta, rat aortic smooth muscle cells (RASMC) in culture did 
not express iNOS, as assessed by measuring nitrite accumulation and cyclic 
GMP content, when stimulated by LPS (1 - 100 pg mM) alone except at
■Iexceptionally high concentrations (300 and 1000 pg mb'*). Certain cytokines, 
i.e. IFN-y (1 - 100 u ml""') and interleukin-1 a (1 - 10 u ml""'), did however, lead
:
to expression of iNOS. The presence of serum appeared to inhibit the 
expression of iNOS, probably because of the presence of platelet-derived
,
growth factor and transforming growth factor. The production of nitrite and 
elevated levels of cyclic GMP were blocked following incubation with inhibitors 
of the expression of iNOS, dexamethasone (1 pM) and cycloheximide (30 u
m il) and by the inhibitors of NOS, l-NAME (100 pM) and l-NMMA (300 pM). :r:i3
Thus, it appeared that LPS alone was able to stimulate expression of iNOS in 
isolated rings of rat aorta but not in cultured RASMC. Whether this apparent 
difference resulted from differences in smooth muscle phenotype in the vessel 
wall and in culture or from any other differences has yet to be resolved.
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C h a p te r  1
General Introduction
Nitric oxide (NO), a rare atmospheric gas and one of the toxic components of 
air pollution that contributes to acid rain and destruction of the ozone layer, is 
now known to be enzymatically synthesised in a number of cell types. It has 
been demonstrated that NO is responsible for diverse functions such as cell- 
cell signalling and immune-mediated cytotoxicity.
Discovery
the noradrenergic response is blocked with guanethidine, field stimulation of 
the preparation produces a powerful relaxation and this response can be 
mimicked by NO and blocked by agents which block the conversion of
2
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It was first suggested in 1916 by Mitchell et al. that mammals produced oxides 
of nitrogen, when it was shown that more nitrate was excreted than was 
ingested. For a long time this excess was thought to be produced by intestinal 
micro-organisms and it was not until work in the early 1980's that Mitchell's 
findings were substantiated. Work studying carcinogenic actions of 
nitrosamines confirmed that mammals produced nitrate (NO3") and this 
production was enhanced by infection in human subjects and after endotoxin 
treatment in rodents (Green et al., 1981a; Green et al., 1981b). Stuehr and 
Marietta (1985) demonstrated that murine macrophages released nitrate and
this was the first evidence of the formation of nitrogen oxides from a specific
.cell type. Hibbs then went on to show that the nitrite and nitrate were produced 
from the substrate L-arginine (Hibbs et al., 1987). In a separate line of work 
investigating the endothelium-derived relaxing factor (EDRF) described by 
Furchgott and Zawadzki (1980), Ignarro and Palmer independently reported 
this EDRF to be NO (Ignarro et al., 1987; Palmer et al., 1987). Palmer's group
also showed that the substrate for this NO was L-arginine (Palmer et al.,
■1988). In yet another separate line of work examining the rat anococcygeus 
muscle, it was discovered that it has a motor noradrenergic and an inhibitory 
non-adrenergic, non-cholinergic (NANC) innervation (Gillespie, 1972). When
I
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L-arginine to NO (Gillespie et al., 1989). Similar responses have since been 
established in other peripheral nerves in many systems including the gut (Bult 
et al., 1990), respiratory tract (Tucker et al., 1990), reproductive system (Liu at 
ai, 1991) and penile arteries (Liu et ai, 1991). NO-like activity has also been 
established by Garthwaite's group in the central nervous system after 
N-methyl-D-aspartic acid stimulation in the brain (Garthwaite et ai, 1988). 
These and other studies have demonstrated that NO plays a key role in many 
of the processes in the body and is produced from the amino acid L-arginine. 
However, from an evolutionary point of view NO is not a new biological 
molecule as evidence of NO and its actions have been found in the limulus 
crab which according to fossil records, has not evolved in 500 million years 
(Radomski et ai, 1991; McCall & Vallance, 1992; Moncada & Martin, 1993).
Controversy over identity of EDRF
There is wide debate as to whether EDRF is truly NO or an NO-releasing 
molecule. Reports that EDRF is NO came from Palmer's group where they 
used chemiluminescence in the presence of a reducing system to detect the 
metabolites of NO (Palmer et ai, 1987) and also from Kelm and Schrader 
(1988) who used methaemoglobin detection, where oxyhaemoglobin is 
oxidised to methaemoglobin in the presence of NO. However, neither of these 
methods measure native NO. Myers tried to measure native NO using the 
chemiluminescence method without reducing solutions and found the amount 
of NO present was insufficient to account for the activity of EDRF; it was still 
insufficient even when a reducing system was introduced (7-10 times too low) 
(Myers et ai, 1989). It was then suggested that EDRF resembled a 
S-nitrosothiol more closely than NO (Myers et ai, 1990). Other groups have 
since agreed with these findings; firstly, Rubanyi's group found that whilst 
EDRF and NO were both inactivated when passed through a haemoglobin- 
agarose column, only authentic NO gave a NO-haemoglobin electron
3
An area of general agreement, however, is that NO derived from L-arginine is 
the active component of EDRF even if it is released bound to a thiol or some 
other molecule such as an iron haem moiety.
inorganic chemistry of NO
■4paramagnetic signal (Rubanyi at ai, 1991). This study suggested that 
S-nitrosocysteine was more likely to be EDRF as it also gave no electron 
paramagnetic signal (Rubanyi et ai, 1991). Another group (Kukreja et ai,
1993) in agreement with Myers found that S-nitrosocysteine produced 
relaxations in cerebral arteries in cats but that native NO was 10-fold less 
potent. In contrast, Liu found that S-nitrosothiols were unlikely to function as 
the nitergic neurotransmitter in bovine retractor penis muscle, since the 
neurotransmitter was found to be resistant to destruction by superoxide anion
'whereas S-nitrosogIutathione and S-nitrosocysteine were not (Liu et ai, 1994).
Also, Feelisch found that EDRF was more likely to be NO than an 
S-nitrosothiol as the activities of EDRF and NO were inhibited by L-cysteine 
but the actions of S-nitrosothiols were not (Feelisch et ai, 1994). Another 
possibility is that NO binds to iron haem moieties forming dinitrosyl iron (Vanin,
1991). This dinitrosyl iron has been detected by electron spin resonance 
spectroscopy (Vanin et ai, 1993). It is possible that the release of these 
complexes accounts for the activity of EDRF (Müisch et ai, 1993). Thus, there 
is still debate as to the true identity of EDRF.
NO is a radical (i.e., it has an unpaired electron) that is reactive with other 
substances but does not self-react, perhaps because its bond length is 
intermediate between double and triple bond lengths (table 1.1). NO is not as 
unstable as many other radicals, but has a half life of 3 - 50 s in aqueous 
solution at biological pFl (McCall & Vallance, 1992). NO readily reacts with O2
4
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Molecular weight 30.006 (1 mole = 0.03006 kg)
N - 0  bond distance^ 1.1508Â
Partition coefficient^ ^ 2 0
Saturated NO solution^ 3 mM
Oxidation products nitrite, nitrate
Dissociation t i /2 Hb-NO^ «3  h
Absolute density 101.325 kPa at 25X
Solubility in H2O at 0, 20 and
60"C
7.34,4.6 and 2.37 ml/100 ml
Physico-chemical properties High lipid solubility 
Highly diffusible
Gas or in solution at body temperature
Redox-activated forms
Nitric oxide (NO) 
Nitrosonium cation (NO'*') 
Nitroxyl anion (NO")
Half-life and fate
very short (3 to 50 s)
Gaseous - oxidised to NO2 and higher 
oxides of nitrogen
Solution - oxidised to nitrite and nitrate
Table 1.1: Properties of nitric oxide (nitrogen oxide, NO).
® The bond distance of N - O is intermediate between that of a typical 
double and triple bond (1.18 and 1.06 A, respectively).
 ^Partition coefficient = molecules per unit volume gas/molecules per unit 
volume solution.
 ^Saturated NO solutions contain approximately 3 nmol NO/pl when in the 
absence of oxygen.
 ^ The dissociation of NO from haemoglobin is much slower than the 
dissociation of carbon monoxide (CO) from Hb (T^/2 35 s), accounting 
for the much higher affinity of Hb for NO than O2 or CO.
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(Wennmalm et al., 1992; Ignarro et al., 1993). In aqueous solution containing 
O2 , NO is oxidised mainly to NO2" with little or no formation of NO3" by the 
following reaction (Ignarro et al., 1993):
4N0* 4. O2 + 2 H2O 4 NO2" + 4H+
NO in gaseous mixtures containing oxygen, however, forms NO2 by the 
following reaction (Ignarro et al., 1993):
NO* + O2 OONO
OONO + NO* -> ONOONO 2N0g O2 NNO2 (NgO^)
The N2O4 formed dismutases spontaneously in water (pH 7.4) to yield both 
nitrite and nitrate by the following reaction (Ignarro et al., 1993):
N2O4 + HgO NOg" + NO j' + 2H’*'
Wennmalm et al. (1992) found in blood with high oxygen saturation of 
haemoglobin that nitrate is the main product by the following reaction:
Hb(Fe2'^)02 + NO ^  Hb(Fe3+) + NOg"
NO also reacts with superoxide radical to yield peroxinitrite (OONO") by the 
following reaction (Gryglewski et al., 1986):
NO + O2" ONOO"
Peroxynitrite (ONOO") when formed is a powerful oxidant which is freely 
diffusible and can cause tissue damage (Ignarro et al., 1987; Freeman, 1994; 
Stamler et al., 1992).
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NO is poorly soluble in water, which is indicated by its high partition coefficient 
(table 1.1), and tends to exist as a gas. It has great potential as a biological 
messenger due to its small size which facilitates diffusion across biological 
membranes, thus permitting its entry into and exit from cells (ignarro et al., 
1987). Once within the cell it avidly binds to transition metals such as Fe, Cu, 
Co and Mn (Henry et al., 1991; Stamler et al., 1992), which are crucial to the 
function of many cytochromes and oxidases.
The reactivity and properties of NO depend on its interrelated redox forms 
(Stamler et al., 1992): neutral nitric oxide (NO*); nitrosonium cation (NO"*", with 
the removal of an electron at its outer orbit) and nitroxyl anion (NO", with the 
addition of an electron to its outer orbit). The reactions of NO* have been 
discussed above. NO’*’ reacts with nucleophiles such as electron-rich bases, 
aromatic compounds and hydrogen peroxide. A variety of nitrosocompounds 
that form efficiently under neutral physiological conditions can be viewed as 
NO**" carriers and these include metal-nitrosyl complexes, thionitrites, 
nitrosamines, alkyl and aryl nitrites, and dinitrogen tri- and tetra-oxides (N2O3 
and N2O4 ). NO" reverts rapidly to N2O through dimerization and dehydration. 
NO" also undergoes reversible addition to low molecular weight and protein 
thiols leading to sulfhydryl oxidation.
The properties of NO are summarised in table 1.1.
NO biosynthesis
It is accepted that NO is derived from either of the chemically equivalent 
guanidine nitrogens of the amino acid L-arginine (Palmer et al., 1988) following 
activation of the enzyme nitric oxide synthase (NOS). This reaction involves a 
five-electron oxidation of L-arginine to yield NO. The reaction scheme for the 
production of NO is not fully understood but N^-hydroxyl-L-arginine appears to
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be an intermediate in the reaction (Stuehr et al., 1991c). A second amino acid 
L-citrulline is produced as a by-product (Hibbs et al., 1987). It has also been 
shown that the oxygen in NO and the ureido oxygen in L-citrulline are derived 
from molecular oxygen (Leone et al., 1991). The reaction mechanism is shown 
in fig 1.1. NADPH is required as a cosubstrate and FAD, FMN (Stuehr et al., 
1991a) and tetrahydrobiopterin (Müisch & Busse, 1991; Schmidt et al., 1992) 
are required as cofactors. An additional cofactor required is calmodulin 
(Forstermann et al., 1991; Pollock et al., 1991; Schmidt et al., 1991). In the 
presence of elevated calcium, the calcium/calmodulin complex binds to 
constitutive NOS (cNOS), which exists in endothelial cells (Sessa et al., 1992) 
and certain neurones (Bredt et al., 1990). Another form of NOS is inducible 
NOS (iNOS). Originally it was thought that iNOS was calcium/calmodulin- 
independent, however, iNOS has now been found to bind calmodulin so tightly 
that calcium is not required for activation (Cho et al., 1992).
Isotvpes of NOS
NOS, thus far, is known to exist in at least three distinct isoforms representing 
three distinct gene products which have been isolated, purified and cloned. 
These three isoforms vary in subcellular location, amino acid sequence, 
regulation and functional roles. Two isoforms are present in the cell under 
normal resting conditions and are termed cNOS, whereas the third isotype is 
only expressed under pathological conditions following stimulation by certain 
cytokines, microbes or microbial products and is thus termed iNOS.
One of the two isotypes of cNOS has been localised to the endothelium and is 
mostly membrane bound via a myristylation site (Sessa et al., 1992; Sessa,
1994). A second cNOS has been localised to the cytosol of central and 
peripheral neurones but is also found in extraneuronal sites such as skeletal
HgN^N Hz 
NH
H3N COO" /O 2 
L-arginine
1.0 NADPH X
O H OH'xVYrH,N" "N'
H4 Biopterin
NOS
FAD
FMN
HzN^^N'OH 
NH
H3N COO"
0.5 NADPH N^-hydroxyl-L-arginine
H2N 0
NH
H3N COO" 
L-citrulline
DHPR
NAD(P)H
DHFR
NADPH
HN"
H zN -^N ^^N ""^  
H
Hz Blopterin
N '
HzN-^N^ "N'
HQuinonoid Hz Biopterin
Figure 1.1: Biosynthesis of nitric oxide. A guanidino nitrogen of L-arginine 
undergoes a five electron oxidation to yield the gaseous radical nitric oxide 
(NO) via an N^^-hydroxyl-i-arginine intermediate. NADPH donates two 
electrons for the formation of this intermediate and one electron for its further 
oxidation. Both steps are catalyzed by the FAD- and FMN-containing enzyme, 
nitric oxide synthase (NOS). Molecular oxygen is incorporated into both the 
ureido group of the by-product L-citrulline and NO itself. Tetrahydrobiopterin 
(H4 biopterin) is also required; the amounts needed are substoichiometric with 
respect to the amount of NO generated, provided that tetrahydrobiopterin can 
be regenerated from its oxidised form, quinonoid dihydrobiopterin (H2 
biopterin). Regeneration of tetrahydrobiopterin proceeds both through the 
methotrexate-sensitive enzyme dihydrofolate reductase (DHFR) and through 
the methotrexate-resistant enzyme, dihydropteridine reductase (DHPR). 
Modification of a diagram by Nathan (1992).
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muscle, pancreas and kidney (Bredt et al., 1990; Nathan, 1992; Nakane et 
a/., 1993). This isoform may also be termed neuronal NOS (nNOS). When 
activation occurs calcium/calmodulin binding permits electron transfer from 
NADPH via flavin groups within the enzyme to a heme-containing active site 
(Stuehr et a!., 1991a; Abu-soud & Stuehr, 1993) resulting in small amounts 
(pmol) of NO being generated by these two types of cNOS. This activation is 
short lived, and the NO produced serves as a diffusible signalling molecule, 
mediating numerous physiological processes, including vasodilation and 
neurotransmission.
In contrast to cNOS, iNOS is not expressed under normal conditions but as 
already stated requires induction by certain cytokines, microbes or microbial 
products (Nussler & Billiar, 1993). Furthermore, there is often strong synergy 
between stimulating agents. For example, murine macrophages express high 
levels of iNOS upon exposure to lipopolysaccharide (LPS), with strong synergy 
occurring with the additional presence of interferon-y (IFN-y) (Stuehr &
'Marietta, 1987a). Regulation of iNOS activity seems to occur primarily at 
transcriptional level but may also be affected by mRNA stability (Beasley et a!.,
1991; Xie et a!., 1992). Changes in iNOS mRNA probably reflect changes in 
iNOS gene translation (Beasley et a!., 1991). After stimulation, NO synthesis is 
delayed for several hours by de novo synthesis of iNOS protein and by the 
production of essential cofactors (Beasley et a!., 1991). iNOS expression 
results in a sustained production of NO, which exerts both cytostatic/cytotoxic 
and antimicrobial activity towards certain pathogens (Nussler & Billiar, 1993).
Unlike the cNOS isoform, iNOS remains activated and continuously produces 
NO for the life of the active enzyme and, as already stated, it is not regulated 
by calcium (Cho et a!., 1992). The capacity to express iNOS exists in nearly 
every tissue in the body from immune cells such as macrophages (Stuehr &
Marietta, 1985; Stuehr & Marietta, 1987a) to cells such as hepatocytes (Geller 
et a!., 1993b), vascular smooth muscle cells (Busse & Müisch, 1990; Fleming
1 0
et al., 1991a), endothelial cells (Radomski et al., 1990b; Gross et al., 1991), 
chondrocytes (Palmer et al., 1993), cardiac myocytes (Schulz et al., 1992) and 
neurones (Minc-Golomb et al., 1994), when appropriately stimulated.
The complementary DNA for the three isoforms of NOS has been cloned and 
a comparison of these is made in table 1.2. These isotypes appear to come 
from distinct genes, however there is a high degree of homology among them 
and also with cytochrome P450 reductase (Bredt et al., 1991). For each 
isoform (cNOS or iNOS) there is a high conservation of amino acid identity 
between species (50 - 94%). Figure 1.2 shows a schematic alignment of the 
amino acids for the 3 major forms of NOS and their similarity to cytochrome 
P450 reductase.
Actions of NO
NO, once produced, is involved in many processes in the body from 
intercellular signalling to cytotoxic actions on invading organisms.
NO in the cardiovascular system
NO is responsible for active vasodilation in the vasculature. Endothelial cells 
continually release small amounts of NO exerting a tonic basal vasodilation 
tone. Furthermore, the release of NO can be increased by shear stress 
exerted by the flow of blood (Rubanyi et al., 1986; Rees et al., 1989) or by 
agonists such as acetylcholine (ACh) and bradykinin (Furchgott & Zawadzki, 
1980; Palmer et ai, 1988). A list of agonists is given in table 1.3. These 
agonists act by binding to their receptors on the cell membrane of endothelial 
cells, causing a transient increase in intracellular calcium. Calcium binds to 
calmodulin and this complex activates cNOS increasing the production of NO.
11
NOS
isoform
species cell type® size of
transcript,
kbb
Protein
Mr
(deduced)
Ca2 -^
dependence 
of NOS 
activity
Neuronal Human"' Cerebellum 1 0 161037
(cNOS) Rat2 Cerebellum 10.5 160458
Cytokine Human3 Hepatocyte 4.5 131000 ?c '
inducible Murine^ Macrophage 4.5 130556 -
(iNOS) Rats Hepatocyte 4.5 130653 -
Rats Vascular 4 131000 -
smooth
muscle
Endothelial Human^ Aortic EC 4.4-4.8 133000 +++
(cNOS) BovineS Aortic EC 4.4-48 133286 +++
Table 1.2: Comparison of cloned NOS isoforms. Modification of a table by 
Sessa (1994).
3 Source of cDNA library
b Approximate size of mRNA under high stringency hybridisation and wash 
conditions
G Partial calcium-dependence of expressed cDNA based on the ability of EDTA 
to inhibit NOS activity
(Nakane et al., 1993)
2 (Bredt etal., 1991)
3 (Geller et al., 1993a)
(Lyons etal., 1992; Marczin etal., 1992) 
s (Wood et al., 1993)
6 (Nunokawa etal., 1993)
7 (Janssens et ai, 1992)
8 (Sessa et al., 1992; Lamas et al., 1992; Nishida et al., 1992)
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ïNeuronal (cNOS) 
Heme CaM NADPH
Bldotheliai (cNO^ 
Heme CaM N.^D|PH
NH. L-Arginine FMN FAD -COOH
Cytochrome P450 reductase 
NHg- FMNTTransmembrane
domain
N ^ P p H
FAD COOH
Figure 1.2: Schematic alignment of the deduced amino acid sequences of 
neuronal, inducible and endothelial nitric oxide synthase (NOS) with 
cytochrome P450 reductase. Consensus sequence sites include binding sites 
for heme, L-arginine, calmodulin (CaM), FMN, FAD and reduced FAD 
phosphate (NADPH), Endothelial NOS is the only isoform that contains a 
unique N-terminal myristylation site permitting adherence to cell membrane. 
Modification of a figure by Sessa (1994).
NHg- |L-Arginine FMN ] fa d -COOH
Inducible (iNOS) I"I
Heme CaM 1 1 N^DPH
NH2- L-Arginine FMN FAD -COOH 1
Ï
:
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Activators of cNOS in vascular Acetylcholine
endothelium ATP
Bradykinin
Calcium inophores
Electrical field stimulation
Excitatory amino acids
Formylated peptides
Histamine
Leukotrienes
Noradrenaline
Phorbol myristate acetate
Platelet activating factor
Thrombin
6 HT
Table 1.3; Some activators of endothelial constitutive nitric oxide synthase 
(cNOS). It should be noted that receptors do exist for all agents in every 
endothelial cell type.
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This NO then diffuses out of the endothelium and into adjacent vascular 
smooth muscle cells where it binds to the haem moiety of soluble guanylate 
cyclase. This causes the activation of soluble guanylate cyclase resulting in an 
increased production of cyclic guanosine monophosphate (cyclic GMP) 
(Ignarro et al., 1987). This in turn, decreases the intracellular calcium 
concentration in the vascular smooth muscle cell, mediated by the activity of 
cyclic GMP-dependent protein kinases (Warner et a!., 1994). This activity of 
cyclic GMP-dependent kinases results in the blockade of intracellular calcium 
release and calcium entry together with stimulation of calcium extrusion via 
calcium pumps, thus leading to relaxation of the smooth muscle (Collins et al., 
1986; Rapoport, 1986; Warner et al., 1994). NO also activates the sodium- 
potassium pump, which leads to transient hyperpolarisation of the vascular 
smooth muscle cell membrane (Archer et al., 1994). This latter mechanism is 
thought to mediate shear stress induced, or flow-dependent, vasodilation. Fig
1.3 shows the production of NO by cNOS in the endothelium and the 
mechanism of vasodilation of the smooth muscle, it also shows the potential 
for production of NO by vascular smooth muscle cells following expression of 
iNOS.
NO automatically regulates blood flow in response to local changes in some 
regions of the vasculature. The actions of NO in ischemia followed by 
reperfusion are complex. In rat brain, for example, occlusion of the middle 
cerebral artery increased cerebral NO levels, but levels subsequently declined 
and increased again upon reoxygenation as measured using a NO-sensitive 
microelectrode (Malinski et al., 1993). NO appears to function in a protective 
role to reduce infarct size and preserve cerebral blood flow (Morikawa et al.,
1992). In contrast, NO has also been implicated in the myocardial injury 
associated with ischemia/reperfusion. Specifically, in anaesthetised pigs, NO 
production was decreased by hypoxia and increased upon reoxygenation
1 5
Agonist
Receptor
Ca/cal0 )+  L-arginine—^  NO L-dtrulline
CNOS
Endothelium
LPS
Cyto
Ok+ L-arginine—^  NO + L-dtrulline 
iNOS ^
(ines
soluble guanylate 
cydase
Smooth muscle
cGMP
Relaxation
Figure 1.3: Schematic diagram illustrating the relaxation of vascular smooth 
muscle via the generation of nitric oxide (NO) by inducible and constitutive 
nitric oxide synthase (i and cNOS, respectively). cNOS: agonists bind to their 
membrane bound receptors on the endothelium causing a transient increase 
in intracellular calcium. Calcium binds to calmodulin and this complex (Ca/cal) 
activates cNOS increasing the production of NO. This NO then diffuses out of 
the endothelium and into adjacent smooth muscle cells where it binds to 
soluble guanylate cyclase. This causes activation of the soluble guanylate 
cyclase, thus increasing cyclic GMP (cGMP) levels leading to relaxation. 
iNOS; lipopolysaccharide (LPS) and cytokines can stimulate the expression of 
iNOS in smooth muscle. Expression of iNOS leads to the production of NO 
which activates soluble guanylate cyclase and in turn leads to relaxation.
g
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(Matheis et a!., 1992). Furthermore, inhibitors of NOS protected against 
reoxygenation-elicited injury, measured as a decrease in contractility and an 
increase in lipid peroxidation (Matheis et al., 1992). In addition, inhibition of 
NOS also appears to limit infarct size in the rabbit heart (Patel et al., 1993),
The release of NO into the vasculature is also controlled by the autonomic 
nervous system. Parasympathetic nerves containing NOS terminate in the 
adventitia of certain large vessels, such as the cerebral and retinal arteries 
(Nozaki et al., 1993). NO is released from the nerves and diffuses Into the 
muscular media from the outside of the vessel, causing vasorelaxation.
Dysfunction of the L-arginine/NO pathway is believed to contribute to many 
vascular pathologies. For example, impaired NO-related, endothelium- 
dependent vasorelaxation has been observed in essential hypertension 
(Panza et al., 1990). Clearly the endothelium is abnormal in patients with 
hypertension because ACh causes less vasodilation in hypertensive than in 
healthy patients (Panza et al., 1990). In contrast, the vascular smooth muscle 
is normal in patients with hypertension because intravenous nitroprusside, 
which releases NO, causes comparable vasodilation in both normal and 
hypertensive patients (Panza et al., 1990). Also, the blood pressure of healthy 
patients increases when NOS inhibitors are infused, but that of patients with 
hypertension increases to a much less degree (Panza et al., 1993).
I
Other diseases where endothelial dysfunction is characteristic are 
atherosclerosis/hypercholesterolaemia (Drexler et al., 1991) and the 
pulmonary arterial hypertension of chronic obstructive lung disease (Dinh- 
Xuan et al., 1991). Scavenging of NO by advanced glycosylation end products 
(Bucala et al., 1991) and oxidised lipoproteins (Chin et al., 1992) may 
contribute to defective vasoregulation in diabetes and atherosclerosis.
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As already mentioned, NO can also be produced within the smooth muscle 
cells themselves following expression of iNOS (Busse & Müisch, 1990) by the 
administration of LPS (Kilbourn et al., 1990b; Thiemermann & Vane, 1990) or 
cytokines (Kilbourn et al., 1990a). Following expression of iNOS large 
quantities of NO are produced for prolonged periods and this may be 
responsible for the hypotension seen in septic shock (Kosaka et al., 1992). 
The effects of septic shock on the cardiovascular system are discussed in 
more depth in the next chapter.
NO can also act on other areas of the cardiovascular system including the 
heart. Here NO exerts negative chronotropic and negative inotropic effects on 
cardiac muscle cells (Brady et al., 1993) by an action similar to its relaxation of 
smooth muscle cells, i.e. activation of cGMP-dependent protein kinase (Méry 
et al., 1991). In addition to production of NO in coronary endothelium, NO has 
been shown to be synthesised by calcium-dependent enzymes in the 
endocardial endothelial cell (Schulz et al., 1990) as well as in the 
cardiomyocyte itself (Schulz et al., 1992).
The NO produced by endothelial cells can diffuse not only towards the vessel 
wall but also into the lumen and thus enter blood platelets. NO acts as an 
endogenous antithrombic via a direct action on blood platelets. This occurs 
through inhibition of platelet aggregation (Radomski et al., 1990a) and 
adhesion (Radomski et al., 1987b). The molecular basis of this action is not 
yet fully established, but possible mechanisms include activation of platelet 
guanylate cyclase (Radomski et al., 1987b), inhibition of platelet 
phospholipase C (Durante et al., 1992), or ADP-ribosylation of platelet 
glyceraldehyde 3-phosphate dehydrogenase (Brune et al., 1990). The anti- 
aggregating actions of NO act in synergy to those of prostacyclin (Radomski et 
al., 1987a).
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NO also inhibits leukocyte adhesion (Kubes et a!., 1991) to the vascular 
endothelium, endothelin production by endothelial cells (Boulanger & Lüscher, 
1990) and smooth muscle proliferation (Nakaki et al., 1990).
Immune effects of NO
NO plays an important role in the host defence mechanism. The large 
amounts of NO produced in the immune system arise from the expression of 
iNOS in macrophages and other cell types. The NO thus produced can kill or 
inhibit the growth of many pathogens, including bacteria (Adams et al., 1991), 
fungi (Alspaugh & Granger, 1991) and parasites (Green et al., 1990; Liew et 
al., 1990). Recent papers suggest NO may also block viral replication (Croen, 
1993; Karupiah et al., 1993) and kill tumour cells (Hibbs et ai, 1988). NO also 
regulates lymphocyte function and may have a role in inhibiting certain 
subsets of T helper cells (Liew et ai, 1991). Lymphocytes and neutrophils also 
synthesize and release NO although its role in the normal function of these 
cells is unknown. NO may, in addition, play a role in auto-immune diseases in 
which NOS maybe inappropriately induced (Weinberg et ai, 1994). These 
cytotoxic and cytostatic actions of NO are mediated by a variety of 
mechanisms but one of the main mechanisms may be via the ability of NO to 
react with the iron containing enzymes, thus leading to inhibition of their 
activity (Lancaster & Hibbs, 1990). NO is known to inhibit adenosine 
triphosphate production at three separate stages, i.e. by blocking glycolysis 
through transferring ADP-ribose to glyceraldehyde-3-phosphate 
dehydrogenase, disrupting the Krebs cycle by binding to the heme group of 
cis-aconitase, and inhibiting oxidative phosphorylation by binding to the heme 
group of ubiquinone reductase (Lepoivre et ai, 1991; Kwon et ai, 1991). 
Furthermore, NO inhibits DNA synthesis by inactivating ribonucleotide 
reductase and can damage DNA directly by deamination (Wink et ai, 1991).
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The mechanisms by which macrophages avoid these toxic effects of NO are 
unknown.
NO also contributes to the inflammatory response (Nussler & Billiar, 1993). 
The associated vasodilatation may be mediated by inflammatory mediators 
stimulating endothelial NOS or by induction of the inducible isoform in 
endothelium, smooth muscle, and inflammatory cells in the vessel wall. The 
NO produced is thought to contribute to local vascular leakage, oedema, 
(Hughes et al., 1990) and cell damage (Palmer et al., 1992).
NO as a neurotransmitter
NO is involved in neurotransmission both peripherally and centrally.
In the peripheral autonomic nervous system NO mediates neurotransmission 
by certain NANC nerves. Early evidence of the involvement of NO came from 
experiments on the rat and mouse anococcygeus and bovine retractor penis 
muscles in which haemoglobin, methylene blue and free radical generators, 
which inhibit the actions of NO (Furchgott & Zawadzki, 1980; Martin et ai, 
1985; Moncada et ai, 1986) were shown to inhibit neurogenic relaxation 
(Bowman et ai, 1982; Bowman et ai, 1986; Gillespie & Sheng, 1990). The 
actions of NO in these tissues, like the actions on vascular smooth muscle 
(Rapoport & Murad, 1983) have been shown to proceed through elevation of 
cyclic GMP (Bowman & Drummond, 1984). The most compelling evidence that 
NO acts as the neurotransmitter is the finding that inhibitors of NOS produce 
inhibition of neurogenic relaxation in the anococcygeus of the mouse and rat 
(Gillespie et ai, 1989; Liu et ai, 1991; Martin et ai, 1993).
NOS has also been found in the myenteric plexus throughout the 
gastrointestinal tract (Young et ai, 1992). Activation of these NOS-containing 
nerves causes gastric relaxation in response to a food bolus as well as
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relaxation of the ileocolonic junction and anal sphincter (Bull et al., 1990; 
Desai et al., 1991). Pelvic plexus neurones also contain NOS and NO is the 
mediator of penile erection (Burnett et al., 1992).
NOS is also found in the central nervous system. In the brain, immunoactive 
NOS has been found in discrete populations in the striatum, hypothalamus, 
posterior pituitary, midbrain, basal forebrain and cerebellum of the rat (Bredt et 
al., 1990). NO is produced in response to stimulation of excitatory amino acid 
receptors and also by action potentials (Garthwaite et al., 1988). Evidence has 
been presented suggesting that it may be a mediator of long-term synaptic 
depression and long-term potentiation, and thus be responsible for learning 
and memory (O'Dell et al., 1991). NOS-containing neurones also innervate the 
adventitia of cerebral blood vessels (Bredt et al., 1990).
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Inhibition of NOS and the actions of NO
The L-arginine/NO system can be influenced at a number of key stages by 
drugs. For example, many compounds are available which can inhibit the 
expression of iNOS, the activity of both cNOS and iNOS or the actions of NO. 
Table 1.4 provides a summary of these agents. The next few sections will 
discuss some of these in more detail.
Inhibition of NOS
The activity of NOS is inhibited by analogues of L-arginine including 
NG-monomethyl-L-arginine (l-NMMA), N^-nitro-L-arginine (i-NOARG), 
N^-nitro-i-arginine methyl ester (l-NAME), N-iminoethyl-i-ornithine (i-NIO) 
and N^-amino-L-arginine (l-NAA). The structure of these analogues is shown 
in fig 1.4. These enantimer-specific analogues competitively Inhibit all types of
fi
class cNOS iNOS
Inhibitors of 
action
Substrate analogues 
of L-arginine
NG-nitro-L-arginine
NG-iminoethyl-L-ornithine
N^-amino-L-arginine
N^-monomethyl-L-arginine
NG-nitro-L-arginine methyl
ester
N^-nitro-L-arginine
NG-iminoethyl-L-ornithine
N^-amino-L-arginine
N^-monomethyl-L-arginine
N^-nitro-L-arginine methyl
ester
Aminoguanidine
L-Canavanine
Flavoprotein
binders
Diphenylene iodonium 
lodonium diphenyl 
Di-2-thienyl iodonium
Diphenylene iodonium 
lodonium diphenyl 
Di-2-thienyl iodonium
Calmodulin binders Calcineurin
Trifluoroperazine
N-(4-aminobutyl)-5-
chloro-2-
napthalenesulfonamide
None described
Inhibitor of 
guanylate cyclase
Methylene blue Methylene blue
Destroys NO Superoxide anion Superoxide anion
Bind NO Haemoglobin 
Carboxy PTIO 
Hydroxocobalamin
Haemoglobin
Heme binder Carbon monoxide 
L-Thiocitrulline
Carbon monoxide 
L-Thiocitrulline
Depleter of 
tetra hydrobio pterin
2,4-Diamino-6-
hydroxypyrimidine
Inhibitors of 
induction
None described Dexamethasone
Cycloheximide
Hydrocortisone
Transforming growth
factor-p-1,-2,3
Platelet derived growth
factor AB cind bb
interleukin-4
Interleukin-10
Macrophage deactivating
factor
Thaliporphine
Table 1.4: Inhibitors of the actions of nitric oxide, of nitric oxide synthase or of 
the expression of inducible nitric oxide synthase.
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0 9 N.N
H3C
l-ARG
l-NMMA
l-NOARG
l-NAME
l-NAA
l-NIO
NH
H NH2
Figure 1.4: Structure of L-arginine (l-ARG) and N^-substituted analogues of 
L-arginine, N^-monomethyl-L-arginine (l-NMMA), NG-nitro-L-arginine 
(l-NOARG), NG-nitro-L-arginine methyl ester (l-NAME), NG« umino-L-arginine 
methyl ester (l-NAA), and NG-iminoethyl-L-ornithine (l-NIO).
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NOS. The inhibition can be reversed by L-arginine but the potency of these 
inhibitors differs between the isotypes. Against endothelial cell cNOS, l-NAME 
and l-NOARG are more potent than l-NIO and l-NMMA (Gross et al., 1990; 
Moore et al., 1990; Rees et al., 1990b), whereas against macrophage iNOS, 
l-NMMA and l-NAA are more potent than L-NOARG, with l-NAME having little 
effect (Gross et al., 1990; McCall et al., 1991).
There is also a difference in the ability of L-NMMA to block the basal and 
agonist-induced production of NO in rat aortic rings (Frew et al., 1993a; Frew 
et al., 1993b). Specifically, l-NMMA can augment phenylephrine induced tone 
in a similar manner to other NOS inhibitors, i.e. l-NOARG, but it does not 
inhibit ACh- or ATP-induced relaxations. In fact, it inhibits the ability of 
l-NOARG to block these relaxations to ACh (Frew et al., 1993a; Frew et al., 
1993b). Similarly in the bovine retractor penis muscle, l-NMMA protects 
nitrergic relaxation against the inhibitory actions of l-NOARG (Martin et al.,
1993). These actions of l-NMMA may be explained by the finding that 
L-NMMA can act as an alternative substrate for NOS, thus leading to 
enhanced production of NO (Olken & Marietta, 1993). This proposal is 
supported by recent experiments involving chemiluminescence detection 
showing that l-NMMA, but not L-NOARG, enhances NO production by rat 
aorta and pulmonary artery (Archer & HampI, 1992).
Some inhibitors appear to show some degree of selectivity for iNOS, including 
aminoguanidine, guanidines and L-canavanine (Stuehr et al., 1991b; Hasan et 
al., 1993; Misko et al., 1993). Aminoguanidine is equipotent to l-NMMA as an 
inhibitor of iNOS but is 10 to 100-fold less potent as an inhibitor of cNOS 
(Hasan et al., 1993; Misko et al., 1993). The amount of aminoguanidine 
required to increase blood pressure is 10 - 40 times greater than that of 
l-NMMA (Hasan et al., 1993). L-canavanine also inhibits iNOS more
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other compounds which bind NO include carboxy PTIO and 
hydroxocobalamin. Carboxy-PTIO has been shown to inhibit exogenous NO- 
and agonist-induced (ACh and ATP) relaxation of rat aortic rings (Rand & Li, 
1995). Similarly, hydroxocobalamin also inhibits exogenous NO- and agonist- 
induced (ACh) relaxation of rat aortic rings (Rajanayagam et a/., 1993).
Inhibition of guanylate cvclase
Inhibition of the effects of NO can be produced by inhibiting soluble guanylate 
cyclase, the second messenger system which leads to relaxation of smooth 
muscle cells (Rapoport & Murad, 1983). Methylene blue has been reported to 
inhibit guanylate cyclase by oxidising the haem moiety of soluble guanylate 
cyclase (Martin et al., 1985). There is, however, controversy as to the precise 
mechanism of action of methylene blue. Some recent studies now suggest 
that it may act additionally to inhibit NOS by oxidation of the haem moiety on
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selectively than cNOS, being 30% less effective than l-NMMA on cNOS 
(Misko et al., 1993).
Binding of NO
The actions of NO itself can be blocked by the use of haemoglobin which 
binds NO with high affinity and thus inactivates it (Gibson & Roughton, 1957). 
Haemoglobin is effective at inhibiting NO produced by cNOS, i.e. inhibits ACh 
induced relaxation in rabbit aortic rings (Martin et al., 1985). Haemoglobin also 
inhibits glyceryl trinitiHte, which induces relaxation by releasing NO (Harrison & 
Bates, 1993), suggesting that the inhibition occurs once NO has been 
released (Martin et al., 1985). The actions of NO produced by iNOS are also 
inhibited, i.e. haemoglobin inhibits interleukin-1  (IL-1 ) induced increases in 
cyclic GMP in rat vascular smooth muscle cells (Beasley et al., 1991).
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the enzyme (Marczin et al., 1992), or via an interaction with molecular oxygen 
to generate superoxide anion (McCord & Fridovich, 1970; Keaney et al.,
1994), which then inactivates NO (Gryglewski et al., 1986).
Interactions between NO and superoxide anion
The interactions between NO and superoxide anion represent an important 
mechanism of inactivation of NO (Gryglewski et al., 1986). Superoxide anion 
reacts with NO to form peroxinitrite, a powerful cytotoxic oxidant by the 
following reaction;
NO* + *0%" 0 N 0 0 “
Peroxynitrite itself is unstable and spontaneously rearranges to form nitrate: 
ONOO" ^  NO3"
Destruction of NO leads to the loss of vasodilation as shown by cascade 
bioassay (Gryglewski et al., 1986; Rubanyi & Vanhoutte, 1986; Moncada et 
al., 1986). The ability of superoxide anion to inhibit basal and agonist-induced 
activity of NO, however, differs in rat aortic rings. Basal activity of NO is more 
sensitive to destruction by superoxide anion than agonist-induced activity 
(Mian & Martin, 1995). Superoxide anion can be formed spontaneously by 
tissues and may play a role in the vascular damage associated with 
ischaemia-reperfusion and other pathologies (Downey, 1990).
The destruction of NO by superoxide anion can be examined by adding a 
number of different compounds which are capable of generating the free 
radical. These systems include pyrogallol (Moncada et al., 1986), which 
autoxidises leading to formation of the radical (Marklund & Marklund, 1974).
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other quinone compounds such as LY 83583 (Müisch et al., 1988; Müisch et 
al., 1989) also generate superoxide anion but only in the presence of strong 
reducing enzymes (Müisch et al., 1988; Müisch et al., 1989). Superoxide anion 
is probably generated from the reaction of a 1 electron reduced form of LY 
83583, probably the semiquinone radical, with molecular oxygen (Müisch et 
al., 1988; Müisch et al., 1989), as described for other quinone compounds 
(Hassan & Fridovich, 1979). LY 83583 can produce superoxide both 
intracellularly and extracellularly.
The enzyme system hypoxanthine/xanthine oxidase is also commonly used to 
generate superoxide anion (McCord & Fridovich, 1968). The production of 
superoxide anion by this enzyme system generates the radical only 
extracellularly. This reaction involves xanthine oxidase acting on hypoxanthine 
to produce xanthine and superoxide anion. The product, xanthine, is itself 
metabolised generating further superoxide anion.
All of these superoxide anion generating systems have been shown to destroy 
EDRF activity in cascade bioassay systems (Gryglewski et al., 1986; Downey,
1990) and in isolated vascular preparations (Gosentino et al., 1994; Müisch et 
al., 1988; Katusic & Vanhoutte, 1989; Ohistein & Nichols, 1989; Mian & Martin,
1995). In this study we will examine two superoxide generating systems, LY 
83583 and hypoxanthine/xanthine oxidase.
Superoxide anion itself is destroyed by superoxide dismutase (SOD) to form 
hydrogen peroxide by the following reaction:
Hydrogen peroxide itself is highly toxic to cells and results in impairment of 
EDRF-dependent relaxation of rabbit aortic rings (Dowell et al., 1993). 
Hydrogen peroxide is destroyed by catalase by the following reaction:
Catalase
2 H 2 O 2  ----------^  2 H 2 O  +  O 2
As already stated, superoxide anion is itself destroyed by superoxide 
dismutase. The effects of destroying superoxide anion can be studied by 
adding exogenous superoxide dismutase but this Is a large enzyme which will 
only be effective extracellularly. The role of endogenous superoxide dismutase 
can be examined by using inhibitors of this enzyme which include 
diethyldithiocarbamate (Heikkila et al., 1976; Mian & Martin, 1995). 
Diethyldithiocarbamate is a powerful copper chelator which irreversibly binds 
and inactivates the copper/zinc-containing but not the manganese-containing 
isoforms of superoxide dismutase (Heikkila et al., 1976).
Inhibitors of expression of INOS
The expression of iNOS stimulated by LPS in macrophages can be inhibited 
by steroids such as dexamethasone and hydrocortisone but not progesterone 
(Di Rosa et al., 1990). Similarly, expression of iNOS by LPS in the lung, liver 
and aorta of rats was inhibited by dexamethasone and hydrocortisone 
(Knowles et al., 1990b; Rees et al., 1990a). This inhibition prevents the de 
novo synthesis of proteins probably at the level of transcription of mRNA 
(Baydoun et al., 1993). Cycloheximide also inhibits the expression of iNOS by 
LPS in macrophages (Rees et al., 1990a; Baydoun et al., 1993) by its ability to 
inhibit protein synthesis. These inhibitors have no effect on cNOS (Knowles et 
al., 1990a) and do not affect the activity of iNOS once expressed (Di Rosa et 
al., 1990).
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Thaliporphine, an aporphine derivative, also inhibits the expression of iNOS 
stimulated by LPS in macrophages (Yu, 1994), but has no effect on cNOS (Yu,
1994).
None of the above inhibitors directly block the activity of iNOS or cNOS. 
Inhibition of tetrahvdrobiopterin
As already stated, tetrahydrobiopterin is a cofactor in the production of NO 
from L-arginine (Müisch & Busse, 1991; Schmidt et ai, 1992). Consequently,
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The expression of iNOS in rat smooth muscle cells can also be inhibited by 
certain growth factors such as transforming growth factor-(31 and platelet 
derived growth factorAB and bb (Junquero et ai, 1992; Schini et ai, 1992; 
Scott-Burden et ai, 1993). Transforming growth factor-(31 has also been 
shown to inhibit expression of iNOS in murine macrophages (Chesrown et ai, 
1994). Furthermore, inhibition of the expression of iNOS by retinoids {aW-trans- 
retinoic acid and its active analogues) may be mediated by induction of 
transforming growth factor-(31 (Hirokawa et ai, 1994b). These agents act by 
preventing the induction of iNOS mRNA (Perrella et ai, 1994). Transforming 
growth factor-(31 and platelet derived growth factorAs and bb are present in 
serum, and thus the presence of serum in the tissue culture medium may 
inhibit the expression of iNOS in smooth muscle cells grown in culture.
Certain cytokines can also inhibit the expression of iNOS in murine 
macrophages and these include interleukin-4 and interleukin-10 (Oswald et ai, 
1992; Liew et ai, 1991; Chesrown et ai, 1994). However, there is now 
controversy over the actions of interleukin-1 0 , as recent findings indicate that 
in combination with IFN-y it produces a dramatic augmentation in mRNA levels 
for iNOS (Chesrown et ai, 1994).
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Calmodulin is required as an additional cofactor for cNOS (Forstermann et al., 
1991; Pollock et al., 1991; Schmidt et al., 1991). This accounts for the ability of
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inhibiting the synthesis of tetrahydrobiopterin would be expected to inhibit the 
synthesis of NO. Furthermore, enhanced de novo synthesis of 
tetrahydrobiopterin has been reported to occur concomitantly with expression 
of iNOS in smooth muscle (Hattori & Gross, 1993). The rate-limiting enzyme in 
the synthesis of tetrahydrobiopterin, GTP-cyclohydroIase I, can be inhibited by 
2,5-diamino-G-hydroxypyrimidine (Schmidt et al., 1992; Sakai et al., 1992; 
Schoedon et al., 1993), leading to reduced production of NO by iNOS in 
murine macrophages (Bogdan et al., 1995).
Haem binders
L-Thiocitrulline binds to the haem of NOS and thus prevents L-arginine binding 
and the production of NO (Frey et al., 1994). Carbon monoxide also binds to 
haem and can prevent L-arginine binding. However, carbon monoxide can also 
bind to the haem of soluble guanylate cyclase, leading to activation of the 
enzyme, and smooth muscle relaxation which is NO-independent (Furchgott & 
Jothianandan, 1991).
Flavoprotein binders
As already stated, FMN and FAD are essentia! cofactors for NOS (Stuehr et 
al., 1991a). Inhibitors of flavop rote ins would thus be expected to block the 
actions of NOS. Diphenyfeneiodonium, di-2-thienyl iodonium and iodonium 
diphenyl have been shown to inhibit the actions of cNOS in endothelial cells 
and INOS in macrophages (Stuehr et al., 1991b).
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Calmodulin inhibitors ^ _
the calmodulin antagonists, calmidazolium and trifluoperazine, and the 
calmodulin binding protein calcineurin to inhibit NO formation in bovine aortic 
endothelial cells (Forstermann et al., 1991). Since in iNOS calmodulin is tightly 
bound, these inhibitors have no effect (Cho et al., 1992).
■|
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Endotoxic Shock
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Sepsis and its associated syndromes (table 2.1) represent a potentially 
devastating systemic inflammatory response estimated to occur in 1 % of 
hospitalised patients, 10 - 2 0 % of whom die. Mortality approaches 60 - 90% in 
those who develop septic shock, a figure which has changed little since 
intensive care was first developed (Hess et al., 1981). Septic shock has 
traditionally been recognised as a consequence of Gram-negative 
bacteraemia, but it may also be caused by Gram-positive organisms, fungi and 
possibly viruses and parasites (Bone et al., 1987; Ispahani et al., 1987;
Calandra et al., 1988; Glauser et al., 1991). The mortality of septic shock does 
not depend on the type of organism responsible (Bone et al., 1987; Ispahani et 
al., 1987; Calandra et al., 1988 & Glauser et al., 1991).
UooDolvsaccharide (LPS)
The prime initiator of Gram-negative bacterial septic shock is endotoxin, a 
lipopolysaccharide (LPS) component of the bacterial outer membrane. The 
structure of LPS is shown in fig 2.1. The outermost part of the endotoxin 
molecule consists of a series of oligosaccharides that are structurally and
antigenically diverse. The internal part of the endotoxin molecule is the core 
oligosaccharides, and these are structurally rather similar in common Gram- 
negative bacteria. To the core oligosaccharide is bound a lipid component, 
lipid A. The structure of lipid A is highly conserved, and it is lipid A that is 
responsible for most of the toxicity of endotoxin (Glauser et al., 1991;
Rietschel et al., 1993).
Disease state
Septic shock is predominantly responsible for circulatory failure which is
.characterised by severe hypotension, hyporeactivity to endogenous and
I,
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1 Sepsis __ __________________________________________ __
The systemic response to infection'
Includes two or more of the following 
Temperature > 38°C or < 36*C 
Heart Rate > 90 beats/m in
Respiratory rate > 20 breaths/m in or PaCOg < 4.3 kPa
Leucocyte count > 1 2 0 0 0 /mm^ < 4000/mm^, or > 10% band (Immature)
forms
2 Sepsis syndrome
'Sepsis with evidence of altered organ perfusion'
Altered organ perfusion includes one or more of the following 
PaO2/FiO^ 2 8 0  (without other cardiopulmonary disease) 
Elevated lactate level (> upper limit of normal for the laboratory) 
Oliguria < 0.5 ml/kg body weight _________
3 Systemic inflammatory response syndrome
'The response to a variety of severe clinical insults (not necessarily 
infection), which is indistinguishable from se p s is '_____________
4 Septic shock
'Sepsis with hypotension (sustained decrease in systolic blood pressure < 
90 mmHg, or drop > 40 mmHg, for at least 1 h) despite adequate fluid 
resuscitation, in the presence of perfusion abnormalities that may include, 
but not be limited to lactic acidosis, oliguria or an acute alteration in mental 
status.' Patients who are on inotropic or vasopressor agents may not be 
hypotensive at the time perfusion abnormalities are measured. ______
Table 2.1: Definitive descriptions of sepsis and septic shock. Descriptions are 
from Bone et al. (1992) except that for sepsis syndrome, which is adapted 
from Bone (1991). Table is adapted from Curzen et al. (1994). Abbreviations: 
Pa0 2 , Arterial partial pressure of oxygen; PaC0 2 , Arterial partial pressure of 
carbon dioxide; Fi0 2 , fraction of inspired oxygen.
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polysaccharide iipid
Figure 2.1: Diagramatic representation of the structure of endotoxin 
(lipopolysaccharide). represents monosaccharide, P represents
phosphate, Et represents ethanolamine and —  represents long chain 
(hydroxyl) fatty acid. Modification of a diagram by Glauser et al. (1991).
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exogenous vasoconstrictor agents, myocardial dysfunction, maldistr ibution of 
organ blood flow, and reduced tissue oxygen extraction, which ultimately lead 
to multiple organ failure and death (Thiemermann, 1994). Septic shock affects 
other systems in addition to the circulation, and these are listed in table 2 .2 .
Hypotension
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It has been suggested that the circulatory failure may occur due to the 
hyperproduction of the potent endogenous vasodilator nitric oxide (NO). LPS 
and cytokines, as already stated, can induce the expression of inducible nitric 
oxide synthase (iNOS) in a variety of cell types and thus increase the 
production of NO. The role of NO in circulatory failure is discussed in the next 
few sections.
Septic shock, induced by LPS in mice and rats, is associated with an 
increased production of NO assessed as an increase in nitrosylated 
haemoglobin measured by electron paramagnetic resonance (EPR; Kosaka et 
al., 1992). This increased production of NO contributes to the hypotension 
caused by endotoxin in the anaesthetised rat as it is reversed by intravenous 
infusion of the NOS inhibitor N^-monomethyi-L-arginine (l-NMMA) 
(Thiemermann & Vane, 1990). Similarly, in the anaesthetised dog infusion of 
LPS causes a decrease in peripheral vascular resistance and a fall in mean 
arterial blood pressure, i.e. hypotension, which is reversed by l-NMMA 
(Kilbourn et al., 1990b). The finding that the increase in blood pressure caused 
by l-NMMA in dogs with the early stages of endotoxic shock is significantly 
greater than that elicited in control animals (Kilbourn et al., 1990b; Klabunde & 
Ritger, 1991) supports the view that even brief periods of endotoxemia are 
associated with an enhanced formation of NO.
Central nervous 
system
Encephalopathy
Agitation
Gastrointestinal Cholestatic jaundice
Gastric erosions in 100% (gross bleeding rare)
Blood Early neutropenia, then neutrophilia 
disseminated intravascular coagulation, 
especially with Gram-negative bacteremia 
Thrombocytopenia in 50%
Renal Proteinuria
Focal proliferative glomerulonephritis 
Acute tubular necrosis
Metabolic Hyper-, hypoglycemia 
Skeletal muscle proteolysis 
Hypertriglyceridemia 
Lactic acidosis
Pulmonary Respiratory alkalosis
Respiratory muscle fatigue/failure (terminal)
Table 2.2: Non-cardiovascular effects of septic shock. Table adapted from Dal 
Nogane (1991).
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Continuous infusion of endotoxin for 24 h in anaesthetised Marino ewes 
resulted in a hyperdynamic model of circulatory shock characterised by 
reduced peripheral resistance, increased cardiac output, and increased 
pulmonary vascular resistance (Meyer et al., 1992). Intravenous administration 
of the NOS inhibitor, N^-nitro-L-arginine methyl ester (L-NAME), 24 h after 
commencing the endotoxin infusion, completely restored these alterations in 
peripheral resistance, cardiac output and blood-flow distribution in pulmonary 
vasculature (Meyer et al., 1992). In rats, L-NMMA inhibited the increase in 
plasma levels of both nitrite and nitrate, the stable products of NO (Wennmalm 
et al., 1992; Ignarro et al., 1993), prevented the fall in blood pressure and 
improved the survival rate associated with LPS administration (Nava et al., 
1992). Furthermore, in a murine model of advanced sepsis caused by 
intraperitonea! application of live Escherichia coll bacteria, L-NMMA dose- 
dependently improved the survival rate when co-administered with a 
conventional antibiotic treatment, imipenem-cilastatin (Teale & Atkinson, 
1992). Imipenem is a beta-lactam antibiotic which can be metabolised and 
partially inactivated in the kidney and is therefore administered in combination 
with cilastatin, a specific enzyme inhibitor, which blocks its renal metabolism. 
Thus, taken together, these studies indicate a crucial role for overproduction of 
NO in septic shock.
Although these findings support the view that inhibition of NOS with l-NMMA 
exerts beneficial hemodynamic effects and improves survival in endotoxic 
shock in various species, there is also convincing evidence that at higher 
doses NOS inhibitors exacerbate the circulatory failure caused by endotoxin. 
For instance, in anaesthetised rabbits subjected to endotoxemia for 3 h, 
intravenous bolus injection of a high dose of l-NMMA resulted in severe 
hypotension, intense vasoconstriction, and increased mortality (Wright et al.,
1992). Similarly, in a canine model of endotoxic shock, l-NMMA increased 
systemic vascular resistance, but significantly decreased cardiac output
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(Klabunde & Ritger, 1991). The detrimental hemodynamic effects of high-dose 
l-NMMA in rabbits (Wright et al., 1992) and rats (Nava et al., 1992) with 
endotoxic shock are prevented by co-administration of the NO donor 
S-nitroso-N-acetylpenicillamine suggesting that the formation of NO by the 
endothelium is important for the maintenance of organ blood flow and 
ultimately tissue viability. Thus, although inhibition of NO production from iNOS 
is vital to prevent the hypotension of septic shock, inhibition of endothelial 
cNOS must not be allowed to occur.
I
Selective inhibitors of iNOS, having little or no effect on cNOS, would be 
advantageous in treating septic shock. Such inhibitors include aminoguanidine 
and L-canavanine (Stuehr et al., 1991b; Hasan et al., 1993; Misko et al., 1993) 
but these have still to be evaluated in animal models of septic shock.
Administration of dexamethasone, an inhibitor of the expression of iNOS, prior 
to LPS, prevents the expected decrease in blood pressure, again suggesting 
the hypotension is a result of increased production of NO (Nava et al., 1992;
Hom et al., 1995).
There is increasing evidence that septic shock in man is associated with 
enhanced formation of NO. The relationship between plasma levels of nitrate, 
the major metabolite of NO (Wennmalm et ai, 1992; Ignarro et al., 1993), and 
the observed hemodynamic alterations were recently investigated in 39 
critically ill trauma and septic patients (Ochoa et al., 1992). These findings 
indicated a good correlation between the levels of nitrate and the severity of 
symptoms. Two case studies have now examined the beneficial effects of 
inhibition of NOS in patients with septic shock. In the first study, two patients 
with septic shock received l-NMMA or l-NAME (Petros et al., 1991). Both 
patients had severe hypotension, which was resistant to conventional therapy.
Injection of l-NMMA caused a dose-dependent increase in blood pressure and %
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peripheral vascular resistance. In the second study, a randomised double blind 
placebo-controlled investigation of 12 patients with septic shock, l-NMMA 
caused an increase in vascular tone and increased blood pressure but it also 
caused a fall in cardiac output (Petros et ai, 1994). Thus, NO appears to be 
an important mediator in septic shock, but more studies are required to 
examine the effects of NOS inhibitors on cardiac output, morbidity and 
mortality.
It is not only LPS that can be used experimentally to mimic clinical septic 
shock. Agents known to stimulate the expression of INOS, including cytokines 
such as interferon-y (IFN-y), tumour necrosis factor-a (TNF-a) and interleukins- 
1 and -2 (lL-1, IL-2), have been shown to induce shock-like symptoms in 
experimental animals (Kilbourn et ai, 1990a; Gray et ai, 1991; Hibbs et ai, 
1992; Ochoa et ai, 1992; Szabô et ai, 1993c). Similarly, these septic shock­
like symptoms can be reversed by treatment with NOS inhibitors, l-NMMA or 
l-NAME (Kilbourn et ai, 1990a; Gray et ai, 1991),
Vascular hvooreactivitv to vasoconstrictor agents
1987), histamine and potassium chloride (Wakabayashi et ai, 1987). The 
finding that inhibition of NOS with L-NMMA reverses the depression of the 
pressor effects of noradrenaline observed in rats with endotoxic shock
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It is well documented that the peripheral vascular failure associated with septic 
shock in animals (Parratt, 1973) and man (Teale & Atkinson, 1992) is also 
associated with a reduction of the pressor response caused by vasoconstrictor 
agents, ultimately resulting in therapy-resistant hypotension and multiple organ 
failure. Similarly, isolated vascular rings either treated with LPS or obtained 
from animals subjected to prolonged periods of endotoxemia show a reduced 
contractile response to noradrenaline (Parratt, 1973), vasopressin (Schaller et
ai, 1985), angiotensin II (Schaller et ai, 1985), serotonin (Wakabayashi et ai.
suggests that an enhanced formation of NO accounts for this vascular 
hyporeactivity (Gray et al., 1991; Julou-Schaeffer et al., 1990). There is now 
increasing evidence that excessive formation of NO by vascular smooth 
muscle cells exposed to LPS for several hours (3 - 24) accounts for the 
vascular hyporeactivity to vasoconstrictor agents (Fleming et al., 1990; Rees 
et al., 1990a).
In addition to conductance and resistance vessels, endotoxin also induces 
NOS in various venous vessels in vitro (Parratt, 1973). This NOS induction 
contributes to the hyporeactivity to vasoconstrictor agents demonstrated in the 
jugular vein from rabbits treated with endotoxin (Vallance et ai, 1992). Thus, it 
Is conceivable that enhanced formation of NO in the venous circulation 
contributes to the development of venous pooling and reduced venous return 
associated with endotoxemia. Although the pressor responses elicited by 
systemic application of various vasoconstrictor agents are reduced in animal 
models of septic shock, induction of NOS does not necessarily result in 
vascular hyporeactivity in all vascular beds. For instance, NOS induction in the 
heart is associated with a NO-mediated vascular hyporeactivity to the 
thromboxane analogue U46619 (Smith et ai, 1991). In contrast, the 
vasoconstrictor effects caused by U46619 in the mesenteric artery and vein 
are not diminished despite induction of NOS and this may be due to an 
increased sensitivity of the receptors (Mitchell et ai, 1993).
■
il;Endotoxemia for 3 - 24 h in anaesthetised rats resulted in the induction of a 
calcium-independent NOS isoform in various organs including lung, spleen, 
mesentery, liver, kidney, heart and aorta (Knowles et ai, 1990b; Salter et ai,
1991). The increase in a calcium-independent NOS activity after a single 
injection of endotoxin is maximal within approximately 6  h and returns to 
baseline within 24 h (Knowles et ai, 1990b; Salter et ai, 1991). Moreover, 
endotoxin and certain cytokines induce the de novo biosynthesis of a calcium-
%
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independent NOS in endothelium-denuded segments of rabbit (Busse & 
Müisch, 1990) and rat aorta (Rees et a/., 1990a), and this effect is prevented 
by dexamethasone (Rees et al., 1990a) and by inhibition of protein 
biosynthesis with cycloheximide (Busse & Müisch, 1990; Rees et al., 1990a). 
These findings suggest that enhanced formation of NO by iNOS accounts for 
both the hypotension and vascular hyporeactivity to vasoconstrictor agents 
elicited by endotoxin, indeed, pre-treatment of rabbits (Wright et al., 1992) and 
rats (Szabô et al., 1993b) with dexamethasone prevents the hypotension 
(rabbit and rat) and attenuation of the pressor response to noradrenaline (rat) 
caused by prolonged periods of endotoxemia. However, enhanced formation 
of NO also accounts for the hypotension and vascular hyporeactivity observed 
after brief periods of endotoxemia (60 min) in anaesthetised rats, where 
expression of iNOS had not yet occurred (Julou-Schaeffer et al., 1990). Thus, 
both activation of endothelial cNOS (early phase) and expression of INOS 
(delayed phase) contribute to enhanced formation of NO in endotoxemia. The 
mechanism by which endotoxin activates the cNOS is not well characterised. It 
is possible that endotoxin may stimulate the release of autacoids, including 
bradykinin and platelet-activating factor, which in turn may activate cNOS in 
the endothelium (Fleming et al., 1992).
Agents known to stimulate expression of iNOS including cytokines such as 
IFN-y, TNF-a, IL-1p and IL-2 also cause depression of the contractile effects of 
noradrenaline and phenylephrine (Busse & Müisch, 1990; Alonso et al., 1993). 
The NOS inhibitors l-NAME and l-NMMA reverse this depression (Busse & 
Müisch, 1990; Alonso et al., 1993), confirming that it results from enhanced 
formation of NO.
The smooth muscle layer has been reported to be the major site at which 
iNOS is expressed in the vascular wall (Knowles et al., 1990a), and indeed, 
expression of iNOS can be stimulated in vascular smooth muscle cells in
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Myocardial dysfunction
4 3
culture following treatment with 1L-1(3, TNF-a, IFN-y or a combination of IFN-y 
and LPS (Busse & Müisch, 1990; Beasley et al., 1991; Kanno et al., 1993; 
Koide et al., 1994). Although LPS alone has been reported to stimulate the 
expression of iNOS in rat aortic smooth muscle cells in culture (Marczin et al., 
1993; Szabô et al., 1993a), this is disputed by Sirsjô et al. (1994), who 
suggested that the additional presence of a cytokine was required.
Prolonged periods of circulatory shock are associated with a reduction in 
cardiac contractility and, hence, cardiac output. In rats, prolonged periods of 
endotoxemia are associated with time-dependent induction (minimum: 6 h) of 
calcium-independent NOS activity in cytosolic preparations of the myocardium 
(Schulz et al., 1992). NOS induction also occurs in rat cardiac myocytes 
treated with TNF-a or 1L-1(3 (Schulz et al., 1992). The negative inotropic effect 
caused by TNF-a, IL-ip or IL- 6  in isolated papillary muscle of the hamster is 
reversed by L-NMMA, suggesting that the reduction in myocardial contractility 
caused by these cytokines is mediated by NO (Finkel et al., 1992). Moreover, 
porcine ventricular endocardial cells express a calcium-independent NOS
I
activity when treated with endotoxin, TNF-a or IL-1 (Smith et al., 1993). 
Isolated cardiac myocytes obtained from endotoxin-treated guinea pigs exhibit 
a significant reduction in the contractile response elicited by electrical 
stimulation. This depressed cardiac contractility is due to enhanced formation 
of NO by iNOS for it is prevented by pre-treatment of the animals with 
dexamethasone or reversed by l-NMMA or l-NAME in vitro (Brady et al.,
1992). Expression of iNOS in ventricular myocytes also attenuates the positive 
inotropic effects elicited by isoprenaline (Balligand et a!., 1993). Thus, 
enhanced formation of NO by iNOS may contribute to the myocardial 
dysfunction associated with endotoxemia. However, an improvement of
cardiac performance by NOS inhibitors in animal models of endotoxemia has 
yet to be documented.
Dysfunction of the endothelium
Although enhanced formation of NO by either cNOS (early phase of 
endotoxemia) or iNOS (after several h of endotoxemia) is well documented, it 
should be noted that prolonged periods of endotoxemia also result in an 
inhibition of the NO-mediated vasodilator effects elicited by endothelium- 
dependent vasodilators. Isolated vessels, including mesenteric, femoral and 
renal artery as well as the thoracic aorta obtained from animals subjected to 
prolonged periods of endotoxemia, exhibit reduced responses to endothelium- 
dependent vasodilators ex vivo (Julou-Schaeffer et al., 1990; Parker & Adams,
1993). Interestingly, the degree of inhibition of this receptor-mediated release 
of NO from the endothelium is largely dependent on the vascular preparation 
(Li et al., 1992). Specifically, the relaxation produced by acetylcholine (ACh) is 
unaltered in the ear artery but attenuated in the perfused kidney (Li et al.,
1992). Similarly, inhibition of the responses to endothelium-dependent 
vasodilators occurs in various vessels (middle cerebral artery, renal artery, 
thoracic aorta) of animals with haemorrhagic shock (Wang et al., 1993; Wang 
et al., 1994). This inhibition is already significant in the early phases of 
haemorrhagic shock, persists despite resuscitation with fluids (Wang et al.,
1993), and is prevented with heparin (Wang et a!., 1994).
The mechanism of this inhibition of NO release from the endothelium of 
animals with either endotoxic or haemorrhagic shock is not fully characterised, 
but may involve: (i) inactivation of NO by oxygen-derived free radicals 
produced, for example by activated neutrophils (Csaki et al., 1991); (ii) down- 
regulation of cNOS in the endothelium by TNF-a or other cytokines released 
by endotoxin (Yoshizumi et al., 1993); or (iii) endothelial cell damage due to
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Ithe cytotoxic effects of NO itself. Indeed, activation of endothelial cells with 
cytokines or endotoxin results in endothelial cell death, which can be 
prevented by l-NMMA or dexamethasone (Estrada et al., 1992; Palmer et al.,
1992). These findings suggest that the formation of large quantities of NO 
following iNOS expression in endothelial cells exerts a cytotoxic effect on the 
endothelium. Moreover, NO irreversibly inhibits the activity of a number of 
enzymes, including cNOS (Mitchell et al., 1991) and iNOS (Assruey et al.,
1993). However, the relative importance of this 'autoinhibition' of cNOS or 
iNOS in endotoxemia is not clear.
Our study
in this study we wished to examine the factors controlling expression of iNOS 
in the vascular smooth muscle cells of rat aorta. We used a similar technique 
to Rees et al. (1990a) where endothelium-denuded rings of rat aorta were 
incubated overnight (18 h) at 37°C in Krebs solution with and without the 
addition of endotoxin. The expression of iNOS was assessed indirectly by 
examining the depression of phenylephrine (PE)-induced contractions. To 
examine whether depression of contraction resulted from production of NO by 
iNOS we examined the effects of the inhibitor of NOS, l-NAME (Rees et a!., 
1990b), and the inhibitor of the expression of iNOS, dexamethasone (Rees et 
al., 1990a). We also examined the effects of the scavenger of LPS, polymixin 
B, to determine if the depression of PE-induced contraction obtained in the 
absence of added endotoxin resulted from contamination of the Krebs by 
endotoxin. The effects of drugs that interfere with NO activity were also 
examined to determine if the depression of contraction was indeed due to this 
mediator; these included haemoglobin which binds and inactivates NO 
(Gibson & Roughton, 1957; Martin et al., 1985) and the superoxide anion 
generators, LY 83583 (Müisch et al., 1988; Müisch et al., 1989) and the 
xanthine/xanthine oxidase system (McCord & Fridovich, 1968).
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The induction process was also examined by using antibodies to certain 
cytokines in order to establish if LPS had a direct effect on the vascular 
smooth muscle or whether it acted on other cell types in the vessel wall, such
as macrophages, releasing cytokines which then stimulated expression of 
iNOS in the vascular smooth muscle cells. The actions of pentoxifylline which 
inhibits transcription of mRNA for TNF-a (Strieter et ai, 1988; Han et ai, 1990;
Doherty et ai, 1991) were also examined.
ïl
A second part of the study was an examination of the processes involved in 
the expression of iNOS in rat cultured aortic vascular smooth muscle cells 
(RASMC). Here, iNOS expression was measured as a function of the
accumulation of nitrite, the major in vitro breakdown product of NO
(Wennmalm et ai, 1992; Ignarro et ai, 1993). The ability of LPS and cytokines 
(IFN-y and IL-1 a) to stimulate expression of iNOS were examined and 
compared with their activities on aortic rings.
Some experiments were also conducted on bovine aortic endothelial cells
(BAEC) and on J774.2 murine macrophages in culture to examine the
processes regulating expression of iNOS in these cell types.
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C h a p te r  3
Nitric Oxide 
Detection Systems
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sMeasurement of nitric oxide (NO) in biological samples is difficult both 
because of the small amounts present and its short half-life of 3 - 50 s (McCall 
& Vallance, 1992). The presence of NO in biological systems is usually 
inferred on the basis of one of its physiological effects, such as the relaxation 
of blood vessels, activation of guanylate cyclase activity, increased cyclic GMP 
concentration, production of L-citrulline or inhibition of platelet aggregation. 
Also, inhibitors of NO such as analogues of L-arginine or molecules which bind 
and inactivate NO such as haemoglobin, have been used to estimate NO 
production. Only the cyclic GMP or L-citrulline concentration can be used to 
obtain quantitative information relating to the amount of NO produced, but 
even these results may be misleading. The currently used instrumental 
techniques for NO detection are the chemiluminescence reaction with acid 
reflux (Palmer et al., 1987; Myers et al., 1990) or without acid reflux (Myers et 
al., 1989), spectrophotometric assay involving the diazotization of sulfaniiic 
acid (Green et al., 1982; Ignarro et al., 1987; Schmidt et al., 1988; Tracey et 
al., 1990), electron paramagnetic resonance (EPR) with nitroso or 
haemoglobin traps (Arroyo & Kohno, 1991), and spectrophotometric 
measurement of the conversion of oxyhaemoglobin to methaemoglobin 
(Ignarro et al., 1987; Kelm et al., 1988; Kelm & Schrader, 1988). Other 
detection systems include mass spectrometry (Gustafsson et a!., 1991), gas 
chromatography (Pai et al., 1987), NO-sensitive electrodes (Shibuki, 1990; 
Malinski & Taha, 1992) and a fluorometric assay (Damiani & Burini, 1986; 
Misko et ai, 1993).
Relaxation of tissues
Relaxation of blood vessels occurs in the presence of NO as described earlier 
and in fig. 1.3. If a blood vessel is contracted, e.g. by phenylephrine (PE) or 
noradrenaline, and an agent then causes a relaxation this may be due to 
release of endothelial NO. To test this inhibitors of nitric oxide synthase (NOS),
4 8
such as l-NAME, l-NMMA and l-NOARG, can be used to see if they reverse 
the relaxation. Alternatively, compounds which bind and inactivate NO, such 
as haemoglobin, could be used. Attempts could be made to estimate the 
amount of NO produced by comparing the magnitude of vasodilation obtained 
with that produced by known concentrations of NO. Alternatively, a cascade 
bioassay system could be used, e.g. using endothelium-containing vessels as 
a donor and endothelium-denuded vessel downstream as a detector. Again, 
amounts of NO released could be assessed by comparing the degree of 
relaxation of the detector produced with that obtained to known standards of 
NO.
Another way of assessing, at least indirectly, the activity of NO is to examine 
depression in the contraction produced by a vasoconstrictor such as PE. This 
technique has been used to assess basal NO tone in endothelium-containing 
blood vessels (Martin et al., 1986) and demonstrate the presence of iNOS in 
endothelium-denuded vascular rings (Rees et al., 1990a; this study).
L-CitruUine assay
This assay measures the amount of L-citrulline generated by NOS. L-Citrulline 
is the byproduct of the production of NO as indicated by the following reaction 
(Hibbs et al., 1987);
NOSL-arginine + O2  ------► NO + L-citrulline
The L-citrulline assay has been widely used to examine NOS activity (Rees et 
al., 1990b; Pollock et al., 1991; Bush et al., 1992; Yu, 1994). Typically, cell 
homogenates are incubated in the presence of pH] L-arginine at 37°C for a set 
period of time. The activity of NOS is then stopped by the addition of perchloric 
acid. The reaction mixture is then passed through a dowex AG 50 W-X8  Na'*'
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Chemiluminescence assay
This assay was originally developed to measure NO as an atmospheric 
pollutant but is now used to measure NO in biological systems (Palmer et al., 
1987; Cox, 1980; Braman & Hendrix, 1989). Detection of NO is based on the 
observation that NO spontaneously reacts with ozone to emit light by the 
following reactions:
5 0
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column. This column binds L-arginine but allows L-citrulline to pass through. 
The column is then washed and the effluent is counted by liquid scintillation for 
the presence of pH] L-citrulline.
Cyclic GMP assay
NO activates soluble guanylate cyclase, increasing the production of cyclic 
GMP. The amount of cyclic GMP formed can be measured using a 
radioimmunoassay and used as an index of NO production (Rapoport & 
Murad, 1983). This assay relies on the competition between radioactive and 
non-radioactive antigen for a fixed number of binding sites. As the amount of 
antigen, cyclic GMP, increases it displaces the radioactive antigen from the 
binding sites and thus reduces the amount of radioactive antigen-antibody 
complex. A standard curve of cyclic GMP binding can be used to determine 
the amount of cyclic GMP in the samples. This is a sensitive assay but 
unfortunately it is not entirely specific for the increase in cyclic GMP stimulated 
by NO, as other agents can also increase the production of cyclic GMP without 
involving NO. For example, agonists such as atrial natriuretic factor (Rapoport, 
1986) and arachidonic acid (Ignarro & Wood, 1987) may stimulate the 
particulate or the soluble form of guanylate cyclase increasing cyclic GMP 
thereby causing vasodilation by an NO-independent mechanism.
I
NO* + 0 3 -^ NO2* + O2 
NO2* -> NO2 + hv
Chemiluminescence, measured by a sensitive photomultiplier tube, is 
proportional to the NO levels present. The assay takes advantage of the low 
solubility of NO in aqueous solutions by measuring NO in the gas phase, 
whether the original sample was a gas or a liquid. In the reaction chamber, 
ozone, generated internally by electrical discharge, is mixed with NO in front of 
a cooled, red-sensitive photomultiplier tube.
Nitrite and nitrate, the major breakdown products of NO (Wennmalm et ai, 
1992; Ignarro et ai, 1993), can also be measured using the 
chemiluminescence assay as these can be reduced to NO in the presence of 
strong reducing agents. Nitrite can be reduced to NO in the presence of 
agents such as sodium iodide in glacial acetic acid (Cox, 1980) or alternatively 
by 1 '1 -dimethyIferrocene in acetonitrile (Termin et ai, 1992). Nitrate can be 
reduced to NO in the presence of stronger reducing agents such as titanium 
trichloride or ammonium molydbate in sulphuric acid (Cox, 1980), or 
alternatively vanadium (111) chloride in hydrochloric acid (Braman & Hendrix, 
1989). This is a quantitative and highly-sensitive technique, with a threshold 
detection level of 100 pmol (Braman & Hendrix, 1989; Cox, 1980).
Griess reaction
This two step assay is based on the observation that the adduct of nitroxides 
and sulfaniiic acid reacts with N-(l-naphthyl) ethylenediamine, generating a 
product that is readily monitored by spectrophotometry at an absorbance of 
548 nm (Green et ai, 1982; Tracey et al., 1990). The NO level can be 
calculated by comparing the observed change in absorbance to a
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NO/absorbance calibration curve. In this assay, absorbance at 548 nm should 
increase solely as a function of NO concentration. In view of the short half-life
having a threshold detection level of 500 - 1000 pmol (Green et ai., 1982; 
Tracey et at., 1990).
Of NO, its major stable metabolite, nitrite, is normally the form measured in 
biological samples. This technique is less sensitive than chemiluminescence.
Fluorometric assay
An alternative means of measuring nitrite, the major breakdown product of NO 
in vitro, involves a fluorometric assay. This is based on the reaction of nitrite 
with 2,3-diaminonaphthalene (DAN) in acidic solution to form 
1 -[H]-naphthotriazole, a highly fluorescent compound in alkaline medium 
(Damiani & Burini, 1986; Misko et a!., 1993). The concentration of the sample 
is measured using an excitation wavelength of 365 nm and read at an 
emission wavelength of 405 nm. This is intermediate in sensitivity between the 
chemiluminescence assay and the Griess reaction, having a threshold 
sensitivity of 1 2 0  pmol.
EPR assay
NO is a gaseous, paramagnetic molecule with an unpaired electron in the n 
orbital (Arroyo & Kohno, 1991). The basic principle of detecting radicals by 
EPR spectroscopy is that at a discrete energy level (microwave frequency) 
and magnetic field strength, unpaired electrons are promoted to higher energy 
levels; relaxation from this state produces a characteristic spectrum. NO and 
NO2 cannot be studied by simple EPR as the relaxation time of the stimulated 
electron to ground state is too rapid to be detected (Maples et a!., 1991).
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Methaemoglobin soectrophotometry assay
This technique is based on the rapid oxidation of reduced haemoglobin (Fe^+) 
to methaemoglobin (Fe^^) by NO rather than on detection of the paramagnetic
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Spin traps are compounds that interact with the unstable radicals, producing a 
more stable adduct that can be detected by EPR. The spin traps that can be 
used to detect NO include nitroxide compounds and haemoglobin (Arroyo &
Kohno, 1991). Nitroxide traps are stabilised by the resonance of the unpaired 
electron. There are two types of nitroxide spin trap, the nitrones and the 
nitroso compounds. The nitroso compounds usually provide the best 
information about the identity of a radical, as the radical is added directly to the 
nitroso nitrogen, thereby increasing information in the hyperfine splitting 
parameters (Bueltner, 1987). However, oxygen-based adducts of the nitroso 
compounds are unstable and one must usually rely on the nitrones for such 
studies. The identity of the radical, defined by EPR, is characterised by the 
magnitude and multiplicity of the hyperfine splitting of the spin adduct's 
spectra. The amount of radical present is proportional to the magnitude of the 
signal (Maples et ai, 1991; Bueltner, 1987).
'àI!
A disadvantage of this technique is that EPR spectrometers are not readily 
available to most biologists. The magnetic field is usually set at or near 330 
mT, with a microwave power of 8  - 10 mW, frequency of 9 GHz, and 
modulation amplitude of 0.1 mT. Experiments need to be performed in 
darkness to prevent photolysis of the spin traps. When NO interacts with the 
nitroso compounds (e.g. 2 -methyl-2 -nitrosopropane and 
3,5,-dibromo-4-nitrosobenzene), a triplet signal is formed that can be 
characterised by its line width and hyperfine coupling constant. This technique 
has been used for the detection of NO produced by macrophages (Henry et 
ai, 1991).
NO-Hb complex, which breaks down rapidly in oxygenated solutions (Kelm &
Schrader, 1988; Ignarro et al., 1987; Kelm et al., 1988). The reaction is shown 
below:
NO + Hb(Fe2'^)02 -4. Hb(Fe3'^) + NOa
Commercially available haemoglobin is 50 ~ 95% methaemoglobin and must 
be reduced with a molar excess of dithionite. NO is detected by observing the 
characteristic shift in the So ret absorbance peak of haemoglobin from 433 nm 
to 406 nm (Ignarro et al., 1987; Kelm et al., 1988). The presence of 
oxyhaemoglobin is not a problem in this assay due to a much higher affinity of 
haemoglobin for NO than O2 . Furthermore, oxyhaemoglobin can be detected 
by its Soret peak (416 nm). Conversion of reduced to methaemoglobin can be 
measured as the excitation difference at 401 and 411 nm (the isobestic point).
Gas chromatography
Although NO can be detected by standard gas chromatography techniques, 
this assay is much less sensitive than chemiluminescence or EPR assays (Pai 
et al., 1987). Pai et al. (1987) used a Varian gas chromatography with a 
Porapak Q column and electron capture detector to measure enzymatically 
generated NO. They attributed the low sensitivity of this assay to the sample 
processing methodology required for gas chromatography.
The oxidation of reduced haemoglobin by NO occurs in less than 100 ms, 
suggesting the assay Is sufficiently dynamic to study the time course of NO 
synthesis (Kelm et al., 1988). The threshold for the detection of NO using this 
assay is excellent at around 1 nM (Kelm et al., 1988), which is within the range 
of concentrations produced by endothelial cells.
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Mass spectroscopy
Gustafsson et al. (1991) used mass spectroscopy to measure NO in the 
breath of guinea-pigs. They trapped NO as nitrosothioproline by bubbling the 
expirate through a degassed aqueous solution of thioproline (15 nM). The 
nitrosothioproline was extracted with ethyl acetate, and dried and derivatized 
by N-methyl-N-(tertbutyldimethylsilyl) trifluroacetamide in acetonitrile. Samples 
were placed on a CP-Sil-5-CB column interfaced with a mass spectrometer 
operating in the positive chemical ionisation mode with isobutane. The 
derivatized form of nitrosothioproline had a retention time of 4.76 min 
(Gustafsson et al., 1991). It is not clear whether this assay is more sensitive 
than measuring breath chemiluminescence as the readings were in arbitrary 
units with no calibration with authentic NO. The principle of trapping NO in 
degassed water for subsequent analysis, regardless of the technique, appears 
to be a reasonable strategy for measuring exhaled NO.
Microelectrode NO assay
There are currently two amperometric methods available for measuring NO 
from intact tissues and single cells. Shibuki (1990) recently reported the 
measurement of NO release in the cerebellum using a microelectrode. He 
modified a miniature O2 electrode by sealing its fire-polished 150 - 250 pm tip 
with a thin chloroprene rubber seal so that only low molecular weight gases 
could enter. By introducing a platinum cathode within the pipette and holding it 
at a positive voltage, he was able to detect NO, a readily oxidised gas, by its 
oxidation at the electrode's surface (Shibuki, 1990). Pipettes were filled with 30 
mM NaCI and 0.3 mM HCI (pH 3.5), and a Teflon-coated platinum wire was 
placed as close as possible to the membrane. A 200 pm silver wire was the 
anode. The cathode was kept 0.9 V from the anode and the anode was 
grounded. The principle of the assay is that if the anode is grounded there
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Our study
:
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should be no current. There was a linear relationship between current and NO 
concentration in vivo over a small range ( 1 - 3  pM). Using this electrode,
Shibuki (1990) was able to measure NO release in rat cerebellar tissue elicited
’by electrical stimulation of the white matter. The author claims that NO 
detection limits can easily be improved by signal averaging and that the 
threshold has now reached nanomolar sensitivity (Shibuki, 1990). The linear 
concentration range for NO has now been shown to be 0.2 nM -1 pM (fchimori 
etal., 1994).
A second, more sensitive technique is based on the observation that 
metalloporphyrins catalyse the oxidation of NO, i.e. NO* - e" NO"*", and in so 
doing generate electrical current. Malinski and Taha (1992) coated carbon 
fibres (chosen as a convenient, strong microprobe material) with a thin 
polymeric porphyrin layer and measured NO as the electrical current produced 
at 0.63 V. To minimise detection of NO2" they coated the carbon fibre with 
Nation, a negatively charged material that is highly impermeable to anions. 
Nafion-coated fibres displayed no change in current when 20-fold excess NO2” 
was added to the sample. This technique permitted measurement of NO 
production from cultured endothelial and smooth muscle cells with a detection 
threshold of lO'^o M, a linear response to concentrations of up to 300 pM NO, 
and a response time of 10 ms. This technique offers great promise for the 
measurement of NO production in single cells, both in culture and in situ, once 
the technology is commercially available. This assay is stated to be quite 
specific for NO but also detects catecholamines.
In our study we compared the sensitivity and utility of a number of the above 
techniques for detection of nitrite and nitrate, the major stable metabolites of 
NO. Those examined were chemiluminescence using
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1,T-dimethylferrocene/acetonitrile or sodium iodide/glacial acetic acid reflux, 
the Griess reaction and the fluorometric assay which all measure nitrite. 
Chemiluminescence using vanadium chloride/hydrochloric acid reflux which 
measures nitrite and nitrate. We also used the indirect means of assessing NO 
by measuring the depression of PE-induced contraction of rat aortic rings and
measured cyclic GMP content of cultured rat aortic smooth muscle cells.
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Methods
58
Rat Aortic Rinas
Preparation of rat aortic rings
Incubation of endothelium-denuded rings of rat aorta
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Male Wistar rats (200 - 300 g) were killed by stunning and exsanguination. 
The thoracic aorta was removed, trimmed of adhering fat and connective 
tissue and cut into 2.5 mm long transverse rings using a razor blade slicing 
device. In all experiments the endothelium was removed by placing the aortic 
ring between two stainless steel hooks under 1 g tension and gently rubbing 
the intimai surface with a moist match stick for 20 - 30 s. Removal of the 
endothelium was deemed successful if acetylcholine (ACh; 1 pM) failed to 
produce relaxation after pre-constriction with phenylephrine (PE ; 0.1 pM).
Tension recording
IThe aortic rings were mounted on stainless-steel hooks under 1 g resting tension in 12 ml organ baths and bathed at 37°C in Krebs solution aerated 
with 95% O2 and 5% CO2 . Tension was recorded isometrically with Grass 
FT03C transducers and displayed on a Grass polygraph, model 7. The 
tissues were allowed to equilibrate for 30 - 45 min before experiments were 
begun. During this time resting tension was re-adjusted to 1 g, as required and 
the tissues were washed once. The Grass polygraph and isometric 
transducers were calibrated at the start of each day and contractions to PE 
were measured in g tension.
Previous papers (Rees etal., 1990a; Mitchell etal., 1992; Fleming etal., 1993) 
have reported that overnight incubation of endothelium-denuded rings of rat 
aorta at 37“C in Krebs solution leads to the expression of inducible nitric oxide
synthase (iNOS). An attempt was made to determine if this process of 
induction could be repeated in our laboratory.
Endothelium-denuded rings of rat aorta, prepared as above, were placed in a 
test tube containing 1 ml of Krebs solution and incubated overnight (18 h) in 
an incubator (ICN Flow, model 160, UK) at 37'’C under an atmosphere of 5%
CO2 in air. On removal from the incubator the rings were suspended for 
tension recording, as above, and cumulative concentration-response curves to 
PE (1 nM - 10 pM) were generated. The magnitude of depression of PE- 
induced contraction was assessed by comparing these responses to those 
obtained from freshly isolated endothelium-denuded rings. In some 
experiments the Krebs solution used for the overnight incubation was retained 
for the measurement of nitrite content using a Dasibi chemiluminescence 
analyser (model 2107; Quantitech Ltd, Milton Keynes, UK). These 
measurements were used as an additional means of examining whether there 
had been expression of iNOS, since nitrite is the major breakdown product of 
nitric oxide (NO; Wennmalm etal., 1992; Ignarro etal., 1993).
■I
Experimental protocol with incubated rat aortic rings 
Drugs added during the incubation period
To examine if the depression of PE-induced contraction was due to the 
expression of iNOS, drugs known to affect this induction process were added 
to the Krebs solution for the duration of the overnight incubation (18 h). These 
include, dexamethasone (1 pM), an inhibitor of the expression of iNOS (Di 
Rosa et al., 1990; Knowles et al., 1990b; Rees et al., 1990a), and polymixin B 
(30 pg ml-i), a scavenger of endotoxin (lipopolysaccharide, LPS; Lasfargues et 
al., 1989), to see if this depression was due to LPS contaminating the Krebs 
solution. The effects of adding exogenous LPS (100 ng mM) from Salmonella
60
typhosa to the Krebs solution were also examined on the magnitude of the 
depression of PE-induced contraction.
Additional experiments were conducted to examine if the induction was via a 
direct action of LPS on smooth muscle cells in the arterial wall or via an 
indirect action where the LPS was stimulating the release of a cytokine from 
another cell type in the arterial wall which then led to induction in the smooth 
muscle cells. If the paracrine action of a cytokine was required for induction to 
occur then antibodies to that cytokine should prevent this process. The 
antibodies examined were monoclonal antibodies to; murine interferon-y (anti- 
m IFN-y; 10 - 30 pg mM); murine interleukin-1 p (anti-m IL-ip; 10 - 50 pg ml-'*) 
and human tumour necrosis factor-a (anti-m TNF-a; 10 - 30 pg mb'*). Each of 
these was present during the overnight incubation (18 h) of endothelium- 
denuded rings of rat aorta. The effects of pentoxifylline (0.1 - 10 pM), an 
inhibitor of tumour necrosis factor-a (TNF-a), which inhibits transcription of 
mRNA for TNF-a (Han et a!., 1990; Doherty et at., 1991; Strieter et al., 1988), 
were also examined on the depression of PE-induced contraction by including 
it in the Krebs solution for the overnight incubation (18 h).
In all of these experiments cumulative concentration-response curves were 
prepared to PE (1 nM - 10 pM). Two cumulative curves were prepared, the 
first to sensitise the tissues to PE and the second curve was taken as the test 
result.
Drugs added after the incubation period
To examine if the depression of PE-induced contraction was due to the 
expression of iNOS, drugs which would affect the synthesis or actions of NO 
were added to the tissue baths after the second cumulative concentration- 
response curve had been obtained. Also, as an additional control the effects of
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all drugs were tested on cumulative concentration-response curves to PE (1 
nM - 10 pM) on freshly isolated endothelium-denuded rings of rat aorta. This 
permitted non-specific effects of drugs to be differentiated from effects on NO 
synthesis and actions.
The agents which were added to tissues following the overnight incubation 
were N^-nitro-L-arginine methyl ester (l-NAME; 100 - 1000 pM), an inhibitor of 
NOS (Rees et al., 1990b); haemoglobin (10 - 30 pM), which binds and 
inactivates NO (Gibson & Roughton, 1957; Martin etal., 1985), and methylene 
blue (10 pM), an inhibitor of soluble guanylate cyclase (Martin et al., 1985). In 
each case the agent was added to the tissue bath 1 0  min prior to generating a 
third cumulative concentration-response curve to PE (1 nM -10 pM).
An additional series of experiments were conducted in an attempt to determine 
if the depression of PE-induced contraction resulted from expression of iNOS 
in the smooth muscle cells or in another cell type in the vessel wall. The 
approach here was to compare the effects of LY 83583 
(6-anilino-5,8-quinolinedione), which generates superoxide anion 
extracellularly and intracellularly (Müisch et al., 1988; Müisch et al., 1989), with 
the effects of hypoxanthine/xanthine oxidase, which generates superoxide 
anion only extracellularly. On the basis that NO is destroyed by superoxide 
anion (Gryglewski et al., 1986), if NO was generated and acted within the 
same smooth muscle cell then it should be destroyed by LY 83583 but not by 
hypoxanthine/xanthine oxidase. Alternatively, if NO was produced by another 
cell type in the vessel wall such as a macrophage and had to diffuse to the 
smooth muscle cell in order to produce relaxation, then it should be destroyed 
both by LY 83583 and hypoxanthine/xanthine oxidase. In these experiments 
LY 83583 (0.1 - 3 pM), was added 10 min prior to generating a third 
cumulative concentration-response curve to PE (1 nM - 10 pM), and 
hypoxanthine (100 - 1000 pM)/xanthine oxidase (16 mu mM) was added 2 min
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prior to generating a third cumulative concentration-response curve to PE (1 
nM - 10 pM). The experiments with hypoxanthine/xanthine oxidase were 
carried out in the presence of catalase ( 1 0 0 0  u ml-"*) to prevent the 
accumulation of hydrogen peroxide. The effects of superoxide dismutase (250 
u mM) which destroys superoxide anion were also examined in some 
experiments and this was also added 2  min prior to generating a third 
cumulative concentration-response curve to PE (1 nM -10 pM).
Rat Aortic Smooth Muscle Cells (RASMC)
Smooth muscle cells from rat aorta were isolated and grown in culture in order 
to examine the factors which regulate expression of iNOS in this cell type.
Culture of RASMC
Rat aortic smooth muscle cells (RASMC) were cultured by a modification of 
the explant technique described by Campbell & Campbell (1993).
The aorta was removed from a rat, as above, but placed in sterile saline 
(0.9%), and all further work was carried out in a laminar flow hood (Gelaire, 
model TC48) using sterile instruments. A schematic diagram showing a cross 
section of the aorta is shown in fig. 4.1a. The aorta was trimmed of adhering 
fat and connective tissue and placed in 5 ml of Dulbecco's Modified Eagle's 
Medium (DMEM; Life Technologies Ltd, Paisley, UK) containing 0.125% 
collagenase (type II, Sigma, Poole, UK) and 0.025% elastase (type II, Sigma, 
Poole, UK) and incubated at 37'"C for 5 min. On removal from the incubator, 
the aorta was cut open longitudinally, laid flat with the intimai surface 
uppermost and the endothelium removed by scraping with a scalpel blade (fig 
4.1b). A transverse incision was made through the medial layer using a scalpel
'â
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Figure 4.1: Schematic diagram of rat aorta, a) Transverse cross section of rat 
aorta, b) cross section after opening up the aorta by cutting longitudinally and 
laying flat and c) longitudinal cross section after removal of the endothelium. 
The aorta of a rat was removed and placed in sterile saline. It was trimmed of 
adhering fat and connective tissue and placed in 5 ml of Dulbecco's Modified 
Eagle's Medium containing 0.125% collagenase (type II) and 0.025% elastase 
(type II) and incubated for 5 min at 37®C. On removal from the incubator, the 
aorta was cut open and the endothelium removed by scraping, a transverse 
incision was made and the smooth muscle was peeled away from the 
adventitia and cut into 1 mm^ segments. These segments were then placed on 
the growth surface of a 25 cm^ flask which was kept up-ended and had 9 ml of 
full culture medium added before being placed up-ended in the incubator. After 
2 - 4 h the flask was laid flat. The culture medium was replaced after 7 - 1 0  
days and once a few colonies of smooth muscle had grown out of the 
explants, the cells were subcultured into a new flask.
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blade (fig 4.1c), the smooth muscle was peeled away from the adventitia using 
forceps and cut into 1 mm^ segments. Twenty to thirty of these segments were 
placed on the growth surface of a 25 cm^ flask (Costar Ltd, High Wycombe, 
UK) and 9 ml of full culture medium was added while holding the flask up­
ended. The flask was placed up-ended in an incubator at 37°C in an 
atmosphere of 5% CO2 in air for 2 - 4 h to allow the tissues to adhere firmly to 
the growth surface before laying the flask flat to cover the tissues with full 
culture medium. After 7 - 1 0  days the culture medium was removed and the 
cells were washed twice with 10 ml of sterile saline (0.9%) before fresh full 
culture medium was added.
Once a few colonies of smooth muscle cells had grown out of the explanted 
tissues (14 - 20 days), they were subcultured by removing the culture medium, 
washing three times with sterile saline (0.9%) before adding 3 ml of trypsin 
(0.05%)/EDTA (0.02%; ION Biomedicals Ltd, Bucks, UK) and incubating at 
37°C for 3 - 5 minutes on an orbital shaker. On removal from the shaker the 
flask was shaken, the trypsin was inactivated by the addition of 1 - 2  ml of new 
born serum (NBS; Life Technologies Ltd, Paisley, UK) and the cell suspension 
was decanted into a sterile tube (Falcon, R & J Wood Laboratory Supplies, 
Paisley, UK). The flask was then rinsed with 9 ml of full culture medium and 
this was also decanted into the sterile tube which was then spun at 300 g for 3 
min. The supernatant was discarded and the cell pellet was re-suspended in 5 
ml of full culture medium before being spun again. The cell pellet was ■-à
suspended in 2 0  ml of full culture medium and transferred to a 80 cm^ flask §
(Costar LTD, High Wycombe, UK). These spins were to ensure the cells were 
suspended in fresh full culture medium with no trypsin/EDTA present. The 
cells were then washed every 2 - 4  days with sterile saline (0.9%) and fresh 
full culture medium added (20 ml). They were subcultured, as above, when 
confluent.
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Characterisation of RASMC
Experimental protocol for nitrite measurement using RASMC in full culture 
medium
Previous papers (Busse & Mülsoh, 1990; Beasley et al., 1991; Kanno et ai, 
1993; Koide et ai, 1994) have indicated that RASMC in culture can express 
iNOS. We wished to examine the factors controlling this induction process by 
measuring nitrite, the major breakdown product of NO (Wennmalm et ai, 
1992; Ignarro et ai, 1993), in the medium bathing these cells in culture.
II
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Characterisation of the cells as smooth muscle cells was confirmed by the fact 
that they grew in the typical 'hill and valley' pattern, and by previous work in 
this laboratory where the cells were shown to fluoresce with anti-smooth 
muscle actin antibodies using the technique of Chamley et a i (1977). Fig 4.2 
shows these smooth muscle cells in culture, plated at different densities.
'I
I
.
Confluent smooth muscle cells were dispersed as above with trypsin 
(0.05%)/EDTA (0.02%), re-suspended in 30 ml of full culture medium and cell 
numbers counted using a haemocytometer. Counting was achieved by placing 
a coverslip over the haemocytometer and filling the chamber by capillary 
action from a syringe containing the cell suspension. The cell numbers were 
counted within three or four of the large squares and the following equation 
was used to calculate the number of cells:-
Total number of cells per ml = total number of cells counted x dilution x 1 0  0 0 0
number of squares counted
The volume of full culture medium was then adjusted to obtain a cell 
suspension of 3 x 1 0  ^ cells per ml. One ml of cell suspension was added to
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Figure 4.2: Photomicrographs of rat aortic smooth muscle cells cultured on 
glass microscope slides plated at a high seeding density (top) and a low 
seeding density (bottom).
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each well of a 24 multi-well plate (Costar LTD, High Wycombe, UK) and left to 
reach confluence ( 1 - 2  days). Upon reaching confluence, the medium was 
removed from each well, the wells were washed twice with 1 ml of sterile 
saline (0 .9 %), 1 ml of fresh full culture medium was added and the cells were 
then incubated for 6  - 72 h in the absence or presence of drugs (as indicated 
in the Results). After this period, the medium was removed and nitrite content 
measured using the Griess reaction. The cells were then dispersed using 
trypsin (0.05%)/EDTA (0.02%) and counted using a haemocytometer, as 
above. Nitrite accumulation was expressed as pmol per 10® cells.
Experimental protocol for nitrite measurement using RASMC in serum-free 
culture medium
Our initial attempts to express iNOS in smooth muscle cells in full culture 
medium were unsuccessful. Since serum contains platelet-derived growth 
factor^B 9 nd bb and transforming growth factor-p which are known to inhibit 
expression of iNOS in smooth muscle cells (Junquero et al., 1992; Schini et 
al., 1992; Hirokawa et al., 1994a), a further series of experiments were carried 
out in serum-free medium.
RASMC were plated into 24 multi-well plates as above. Once they had 
attained confluence the full culture medium was removed from each well, the 
wells were washed twice with 1 ml of sterile saline (0.9%) and 1 ml of serum- 
free culture medium was added. The cells were then incubated for 24 h before 
the medium was replaced with fresh serum-free culture medium. Drugs were 
added as indicated in the Results and the plates were incubated for 6  - 72 h. 
When the effects of dexamethasone (0.1 - 1 pM) or cycloheximide (1 -100 pg 
ml""*), inhibitors of the expression of iNOS, or polymixin B (1 - 30 u ml-i), which 
binds and inactivates LPS, were to be examined, they were added as a 2 h 
pre-treatment before addition of iNOS-inducing agent; i.e. IFN-y (30 u mM).
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After 6  - 72 h, the medium bathing the cells was removed and the nitrite 
content was measured using the Griess reaction. Cell numbers were counted 
using a haemocytometer, as above, and nitrite accumulation was expressed 
as pmol per 1 0 ® cells.
Experimental protocol for the measurement of cyclic GMP content
Expression of iNOS can also be assessed by measuring the cyclic GMP 
content of cells, as cyclic GMP is the second messenger produced by NO 
(Rapoport & Murad, 1983). A series of experiments were therefore conducted 
in which this second messenger was measured as an additional means of 
determining if iNOS had been induced in RASMC in culture.
Confluent smooth muscle cells in 80 cm^ flasks were dispersed using trypsin 
(0.05%)/EDTA (0.02%) and counted as before. In these experiments the cell
suspension was adjusted to give a concentration of 5 x 10® cells per ml. Two
;ml of cell suspension was added to each well of a 6  multi-well plate (Costar 
LTD, High Wycombe, UK) and the cells were left to reach confluence ( 1 - 2  
days). Upon reaching confluence, the medium was removed, the cells were 
washed with 1 ml of sterile saline (0.9%) and 2 ml of serum-free culture 
medium was added. After 24 h this medium was removed, replaced with 2 ml 
of fresh serum-free culture medium and the cells were incubated in the 
presence of drugs for 24 h as indicated in the Results. When the effects of 
cycloheximide (1 pg mb'*) or dexamethasone (1  pM), inhibitors of the 
expression of iNOS, were to be examined, they were added as a 2 h pre­
treatment before addition of iNOS-inducing agents. After 24 hours, the 
medium bathing the cells was removed and the nitrite content measured using 
the Griess reaction. Immediately after the medium was removed 1 ml of ice 
cold ethanol was added to each well. The cells were detached using a 'rubber 
policeman', harvested into an Eppendorf tube and extracted overnight at 4°C,
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Following this, the samples were spun at 13 000 rpm for 2 min to form a cell 
pellet. The ethanol extract was removed and placed in a Sarstedt (Leicester,
constant stream of air. The dry samples were then stored at 4"C for 
subsequent cyclic GMP analysis. When required, the extracts were 
reconstituted in 0.5 ml of 0.05 M sodium acetate buffer, pH 6.2.
Bovine Aortic Endothélia! Cells (BAEC)
bovine aortic endothelial cells (BAEC).
Preparation of BAEC
Bovine aortae were collected from the local abattoir. Immediately on removal 
from the animals, they were flushed with a sterile saline solution (0.9%) 
containing penicillin (200 u ml"'*)/streptomycin (200 pg ml-i). The aortae were 
ligated at the proximal end using strong string and cannulated at the distal end 
with an adapter attached to a 60 ml syringe containing the same sterile saline 
solution (fig 4.3). This solution was injected into the aortae and they were 
transported to the laboratory, which took approximately 30 min.
At the laboratory all further work was carried out in a laminar flow hood 
(Gelaire, model TC48). The aortae were filled with 20 ml of fresh sterile saline 
and the intercostal arteries were ligated using surgical suture (gauge 0). The 
saline solution was then replaced with 20 ml of 0.1% collagenase (type II) in 
DMEM and incubated at 37°C for 25 min on an orbital shaker. On removal 
from the shaker the endothelial cells were harvested by massaging the aorta 
and by flushing the collagenase solution in and out of the vessel. This cell 
suspension was spun at 100 g for 4 min and the supernatant was discarded.
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UK) 5 ml tube. The ethanol was evaporated by heating at 50°G under a
Experiments were conducted to determine if iNOS could be expressed in
1
Bovine Aorta
Intercostal arteries
Adapter
Syringe
Figure 4.3: Schematic representation of a bovine aorta, immediately on 
removal from the animal, the aorta was flushed with a sterile saline solution 
(0.9%) containing penicillin (200 u mh^)/streptomycin (200 pg mh^). It was then 
ligated at the proximal end using strong string and cannulated at the distal end 
with an adapter attached to a 60 ml syringe containing the same sterile saline 
solution. At the laboratory the saline solution was removed and replaced with 
30 ml of fresh sterile saline (0.9%) and the intercostal arteries were ligated 
using surgical suture (gauge 0). The saline solution was then replaced with 20 
ml of 0.1% collagenase (type II) in Dulbecco's Modified Eagle's Medium and 
the aorta was incubated at 37°C for 25 min. On removal from the incubator the 
endothelial cells were harvested and grown in 80 cm^ tissue culture flasks.
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pellet was finally re-suspended in full culture medium. The endothelial cells
:i;
The cell pellet was washed twice, by re-suspension in 10 ml of sterile saline, 
spinning at 100 g for 4 min and discarding the supernatant, before the cell
were incubated at 37°C in an atmosphere of 5% CO2 in air and grown to
confluence in either 9.5 cm^ 6 -well cluster plates (2 ml of cell suspension 
added) or in 80 cm^ tissue culture flasks (20 ml of cell suspension added). All 
cells were washed with sterile saline and fresh full culture medium added 
every 2 -3  days.
Characterisation of BAEC
Characterisation of the cells as endothelial cells was confirmed by the fact that 
they grew in a single layer with a 'cobblestone' morphology and by previous 
work in this laboratory where they were shown to produce both prostacyclin 
and EDRF (Martin et al., 1988). Also, no fewer than 98% of cells were 
observed to fluoresce following incubation with acetylated low density 
lipoprotein labelled with 1,1 '-dioctadecyl-1,3,3',3'-tetramethyl-indocarbocyanine
percholate (Voyta eta!., 1984; Martin eta!., 1988).
Experimental protocol for measurement of nitrite or nitrite/nitrate usina BAEC
Previous reports (Radomski et al., 1990b) have suggested that porcine aortic
endothelial cells can express INOS. We wished to examine if BAEC could also 
express iNOS and the factors controlling this induction by measuring the nitrite 
or nitrite/nitrate content of the medium bathing these cells in culture.
■Once the cells had attained confluence ( 3- 5 days) in 80 cm^ flasks, they were 
subcultured into 6  multi-well plates for nitrite or nitrite/nitrate analysis. This was 
achieved by removing the full culture medium from the flask, washing twice
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with 20 ml of sterile saline, adding 3 ml of trypsin (0.05%)/EDTA (0.02%) and 
incubating at 37°C for 3 min. Following this, the flasks were shaken to dislodge 
the cells, 2 ml of NBS was added to inactivate the trypsin/EDTA, the cell 
suspension was removed and spun at 100 g for 4 min. The supernatant was 
discarded and the cell pellet was washed twice with sterile saline (0.9%). The 
cells were re-suspended in 60 ml of full culture medium and seeded into the 6  
multi-well plates with 2  ml of cell suspension added to each well.
When nitrite or nitrite/nitrate accumulation was to be measured, confluent cells 
in 6  multi-well plates were washed twice with 3 ml of sterile saline and then 2 
ml of full culture medium was added to each well. The plates were incubated 
with drugs, as indicated in the Results, for 24 hours at 37*C in an atmosphere 
of 5% CO2 in air. After this incubation, the culture medium was removed and 
the nitrite or nitrite/nitrate content was measured using a Dasibi 
chemiluminescence analyser (model 2107, Quantitech Ltd, Milton Keynes, 
UK).
J774.2 murine macrophage cell line
Experiments were conducted to determine if iNOS could be expressed in the 
J774.2 murine macrophage cell line.
Preparation of J774.2 cells
The J774.2 murine macrophage cell line was obtained from the European 
Collection of Animal Cell Cultures (Porton Down, UK). Cells were maintained 
in siliconised (Replecote, Sigma) Techne stirrer flasks containing 400 ml of full 
HEPES-buffered culture medium (ICN Biomedicals Ltd, High Wycombe, UK) 
at 37°C and stirred continuously under an atmosphere of air. The full HEPES- 
buffered culture medium was changed every 3 - 4  days by spinning the cell
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suspension at 1 0 0  g for 4  min, then reconstituting the cell pellet in 2 0 0  ml of 
saline before a further spin and reconstitution in 400 ml of fresh full HEPES- 
buffered culture medium.
Experimental protocol with J774.2 cells
Previous reports (Stuehr & Marietta, 1987a; Stuehr & Marietta, 1987b) have 
demonstrated expression of iNOS in macrophages following incubation with 
IFN-y. We wished to examine this induction by measuring the nitrite or 
nitrite/nitrate content of the medium bathing the cells.
analyser (model 2107; Quantitech Ltd, Milton Keynes, UK).
I
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For experimentation, the cell suspension was removed from the stirrer flask 
and placed into sterile 50 ml Falcon tubes (R & J Wood Laboratory Supplies, 
Paisley, UK) and spun at 100 g for 4 min. The supernatant was discarded and 
the cell pellet was washed twice with 30 ml of sterile saline (0.9%), re­
suspended in 50 ml of full HEPES-buffered culture medium and the cell 
numbers were counted using a haemocytometer, as before. The cells were 
then spun and reconstituted in an appropriate volume of full HEPES-buffered 
culture medium to give a final density of 10^ cells mH, and seeded into 24-well 
cluster plates (Costar, High Wycombe, UK) with 1 ml of cell suspension added 
to each well. The plates were then incubated in the presence of drugs, as 
indicated in the Results, for 24 h at 37X. At the end of this period, the culture 
medium was removed from the plates, spun in a micro-centrifuge at 13000 
rpm for 2 min to remove any dislodged cells. Nitrite content of the supernatant 
was measured using the Griess reaction or with a Dasibi chemiluminescence
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Measurement of nitrite or nitrite/nitrate accumulation
Griess reaction
The accumulation of nitrite, the major breakdown product of NO (Wennmalm 
et ai., 1992; Ignarro et ai., 1993), in the medium bathing cells was measured 
by the formation of a diazo product by a variant of the method of Green et al. 
(1982). This is a two step assay based on the fact that the complex formed 
between nitroxides and sulfanilic acid reacts with N-(l-naphthyl) 
ethylenediamine generating a product that is easily measured
spectrophotometrically.
The measurement of nitrite involved using 0.4 ml samples from experiments, 
to which 0.4 ml of 1% (w/v) sulfanilic acid (Sigma) in 2 M HCI and 0.4 ml of 1% 
(w/v) aqueous N-(l-naphthyl) ethylenediamine dihydrochloride (Sigma) were 
added, and the absorbance of the purple azo complex determined at 548 nm 
using a Shimadzu (UV240) recording spectrophotometer. Towards the end of 
the project, a Dynatech micro plate reader (DS2000) was obtained which 
permitted 96 samples to be measured simultaneously. Nitrite
in these experiments was measured using a 550 nm filter, and the sample 
volume, as well as the volume of the two reagents, was reduced to 40 pi.
A standard curve was prepared in these experiment using sodium nitrite 
standards (0 - 9000 pmol) dissolved in the appropriate medium, i.e. full culture 
medium, serum-free culture medium or full HEPES-buffered culture medium. 
The Griess reaction could only satisfactorily measure concentrations of 300 
pmol and above, and when values between 300 - 9000 pmol were plotted, the 
resulting line was linear (fig 4.4). A regression line of best fit was used to 
determine the nitrite content of experimental samples.
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Figure 4.4: Standard curve for sodium nitrite (300 - 9000 pmol) obtained using 
the Griess reaction by spectrophotometric analysis at 548 nm. Each point is 
the mean of 4 observations and a regression line of best fit was obtained 
(broken line).
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Chemiluminescence detection of nitrite or nitrite/nitrate
Chemiluminescence has been successfully used for the detection of NO 
(Palmer et ai, 1987). The basis of this method is that NO reacts 
spontaneously with ozone to emit light as indicated by the following reactions
NO + O3 N0*2 
NO'g ^  NO2 -Î- hv
Native NO has a very short half-life, however, and is not easily measured. 
Techniques have, therefore, been developed to reduce nitrite and/or nitrate, 
the more stable metabolites of NO, back to NO (Cox, 1980; Braman & 
Hendrix, 1989; Termin et ai, 1992). Nitrate can be reduced to NO, but this 
involves the use of strong reducing agents such as titanium trichloride, 
ammonium molydbate in sulphuric acid (Cox, 1980), or vanadium (III) chloride 
in hydrochloric acid (Braman & Hendrix, 1989). Nitrite can be reduced to NO in 
the presence of weaker reducing agents such as sodium iodide in glacial 
acetic acid (Cox, 1980) or alternatively by 1,1 '-dimethylferrocene in acetonitrile 
(Termin et ai, 1992).
The reducing systems used in this study were
1,1 '-dimethylferrocene/acetonitrile system. This consisted of 900 mg of
1 ,T-dimethylferrocene in 90 ml acetonitrile (HPLC grade) to which 1.5 \x\ of 
70% perchloric acid was added. This reducing system was used at room 
temperature and is reported to reduce nitrite to NO (Termin et ai, 1992).
Sodium iodide/glacial acetic acid reflux system. This consisted of 25 ml of 
a 6 % solution of sodium iodide in 75 ml of glacial acetic acid under reflux at 
65°C and reduces nitrite to NO (Cox, 1980).
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Vanadium chloride/hydrochloric acid reflux system. This consisted of 1.5 g 
of vanadium chloride in 100 ml of 2 N HCI under reflux at 95“C and reduces 
both nitrite and nitrate to NO (Braman & Hendrix, 1989).
These reducing systems were used in conjunction with a Dasibi 
chemiluminescence analyser (model 2107: Quantitech Ltd, Milton Keynes, UK) 
to measure the nitrite or nitrite/nitrate content of biological samples using 
standards of sodium nitrite and sodium nitrate. For calibration of this system 
see Results.
Apparatus for chemiluminescence detection of nitrite or nitrite/nitrate 
A schematic diagram of the apparatus used is shown in fig 4.5.
Briefly, this consisted of a 250 ml flask, containing 100 ml of the reducing 
solution. The 250 ml flask was placed on a heating mantle, which was used 
when the reducing solution was required to be under reflux (i.e. for acidic 
vanadium chloride and for sodium iodide/glacial acetic acid). The NO 
produced by the reducing solution was carried from the flask by a constant 
flow of oxygen-free nitrogen (British Oxygen Co. Ltd). The flow then passed 
through a number of traps, to ensure no acid entered the analyser: the first 
trap was a water-cooled condenser, which was followed by an ice-cooled liquid 
trap and finally a trap containing sodium hydroxide pellets. The gas flow then 
entered the analyser. Inside the analyser NO reacted, in the reaction chamber, 
with ozone produced by a high electrical charge. Ozone and NO react to 
produce N0 * 2  which decays to NO2 while emitting light at 650 - 800 nm. The 
amount of light generated by the system was dependent upon the amount of 
NO generated from nitrite and/or nitrate and was measured with a 
photomultiplier tube linked via an integrator to a Linseis recorder and an IBM
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Figure 4.5: A schematic illustration of the chemiluminescence apparatus used 
to measure nitric oxide (NO) generated from samples containing nitrite and/or 
nitrate. Samples are injected into the reaction vessel containing the reducing 
solutions (see Methods), some of which require reflux, and for these the 
heating mantle was turned on. A constant flow of N2  ^ was supplied from an 
oxygen-free nitrogen cylinder. The NO produced from nitrite and/or nitrate is 
carried in the N2 stream through the condenser, cooled by cold water direct 
from a tap, from here the NO passes into a liquid trap, cooled by ice, and then 
into an acid trap, containing sodium hydroxide pellets to remove any traces of 
acid, after which the gas then enters the analyser. Inside the analyser the gas 
reacts with ozone, produced by high voltage, in the reaction chamber to form 
N0 * 2  which breaks down to emit light. This light is measured by a 
photomultiplier tube connected through an integrator to a computer.
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compatible personqf computer. This computer ran a program called 'SCAN'
(Dr. Dempster, Department of Physiology and Pharmacology, University of 
Strathclyde, Glasgow, UK) that could measure both the peak of the signal 
generated in parts per billion (ppb) and the area under the curve in parts per 
billion times seconds (ppb.s).
NO gas
;
In the early chemiluminescence experiments known amounts of NO gas were 
used to calibrate the chemiluminescence NO analyser. NO gas was diluted 
with oxygen-free nitrogen (British Oxygen Co. Ltd) to pmol levels and injected 
into the analyser. Specifically, a 2 I volumetric flask was flushed for 5 min with
oxygen-free nitrogen and sealed with a rubber subaseal. This subaseal was 
then punctured with two syringe needles attached via a steel tube to a supply 
of oxygen-free nitrogen so that the flask could be flushed and the other to 
allow escape of gas. After flushing for 15 min the flask was re-sealed. A 
constant flow of NO was established along an open-ended tube from a NO 
gas cylinder (British Oxygen Co. Ltd). A gas-tight syringe was filled and 
emptied several times with this NO, before being filled and sealed. Two 
hundred pi of NO was then injected into the 2 I flask giving a 4.5 pM stock of 
NO. From this stock, a gas-tight syringe was filled and used to calibrate the 
analyser. Fresh stock was made once the gas-tight syringe was emptied. The 
stock was such that a 50 pi sample was equivalent to 225 pmol.
Fluorometric determination of nitrite
In some experiments an alternative fluorometric assay for nitrite was 
employed. The fluorometric determination of nitrite is based on the reaction of 
nitrite with 2,3-diaminonaphthalene (DAN) in acidic solution to form
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1-[H]-naphthotriazoie, a highly fluorescent compound in alkaline medium 
(Damiani & Burini, 1986; Misko etal., 1993).
The measurement of nitrite using this technique involved using 0.4 ml samples 
or standards which were mixed with 0.04 ml of DAN solution (0.05 mg m |i in 
0.62 M HCI; pH 1.6) and incubated at 37X  for 10 min. Following incubation 
the reaction was stopped with 0.01 ml of 5.6 N NaOH (pH 11.6). The 
1 -[Hj-naphthotriazole formed was highly fluorescent and fluorescence intensity 
of samples was measured using an excitation wavelength of 365 nm and read 
at an emission wavelength of 405 nm using a Perkin-Elmer LS-3B fluorometer. 
The 1~[H]-naphthotriazole was stable for approximately 10 min. Validation of 
this detection system is shown in the Results section.
Measurement of cyclic GMP content
Principle of radioimmunoassay (RIA)
The basic principle of radioimmunoassay (RIA) is the competition between 
radioactive and non-radioactive antigen for a fixed number of antibody binding 
sites. This interaction is represented schematically in fig 4.6. If increasing 
amounts of non-radioactive antigen (i.e. in standard or unknown samples) and 
a fixed amount of radioactive antigen are allowed to react with a constant 
amount of antibody, a decreasing amount of radioactive antigen is bound to 
the antibody. This relationship can be expressed as a standard curve and the 
amount of unlabelled antigen in a sample determined by interpolation from this 
curve.
81
Labeled Antigen Specific Antibody
+
Unlabelled Antigen
Labeled Antigen 
Antibody Complex
X
Unlabeled Antigen 
Antibody Complex
Figure 4.6: A schematic representation of the principle of radioimmunoassy 
(RIA). RIA is based on the competition between radiolabelled and unlabelled 
antigen for a fixed number of antibody binding sites. Increasing amounts of 
unlabelled antigen in the presence of a fixed amount of antibody and 
radiolabelled antigen, results in decreasing amount of radiolabelled antigen 
bound to the antibody. This relationship can be expressed as a standard curve 
after separation of bound from free radiolabelled antigen, and amounts of 
unlabelled antigen determined by interpolation from the curve.
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Chemicals for RIA
Cyclic GMP antiserum complex
One vial of lyophilised, pre-reacted, first and second antibody was supplied. It 
was reconstituted with 21 ml of distilled water. The resulting solution, in 0.1 M 
sodium phosphate buffer (pH 6.2) with 0.05% thimerosal, contained sufficient 
antibody to bind approximately 40 - 50% of the labelled antigen in the absence
8 3
RIA
Determination of cyclic GMP was adapted from the procedure of Steiner et al. 
(1972), using New England Nuclear RIA kits (Du Pont). Steiner et al. (1972) 
reported that cyclic nucleotides substituted at the 2 '-a-position had a higher 
affinity for the antibody and thus displace the ['•25|].methyl ester derivative 
better than unsubstituted cyclic nucleotides. Thus, standards and samples 
were acetylated with acetic anhydride to give 2'-a-acetyl cyclic GMP, thereby 
Increasing the sensitivity of the assay (Harper & Brooker, 1975).
The labelled antigen was a succinyl tyrosine-[i25|]_methyl ester derivative of 
cyclic GMP. Separation of bound from free antigen was achieved by the use of 
a pre-reacted primary and secondary antibody complex. The primary antibody 
was prepared in rabbits against a succinyl cyclic GMP-albumin conjugate, 
while the second antibody was prepared in sheep against rabbit globulin. With 
this pre-reacted system, pipetting and incubation times were reduced 
compared to the usual sequential double antibody assay and no intermittent 
incubation was required. After the single overnight incubation at 4°C, 0.5 ml of 
propan-1 -ol was added to aid precipitation, the tubes were centrifuged at 2 0 0 0  
g for 15 min, the supernatants discarded, and the radioactivity in the 
precipitates counted.
of unlabelled antigen when used as indicated below. The reconstituted 
antiserum complex was stable for at least 2 months when stored at 4"C.
Succinyl cyclic GMP tyrosine methyl ester-p^^l] (Scyclic GMP-TME-j^^^l])
Two vials of concentrated tracer were supplied. Each vial contained 
approximately 28 KBq (0.75 pCi) on the calibration date in 1 ml of propan-1- 
okwater solution (1:1). The concentrate was stable for at least 2 months when 
stored at 4°C.
Normal rabbit serum
The normal rabbit serum was used to measure the non-specific binding 
obtained with non-immune serum. Two vials of lyophilised normal rabbit serum 
were supplied. Five ml of distilled water was added to each vial of Scyclic 
GMP-TME-p25|] concentrate, and to each vial of lyophilised normal rabbit 
serum. The entire contents of the reconstituted normal rabbit serum vial was 
added to the diluted Scyclic GMP-TME-p^^i] vial and the resulting solution 
mixed. This solution (approximately 11 ml) contained Scyclic G M P -T M E -p ^ ^ j]  
(0.068 pCi ml-i), 1% normal rabbit serum, and 0.05 M sodium acetate buffer, 
pH 6.2. The solution was stable for at least 2 weeks when stored at 4°C.
Acetic anhydride and triethylamine
A mixture of these two solutions was used to acetylate cyclic GMP in 
standards and samples in order to increase the sensitivity of the assay. One 
vial each of acetic anhydride and triethylamine was supplied. They were 
allowed to equilibrate to room temperature before use. When protected from 
moisture these chemicals were stable for at least 2 months. Immediately prior 
to use, 1 volume of acetic anhydride was mixed with 2  volumes of
8 4
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triethylamine: the exact volume of each was dependent upon the number of 
samples to be acetylated.
Cyclic GMP standard
This was the unlabelled antigen. One vial of lyophilised standard was supplied.
It was reconstituted with exactly 2 ml of distilled water and contained 2000 
pmol ml-^  in 0.05 M sodium acetate buffer, pH 6.2. The cyclic GMP standard 
had been calibrated spectrophotometrically using the molar absorption 
coefficient for cyclic GMP, 8=13.7 x 10^ moh'* cm-  ^ at 252 nm, pH 7. The 
reconstituted standard was stable for at least 2 months when stored at 4°C.
Preparation of standard curve and assay of cell extracts
A series of 5 ml plastic tubes (Sarstedt, Leicester, UK) were numbered for 
identification and the standard cyclic GMP stock solution (2000 pmol ml-^) was 
diluted with 0.05 M sodium acetate buffer, pH 6.2, to a concentration of 100 
pmol mM. Further serial dilutions with sodium acetate buffer were made to 
prepare the following standards for assay: 0.025, 0.05, 0.1, 0.25, 0.5, 1, 2.5 
and 5 pmol. mh  ^All standards were run in duplicate.
Tubes 1 and 2 were used to measure 'total counts' i.e. the total amount of 
radioactivity added to each tube, tubes 3 and 4 were 'blanks' and tubes 5 and 
6  were used to measure the '0 standard'. One hundred pi volumes of each 
standard solution (in duplicate) or sample were added to appropriately labelled 
tube. All tubes except for 'total counts' and 'blanks' received 5 pi of the 
acétylation mixture, ensuring that the reagents were added directly to the 
solution and were immediately vortex mixed for 2 s. All tubes received 100 pi 
of Scyclic GMP-TME-[''25|] tracer solution, and all tubes except for 'total 
counts' and 'blanks' received 100 pi of antiserum complex. All tubes were
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vortex mixed for 5  s, covered with aluminium foil and equilibrated overnight (18 
h) at 4 X .
Following overnight equilibration at 4°C, 0.5 ml of ice cold propan-1-ol was 
added to each tube except for 'total counts'. This aided the precipitation of the 
antigen-antibody complex. The tubes were vortex mixed and centrifuged at 
2000 g for 15 min at 4°C (Damon I EC centrifuge). The supernatants were 
discarded and the pellets together with the 'total counts' tubes were counted 
for 1 min in a gamma counter (Packard Cobra Auto gamma).
Analysis of radioactivity
Analysis of the radioactivity in the tubes (counting and background reduction) 
was performed by an IBM-compatible computer with a defined RIA protocol.
This allowed the user to define the nature of the samples and the count time.
The standard curve was plotted with the characteristics of a Bound Fraction 
RIA curve with a negative slope (spline-fitted). The content of each unknown 
sample was calculated by interpolation from the standard curve and the value 
printed. Table 4.1 and fig 4.7 represent a typical standard curve obtained from 
an acetylated cyclic GMP RIA.
IDrugs
Acetylcholine chloride (ACh), L-arginine hydrocholine, catalase (bovine liver), 
dexamethasone, hypoxanthine, haemoglobin (bovine; Fib), interferon-y 
(murine, recombinant; IFN-y), interleukin-1 a (human; lL1-a), 
lipopolysaccharide from Escherichia coli (prepared by phenol extraction; LPS), 
lipopolysaccharide from Salmonella typhosa (prepared by phenol extraction; 
LPS), methylene blue, NQ-nitro-L-arginine methyl ester (l-NAME),
8 6
cpm mean cpm
total counts 6632.9
6337.9
6485.4
blanks 46.9
34.9
40.9
'O' standard 2297.9
2170.9
2234.4
0.00125 pmol 2254.9
2000.9
2127.9
0.0025 pmol 1966.9
2043.9
2005.4
0.005 pmol 1832.9
1819.9
1826.4
0.0125 pmol 1505.9
1493.9
1499.9
0.025 pmol 1154.9
1069.9
1112.4
0.05 pmol 835.9
729.9
782.9
0.125 pmol 422.9
390.9
406.9
0.25 pmol 279.9
273.9
276.9
Table 4.1; Typical data for radioimmunoassay (RIA) of cyclic GMP showing 
decreased binding of Scyclic GMP-tyrosine methyl ester p25|] (Scyclic GMP- 
TME-[125|]) tracer to the antibody as the amount of unlabelled cyclic GMP in 
standards increases. Total counts' measures total activity of Scyclic GMP- 
TME-p25|] tracer, 'blanks' measures non-specific binding, and '0 standard' 
measures total binding of Scyclic GMP-TME-[’’25|] tracer to antibody in the 
absence of any unlabelled antigen.
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Figure 4.7: Standard curve for cyclic GMP radioimmunoassay using data 
shown in table 4.1. The amount of cyclic GMP in experimental samples was 
calculated from this curve by the computer.
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pentoxifylline, phenylephrine hydrochloride (PE), polymixin B sulphate, 
superoxide dismutase (bovine erythrocyte, Cu-Zn-containing) and xanthine 
oxidase (buttermilk) were obtained from Sigma (Poole, UK). Whilst 
NG-monomethyl-L-arginine (l-NMMA) was a gift from Wellcome Laboratories 
(Beckenham, UK); LY 83583 (G-anilino-5,8-quinolinedione) was obtained from 
Calbiochem (Nottingham, UK); anti-tumour necrosis factor-a (murine, 
monoclonal; anti-m TNF-a) and anti-interferon-y (murine, monoclonal; anti-m 
IFN-y) were obtained from Boehringer Mannheim (Lewes, UK) and anti- 
interleukin-1 p (human, monoclonal; anti-m IL-ip) was obtained from TCS 
Biologicals Ltd (Buckingham, UK). All drugs were dissolved and dilutions made 
in saline (0.9%), except for hypoxanthine which was dissolved in 0.1% sodium 
hydroxide and dexamethasone and LY 83583 which were dissolved in 0.1% 
ethanol with further dilutions in saline. N^-nitro-i-arginine at 10-2 y  was 
soluble only after sonication.
Preparation of Haemoglobin
Bovine haemoglobin (Fib) as supplied by Sigma (Poole, UK) is mainly present 
in the oxidised state (methaemoglobin, Fe^+Hb). A 10 fold molar excess of 
dithionite was used to reduce methaemoglobin (Fe^+Hb) to oxyhaemoglobin 
(Fe2+(Hb(0 2 )4 ). Briefly, dialysis tubing was boiled in distilled water for 15 min 
then rinsed with distilled water. Hb 1.29 g was dissolved in 20 ml of distilled 
water to give a 1 mM solution and 34.82 mg of sodium dithionite was dissolved 
in 100 pi of distilled water and added immediately to the Hb solution with 
thorough mixing. This combined solution was then poured into the dialysis 
tubing expelling all air, this was placed in a flask containing 5 I of distilled 
water at room temperature for 2 h and shaken frequently. After this time the 
solution was aliquotted and stored frozen at-20°C.
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Full culture medium
Serum-free culture medium
Full HEPES-buffered culture medium
Krebs solution
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Culture media and Krebs solutions
.The constituents of DMEM (Life Technologies Ltd, Paisley, UK) and HEPES- 
buffered DMEM (ICN Biomedicals Ltd, High Wycombe, UK) are listed in table 
4.2.
Full culture medium was prepared using DMEM with the addition of foetal calf 
serum (PCS; 10%), new born calf serum (MBS; 10%), glutamine (4 mM) and 
peniciilin(100 u mM)/streptomycin (100 pg ml-'*). All culture medium reagents 
obtained from Life Technologies Ltd, Paisley, UK.
'I
Serum-free culture medium was prepared using DMEM with the addition of 
bovine serum albumin (0.1%), glutamine (4 mM) and penicillin (100 u 
mM)/streptomycin ( 1 0 0  pg mb'*).
HEPES-buffered culture medium was prepared using HEPES-buffered DMEM 
with the addition of PCS (10%), glutamine (2 mM) and penicillin (100 u 
ml-'*)/streptomycin ( 1 0 0  pg mb'*).
Krebs solution was prepared daily from a 10 times concentrated stock 
containing NaCI, KCI, CaCl2 , MgSO^ and KH2PO4 . This concentrated stock
__J
Constituents mg 1-1 DMEM
mg 1-1 HEPES- 
buffered 
DMEM
L-arginine HOI 84 84
L-cysteine disodium salt 56.78 62.57
L-glutamate 584 584
glycine 30 30
L-histidine HCl H2 O 42 42
L-isoleucine 104.8 104.8
L-leucine 104.8 104.8
L-lysine HCl 146.2 146.2
L-methionine 30 30
L-phenylalanine 66 66
L-serine 42 42
L-threonine 95.2 95.2
L-tryptophan 16 16
L-tyrosine disodium salt 89.5 103.8
L-valine 93.6 94
D-Ca pantothenate 4 4
choline chloride 4 4
folic acid 4 4
i-inositol 7 7.2
nicotinamide 4 4
pyridoxal HCl 4 4
riboflavin 0.4 0.4
thiamin HCl 4 4
CaCl2.2H20 264.9 200
Fe(N03)3.9H20 0.1 0.1
KCI 400 400
MgS04.7H20 200 97.9
NaCI 6400 6400
NaHC0 3 3700
NaH2P0 4 .2 H2 0 141.3 125
D-glucose 4500 4500
phenol red sodium salt 15 15
sodium pyruvate 110 110
HEPES ■■■— - 1 4766
I
Table 4.2: Constituents of Dulbecco's Modified Eagle's Medium (DMEM) and 
of HEPES-buffered DMEM.
was diluted with distilled water, and glucose and NaHCOg were added. The 
final concentration of reagents was: NaCI 118 mM, KCI 4.8 mM, CaCl2 2.4 
mM, MgSO^ 1.2 mM, KH2PO4 1.2 mM, glucose 11 mM and NaHCC^ 24 mM. 
This was gassed with 95% O2 and 5% CO2 .
HEPES-buffered Krebs solution
HEPES-buffered Krebs solution was prepared daily from a 10 times 
concentrated stock Krebs solution containing NaCI, KCI, CaCl2 , MgSO^ and 
KH2PO4 . This concentrated stock solution of Krebs was diluted with distilled 
water, and glucose, HEPES and NaHCC^ were added. The final concentration 
of reagents was: NaCI 118 mM, KCI 4.8 mM, CaC^ 2.4 mM, MgS0 4  1.2 mM, 
KH2 PO4 1.2 mM, glucose 11 mM, NaHCOg 2.4 mM and HEPES 5 mM. This
9 2
solution was not gassed. 
Statistical Analysis
Results are expressed as means ± s.e. mean and were compared using one­
way analysis of variance followed by Fisher's test. A probability of less than 
0.05 was taken as significant.
?
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Nitric oxide (NO) aas
The first set of experiments conducted using the chemiluminescence analyser 
involved calibration with authentic nitric oxide (NO) gas. NO (200 - 1600 pmol) 
produced chemiluminescence signals that were proportional to the amount 
added (fig 5.1a). When the amount of NO (pmol) was plotted against the area 
under the curve (ppb.s) for each signal, a direct linear relationship was found 
(fig 5.1b). The peak chemiluminescence signal also increased with the amount 
of NO (200 - 1600 pmol) added, but the relationship was not strictly linear (fig 
5.1c). Also shown on fig 5.1b & c are second standard curves obtained 90 min 
after preparing the gas and these show that the NO had decayed during this 
time despite being in a sealed flask.
Conversion of nitrite or nitrite/nitrate to NO
Before measuring nitrite or nitrite/nitrate content of biological samples it was :
first necessary to develop a suitable reducing system to convert these to NO.
Three different systems were evaluated:-
1: Reduction using 1.1 '-dimethvlferrocene/acetonitrile system
The reducing system using 1,1 '-dimethylferrocene/acetonitrile (Termin et ai.,
1992) was attractive since it operated at room temperature and did not involve 
the use of boiling acid. However, when samples of sodium nitrite (500 - 1000 
pmol) were reduced using this system, the chemiluminescence signals 
generated were small and difficult to discern from the background noise (fig 
5.2). Furthermore, they were long in duration (approximately 10 min) 
suggesting a slow rate of reduction of nitrite to NO. Since only small, slow 
signals were generated by large amounts of sodium nitrite, the use of this 
reducing system was abandoned.
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Figure 5.1; Standard curve to nitric oxide (NO) gas (200 - 1600 pmol) obtained 
from chemiluminescence: (a) chemiluminescence signals plotted as ppb 
versus time (s); (b) plotted as the area under the curve of the signal in ppb.s 
and (c) plotted as the peak signal in ppb. NO gas tested Immediately after 
preparation (• )  and NO gas tested 90 min after preparation (■) showing the 
decay of NO even in a sealed flask. Each point is the mean of 2 observations.
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Figure 5.2: Chemiluminescence signals produced by sodium nitrite standards 
(500 and 1000 pmol) using the 1,1 -dimethylferrocene/acetonitrile reducing 
system plotted as ppb versus time (s).
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2; Reduction usina sodium iodide/atacial acetic acid reflux system
The reducing system using sodium iodide/glacial acetic acid is well established 
(Cox, 1980; Palmer et al., 1987), but involves a reflux procedure at high 
temperature (65“C). When samples of sodium nitrite (200 - 1000 pmol) were 
reduced using this system, the chemiluminescence signals were much larger 
and easier to distinguish from the background noise (fig 5.3a) than those 
produced using the 1 ,T-dimethylferrocene/acetonitrile system (fig 5.2). 
Furthermore, the signals were complete within approximately 5 min suggesting 
a rapid reduction of nitrite to NO. A standard curve (100 - 1000 pmol) was then 
prepared and the amount of sodium nitrite was plotted against the area under 
the curve (ppb.s) for each signal. A direct linear relationship was found (fig 
5.3b) and the minimum detection level for nitrite measured using this 
chemiluminescence technique was 100 pmol. The peak chemiluminescence 
signal also increased with the amount of sodium nitrite ( 1 0 0  - 1 0 0 0  pmol) 
added, but the relationship was not strictly linear (fig 5.3c). To calculate the 
nitrite content in experimental samples a regression line of best fit for the area 
under the graph was used (fig 5.3b).
In order to validate the selectivity of the chemiluminescence assay for the 
detection of nitrite, certain compounds containing nitrogen which were 
subsequently used in experiments were examined using the sodium 
iodide/glacial acetic acid reflux system to see if they generated false 'nitrite' 
signals. Sodium nitrate ( 1 0 0 0  pmol) was injected into the reducing system and 
this produced no signal (fig 5.4). L-Arginine (1000 pmol), the endogenous 
substrate for nitric oxide synthase (N08)(Palmer et a!., 1988), and analogues 
of L-arginine, which inhibit NOS (Moore et a!., 1990; Rees et a!., 1990b), i.e. 
N^-nitro-i-arginine (l-NOARG; 1000 pmol) and N^-monomethyl-L-arginine 
(l-NMMA; 1000 pmol), also produced no signal (fig 5.4).
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Figure 5.3; Standard curve to sodiunn nitrite (100 - 1000 pmol) obtained using 
the sodium iodide/glacial acetic acid reflux system: (a) chemiluminescence 
signals plotted as ppb versus time (s); (b) plotted as the area under the curve 
of the signal in ppb.s and (c) plotted as the peak signal in ppb. A continuous 
line joins the points and the broken line indicates a regression line of best fit. 
Each point is the mean of 10 - 34 observations with vertical bars representing 
the s.e. mean.
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Figure 5.4: Chemiluminescence signais detected following injection of sodium 
nitrite, sodium nitrate, L-arginine (L-ARG), N^-monomethyl-L-arginine 
(l-NMMA) and N^-nitro-L-arginine (l-NOARG), ail at 1000 pmol, into the 
sodium iodide/glacial acetic acid reflux system: (a) plotted as ppb versus time 
(s) and (b) plotted as the area under the curve in ppb.s. Each column is the 
mean of 3 -15 observations with vertical bars representing the s.e. mean.
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Culture media and Krebs solutions which were subsequently used in 
experiments were also examined to see if they generated false 'nitrite' signals 
(fig 5.5). One ml volumes of bicarbonate-buffered Krebs or HEPES-buffered 
Krebs produced no signal, nor did 100 pi of foetal calf serum (PCS), but 100 pi 
of new born serum (MBS) produced a small signal (220 ± 33 ppb.s, n~4). One 
ml of bicarbonate-buffered Dulbecco's Modified Eagles Medium (DMEM) 
produced a signal equivalent to 723 ± 165 ppb.s (n=4), and when PCS (10%),
NBS (10%), penicillin (100 u m|i)/streptomycin (100 pg mh"^ ) and glutamate (4 
mM) were added, to give full culture medium, there was no significant 
difference in the signal obtained ( 8 8 8  ± 114 ppb.s, n=8 ). Similarly, 1 ml of 
HEPES-buffered DMEM produced a signal (830 ± 105 ppb.s, n=5) that was
■not significantly different from bicarbonate-buffered DMEM, and when PCS 
(10%), penicillin (100 u mM)/streptomycin (100 pg ml-i) and glutamate (2 mM) 
were added, to give full HEPES-buffered culture medium, there was no 
significant difference in the signal obtained (632 ± 89 ppb.s, n=8 ). The
II
constituents of DMEM producing the chemiluminescence signals are unknown 
but a full list is given in the Methods (table 4.2). In experiments, the area under 
the curve of the signals obtained from culture media W9 f  subtracted from 
experimental samples so that cellular production of nitrite could be assessed.
:Since, Krebs produced no signal by itself, background subtractions were not 
required when this was used in experiments.
3: Reduction using vanadium chloride/hvdrochloric acid reflux system
The reducing system using vanadium chloride/hydrochloric acid reflux is also 
well established (Braman & Hendrix, 1989; Bush et ai, 1992), but involves a 
reflux procedure at high temperature (95°C). This reducing system was 
expected to be a more sensitive index of NO production by cells than the 
sodium iodide/glacial acetic acid reflux system as it had the additional
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Figure 5.5: Chemiluminescence signals detected following injection of culture 
media or Krebs solutions into the sodium iodide/glacial acetic acid reflux 
system. New born serum (NBS) and foetal calf serum (PCS) were injected in 
100 gl volumes, all other samples were in 1 ml volumes. Values are plotted as 
area under the curve in ppb.s. Samples tested were: Krebs; HEPES-buffered 
Krebs; NBS; PCS; Dulbecco's Modified Eagle's Medium (DMEM); HEPES- 
buffered DMEM; DMEM containing NBS (10%), PCS (10%), penicillin (100 u 
ml-i)/streptomycin (100 pg mb'*) and glutamate (4 mM) (full culture medium) 
and HEPES-buffered DMEM containing 10% PCS, penicillin (100 u 
ml-i)/streptomycin (100 pg mM) and glutamate (2 mM) (full HEPES-buffered 
culture medium). Each column is the mean of 3 -10 observations with vertical 
bars representing the s.e. mean.
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advantage of reducing both of NO's major metabolites, nitrite and nitrate, back 
to NO. When samples of sodium nitrite (200 - 1000 pmol) or sodium nitrate 
( 2 0 0  - 1 0 0 0  pmol) were reduced using this system, the chemiluminescence 
signals were large and easy to distinguish from the background noise (fig 5.6). 
Furthermore, the signals were complete within approximately 5 min, 
suggesting a rapid reduction of nitrite and nitrate to NO. Standard curves for 
sodium nitrite ( 2 0 0  - 1 0 0 0  pmol) and sodium nitrate ( 2 0 0  - 1 0 0 0  pmol) were 
prepared and when the amount added was plotted against the area under the 
curve (ppb.s) for each signal a direct linear relationship was found (fig 5.7a). 
Furthermore, at each concentration tested, the signals for nitrite and nitrate 
were not significantly different. The peak chemiluminescence signals also 
increased with the amount of sodium nitrite or sodium nitrate added, but the 
relationship was not strictly linear (fig 5.7b). Since biological samples would be 
expected to contain a mixture of nitrite and nitrate, and as the two standard 
curves for the area under the curve were similar, a combined standard curve 
(nitrite/nitrate) was produced (fig 5.7c) and this too gave a linear relationship. 
A regression line of best fit for these combined data was used to calculate the 
total oxides of nitrogen in experimental samples (fig 5.7c). The minimum 
detection limit for nitrite/nitrate using this chemiluminescence technique was 
lower ( 2 0 0  pmol) than for the sodium iodide/glacial acetic acid reflux system.
In order to validate the selectivity of the chemiluminescence assay for the 
detection of nitrite/nitrate, certain compounds containing nitrogen which were 
subsequently used in experiments were examined using the vanadium 
chloride/hydrochloric acid reflux system to see if they generated false 
'nitrite/nitrate' signals (fig 5.8). Sodium nitrite (1000 pmol) and sodium nitrate 
(1000 pmol) gave signals (1493 ±112 ppb.s n=10 and 1562 ±126 ppb.s n=21, 
respectively; fig 5.8) that were not significantly different from each other. 
L-Arginine (1000 pmol), the endogenous substrate of NOS (Palmer et al.,
1 0 2
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Figure 5.6: Chemiluminescence signals produced by (a) sodium nitrite and (b) 
sodium nitrate using the vanadium chloride/hydrochloric acid reflux system 
and plotted as ppb versus time (s).
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Figure 5.7: Standard curves to sodium nitrite (200 - 1000 pmol; #), sodium 
nitrate ( 2 0 0  - 1 0 0 0  pmol; ■) and total oxides of nitrogen (nitrite/nitrate 2 0 0 - 
1000  pmol; a ) obtained using the vanadium chloride/hydrochloric acid reflux 
system: (a & c) plotted as the area under the curve of the signal in ppb.s and 
(b) plotted as the peak signal in ppb. In (c) the continous line joins the points 
and the broken line indicates a regression line of best fit. Each point is the 
mean of 5 - 44 observations with vertical bars representing the s.e. mean.
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Figure 5.8: Chemiluminescence signais detected following the injection of 
sodium nitrite, sodium nitrate, L-arginine (L-ARG), N^-monomethyl-L-arginine 
(l-NMMA) and N^-nitro-L-arginine (l-NOARG), ail at 1000 pmol, into the 
vanadium chloride/hydrochloric acid reflux system, and (a) plotted as ppb 
versus time (s) and (b) plotted as the area under the curve of the signal in 
ppb.s. Each column is the mean of 3 - 21 observations with vertical bars 
representing the s.e. mean.
1 0 5
1988), produced a detectable signal (1908 ± 460 ppb.s, n-5) and analogues of 
L-arginine, which inhibit NOS (Moore et al., 1990; Rees et al., 1990b), i.e. 
l-NOARG (1000 pmol) and l-NMMA (1000 pmol), also produced detectable 
signals (2441 ± 381 ppb.s, n= 8  and 867.8 ± 68.2 ppb.s, n=3, respectively). 
The large chemiluminescence signals produced by L-arginine and the 
L-arginine analogues would thus pose problems when attempting to estimate 
the nitrite/nitrate content of experimental samples if these compounds were 
present.
Culture media and Krebs solutions which were subsequently used in 
experiments were also examined to see if they generated false 'nitrite/nitrate' 
signals (fig 5.9). One ml of bicarbonate-buffered Krebs gave no signal. One 
hundred pi of NBS or PCS produced substantial signals equivalent to 2582 ± 
157 ppb.s (n=6 ) and 4987 ± 515 ppb.s (n=4), respectively. One ml of 
bicarbonate-buffered DMEM alone produced a signal (692 ± 52 ppb.s, n=4)
but when PCS (10%), NBS (10%), penicillin (100 u ml-'*)/streptomycin (100 pg 
mM) and glutamate (4 mM) were added, to give full culture medium, the signal 
was substantially larger (11373 ± 854 ppb.s, n=8 ). HEPES-buffered DMEM 
produced a signal (5508 ± 2000 ppb.s, n=3), which was substantially larger 
when PCS (10%), penicillin (100 u mM)/streptomycin (100 pg mh^) and 
glutamate ( 2  mM) were added (11477 ± 2177 ppb.s, n=7). Apart from the 
presence of nitrate (Pe(N0 3 )3 .9 H2 0 ; 0.1 mg mM), the constituents of DMEM
3
responsible for the chemiluminescence signals are unknown but a full list is 
given in the Methods (table 4.2). Clearly, the tissue culture media employed 
gave much larger signals using the vanadium chloride/hydrochloric acid reflux 
system compared with the sodium iodide/glacial acetic acid reflux system. In 
experiments, the area under the curve of the signals obtained from culture 
media alone were subtracted from experimental samples so that cellular
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Figure 5.9: Chemiluminescence signais detected following the injection of 
culture media and Krebs solutions into the vanadium chloride/hydrochloric acid 
reflux system. New born serum (NBS) and foetal calf serum (FCS) were 
injected in 100 pi volumes, all other samples were in 1 ml volumes. Values are 
plotted as the area under the curve in ppb.s. Samples tested were: Krebs; 
NBS; FCS; Dulbecco's Modified Eagle's Medium (DMEM); HEPES-buffered 
DMEM; DMEM containing NBS (10%), FCS(10%), penicillin (100 u 
m|i)/streptomycin (100 pg mb'*) and glutamate (4 mM) (full culture medium) 
and HEPES-buffered DMEM containing 10% FCS penicillin (100 u 
ml-^)/streptomycin (100 pg mM) and glutamate (2 mM) (full HEPES-buffered 
culture medium). Each column is the mean of 3 - 8  observations with vertical 
bars representing the s.e. mean.
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production of nitrite/nitrate could be measured. Since, Krebs produced no 
signal by itself, background subtractions were not required when this was used 
in experiments.
Nitrite or nitrite/nitrate content of experimental samples measured using 
chemiluminescence
Having established that the sodium iodide/glacial acetic acid reflux system 
could measure nitrite content and that the vanadium chloride/hydrochloric acid 
reflux system could measure nitrite/nitrate content, we then went on to 
examine the utility of these methods for assessing cellular production of NO. 
The values obtained using these techniques were compared with those 
measured using the more established Griess reaction. As indicated in the 
Methods the threshold sensitivity of the Griess reaction for nitrite was 300 
pmol.
Expression of INOS in J774.2 murine macrophages
We first wished to examine J774.2 murine macrophages since these cells are 
known to produce large amounts of NO following expression of inducible nitric 
oxide synthase (iNOS) (Stuehr & Marietta, 1985; Stuehr & Marietta, 1987a). 
To do this we examined basal accumulation of nitrite and nitrite/nitrate into the 
medium bathing unstimulated cells then examined accumulation following 
expression of iNOS stimulated by endotoxin (lipopolysaccharide; IPS) and/or 
interferon-y (IFN-y). A comparison was made of the measurements of 
accumulation of nitrite and/or nitrite/nitrate into the bathing media using the 
Griess reaction and both chemiluminescence techniques (sodium 
iodide/glacial acetic acid reflux system and vanadium chloride/hydrochloric 
acid reflux system).
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Basal production of nitrite into the medium bathing J774.2 murine 
macrophages incubated for 24 h at 37°C was similar when measured using 
the Griess reaction and the sodium iodide/glacial acetic acid reflux system (5.3 
± 0.3 nmol, n=10 and 4.5 ± 0.5 nmol, n=3 respectively: fig 5.10a & b). When 
basal production of nitrite/nitrate into the medium bathing the cells was 
measured using the vanadium chloride/hydrochloric acid reflux system the 
value was similar to the value measured by the other two systems (5.3 ± 4.7 
nmol, n=4; fig 5.10c). IFN-y (1 - 1 0 0  u mM) produced a concentration- 
dependent stimulation of nitrite accumulation into the medium bathing J774.2 
murine macrophages following a 24 h incubation (fig 5.10a). Maximal nitrite 
accumulation at IFN-y, 100 u mb'* following subtraction of basal production, as 
measured by the Griess reaction (44.4 ± 0.6 nmol, n=3), was slightly lower 
than that measured using the sodium iodide/glacial acetic acid reflux system 
(54.5 ± 3.5 nmol, n=4; fig 5.10b). Maximal accumulation of nitrite/nitrate 
measured using the vanadium chloride/hydrochloric acid reflux system (fig 
5.10c), was between the values obtained using the other two systems (52.5 ± 
7.3 nmol, n=4). The major NO-derived metabolite produced by unstimulated 
and stimulated J774.2 murine macrophages was therefore nitrite.
IPS from Salmonella typhosa (1 - 1000 ng mM) also stimulated the production 
of nitrite by J774.2 murine macrophages in a concentration-dependent manner 
(fig 5.1 la  and b). Maximal nitrite accumulation into the medium bathing cells 
stimulated by LPS (1000 ng mM), following subtraction of basal nitrite 
production, was lower when measured using the Griess reaction (7,5 ± 0.9 
nmol, n=4; fig 5.11a) than that obtained using the sodium iodide/glacial acetic 
acid reflux system (10.6 ± 0.7 nmol, n=4; fig 5.11b).
An examination was conducted to see if following a 24 h incubation of J774.2 
murine macrophages a combined stimulus of LPS and IFN-y could further
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Figure 5.10: Effects of 24 h incubation with interferon-y (IFN; 0 -100 u ml-i) on 
nitrite or nitrite/nitrate production by J774.2 murine macrophages measured by 
(a) the Griess reaction- (b) the sodium iodide/glacial acetic acid reflux system 
and (c) the vanadium/chloride hydrochloric acid reflux system. Values are 
given as either nitrite accumulation (nmol per 10  ^ cells) or nitrite/nitrate (NOy) 
accumulation (nmol per 10® cells). Also shown on (b) and (c) are the 
background readings obtained from full HEPES-buffered culture medium 
(DMEM). Each column is the mean of 3 -1 0  observations with vertical bars 
representing the s.e. mean. *** P<0.005, indicates a significant difference from 
cells receiving no IFN.
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Figure 5.11: Effects of 24 h incubation with endotoxin from Salmonella typhosa 
(LPS; 0 - 1000 ng ml-'') on nitrite production by J774.2 murine macrophages 
measured by (a) the Griess reaction and (b) the sodium iodide/glacial acetic 
acid reflux system. Values are given as nitrite accumulation (nmol per 10® 
cells). Also shown in (b) is the background reading obtained from full HEPES- 
buffered culture medium (DMEM). Each column is the mean of 3 - 8  
observations with vertical bars representing the s.e. mean. *** P<0.005, 
indicates a significant difference from cells receiving no LPS.
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induce nitrite production over that produced by either stimulus alone. The LPS 
concentration of 1 0 0  ng ml-'* was chosen as this alone gave a near maximal 
increase in nitrite accumulation, when measured using the Griess reaction (8.4 
± 0.9 nmol, n=12; fig 5.12a) or the sodium iodide/glacial acetic acid reflux 
system (5.5 ±1.5 nmol, n=4; fig 5.12b). The concentration of IFN-y was varied 
(1 - 1 0 0  u ml-'*) but each concentration itself produced a significant increase in 
nitrite accumulation. When measured using the Griess reaction and the 
sodium iodide/glacial acetic acid reflux system the combination of LPS (100 ng 
ml-i) with IFN-y at all concentrations tested produced levels of nitrite 
accumulation that were significantly greater than those induced by IFN-y or 
LPS alone (fig 5.12).
Attempted expression of iNOS in BAEC
We wished to examine if expression of iNOS could be stimulated in bovine 
aortic endothelial cells (BAEC). Accumulation of nitrite or nitrite/nitrate into the 
bathing media were measured using both chemiluminescence techniques 
(sodium iodide/glacial acetic acid reflux system and vanadium
chloride/hydrochloric acid reflux system).
The full culture medium bathing the BAEC during a 24 h incubation was taken 
for analysis of nitrite accumulation using the sodium iodide/glacial acetic acid 
reflux system. Accumulation of nitrite into the medium bathing unstimulated 
BAEC was 27.8 ± 4 nmol and this was unaffected by treatment for 24 h with 
LPS from Salmonella typhosa (1 - 1000 ng ml \  n=3; fig 5.13a). When, for 
comparison, the nitrite/nitrate content of unstimulated BAEC were measured 
using the vanadium chloride/hydrochloride acid reflux system, following 
subtraction of background levels for full culture medium, almost identical 
values were obtained (31.2 ± 4 nmol, n=3) and again no stimulation of 
production was observed in response to LPS (1 - 1000 ng ml-''; fig 5.13b).
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Figure 5.12; Effects of 24 h incubation with interferon-y (IFN; 0 - 100 u mM;
™  ); endotoxin from Salmonella typhosa (LPS; 100 ng ml ;^ ^  ) or a 
combination of IFN (1, 10 and 100 u mM) with a fixed concentration of LPS 
(100 ng mM; ™  ) on nitrite production by J744.2 murine macrophages 
measured by (a) the Griess reaction and (b) the sodium iodide/glacial acetic 
acid reflux system. Values are given as nitrite accumulation (nmol per 10® 
cells). Also shown on (b) is the background reading obtained from full HEPES- 
buffered culture medium (DMEM). Each column is the mean of 3 - 16 
observations with vertical bars representing the s.e. mean. ** P<0.01 and *** 
P<0.005, indicate a significant difference from control (c; ^  ).
P<0.005, indicates a significant difference from either drug alone.
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Figure 5.13: Effects of 24 h incubation with endotoxin from Salmonella typhosa 
(LPS; 1 - 1000 ng mM) on (a) nitrite accumulation and (b) nitrite/nitrate 
accumulation into the medium bathing bovine aortic endothelial cells 
measured by (a) the sodium iodide/glacial acetic acid reflux system and (b) the 
vanadium chloride/hydrochloric acid reflux system. Values are given as nitrite 
accumulation (nmol per 10^ cells) or nitrite/nitrate (NOJ accumulation (nmol 
per 10® cells). Also shown are the background signals obtained from full 
culture medium (DMEM). Each column is the mean of 3 - 23 observations with 
vertical bars representing the s.e. mean.
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Experiments were then conducted to determine if the basal production of 
nitrite by BAEC was derived from the L-arginine/NO system. These 
experiments involved examining the effects on basal levels of nitrite of two 
inhibitors of NOS, l-NMMA and N^-nitro-L-arginine methyl ester 
(L-NAI\/lE)(Moore et al., 1990; Rees et al., 1990a), as well as dexamethasone, 
which inhibits the expression of iNOS (Di Rosa et al., 1990; Knowles et al., 
1990b; Rees et al., 1990a). Neither l-NMMA (100 pM) nor l-NAME (100 pM) 
when present throughout the 24 h incubation significantly affected basal 
production of nitrite, as measured using the sodium iodide/glacial acetic acid 
reflux system (fig 5.14a). Furthermore, dexamethasone (1 pM), when present 
throughout the 24 h incubation also failed to affect basal production of nitrite, 
measured using the same assay (fig 5.14b).
Validation of a novel fluorometric method for determination of nitrite
Towards the end of these experiments an apparently attractive fluorometric 
method for the determination of nitrite in biological samples was published 
(Damiani & Burini, 1986; Misko et al., 1993). This was based upon the reaction 
of nitrite with 2,3-diaminonaphthalene (DAN) in acidic solutions to form 
1-[H]-naphthotriazone, a highly fluorescent compound in alkaline medium. An 
attempt was made to compare the utility and sensitivity of this new technique 
with the Griess reaction and the chemiluminescence techniques.
Following reaction with DAN at 37*C for 10 min a standard solution containing 
sodium nitrite (1200 pmoi) in Krebs solution was excited at a wavelength of 
365 nm and the emission spectrum measured (fig 5.15). The greatest 
difference in the emission spectrum from that of the blank (Krebs solution 
reacted in the same way as the nitrite standard) occurred at a wavelength of 
approximately 405 nm. This emission wavelength of 405 nm was then used to
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Figure 5.14: Effects of 24 h incubation with (a) endotoxin from Salmonella 
typhosa (LPS; 100 ng mM), N^-monomethyK-arginine (l-NMMA 100 pM) and 
N^-nitro-L-arginine methyl ester (l-NAME 100 pM) and (b) LPS (100 ng mM) 
and dexamethasone (DEX; 1 pM), alone and in combination on nitrite 
accumulation into the medium bathing bovine aortic endothelial cells 
measured by the sodium iodide/glacial acetic acid reflux system. Values are 
given as nitrite accumulation (nmol per 1 0 ® cells). Also shown are the 
background readings obtained from full culture medium (DMEM). Each column 
is the mean of 3 - 10 observations with vertical bars representing the s.e. 
mean.
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Figure 5.15; Emission spectra of the fluorescence intensity of Krebs (blank) 
and sodium nitrite (3 pM; 1200 pmoi) dissolved in Krebs solution following 
reaction with 2,3-diaminonaphthalene at 37®C for 10 min measured at an 
excitation wavelength of 367 nm. I
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examine the excitation spectrum (fig 5.16). The greatest difference in the 
excitation spectrum from that of the blank occurred at a wavelength of 365 nm. 
A standard curve was then prepared using sodium nitrite (4 - 1200 pmoi) 
dissolved in Krebs solution and following reaction with DAN at 37°C for 10 
min, the relative fluorescent intensities were measured at 405 nm, with 
excitation at 365 nm (fig 5.17). The threshold sensitivity was around 120 pmoi 
and the fluorescent intensity increased in a reasonably linear manner up to 
values of 1200 pmoi. A second standard curve was prepared to sodium nitrite 
(0 - 4000 pmoi) dissolved in full tissue culture medium (fig 5.18). Again, the 
threshold sensitivity was 1 2 0  pmoi and the fluorescent intensity increased in a 
linear manner up to values of 4000 pmoi.
Comparison of measuring techniques
A comparison of the standard curves for each of the techniques for 
measurement of nitrite and nitrite/nitrate used in this study can be made from 
fig 5.19.
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Figure 5.16: Excitation spectra of the fluorescence intensity of Krebs (blank) 
and sodium nitrite (3 pM; 1200 pmoi) dissolved in Krebs solution following 
reaction with 2,3-diaminonaphthalene at 37°C for 10 min measured at an 
emission wavelength of 405 nm.
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Figure 5.17: Standard curve to sodium nitrite (4 - 1200 pmoi) prepared in 
Krebs solution obtained by measuring the fluorescent intensity at 405 nm of 
the product obtained following the reaction with 2,3-diaminonapthalene when 
excited at 365 nm. The continous line joins the points and the broken line 
represents the regression line of best fit. Each point is the mean of 4 
observations with vertical bars representing the s.e. mean.
120
700 -I
600 ”
500 ”
^  400 -
•£ 300 -
200  -
100 -
1000 1600 2000 2500 3000 3500 40000 500
nitrite (pmoi)
Figure 5.18: Standard curve to sodium nitrite (40 - 4000 pmoi) prepared in full 
culture medium obtained by measuring the fluorescent intensity at 405 nm of 
the product obtained following the reaction with 2,3-diaminonapthalene when 
excited at 365 nm. The continous line joins the points and the broken line 
represents the regression line of best fit. Each point is the mean of 2 
observations.
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Fig 5.19: Standard curves to sodium nitrite (4 - 9000 pmoi; • )  and to sodium 
nitrite/nitrate (200 - 1000 pmoi; A) obtained using (a) the Griess reaction; (b) 
the sodium iodide/glacial acetic acid reflux system; (c) the vanadium 
chloride/hydrochloric acid reflux system and (d) the fluorometric assay. The 
continous lines join the points and the broken lines indicate regression lines of 
best fit. Each point is the mean of 4 - 30 observations with vertical bars 
representing the s.e. mean.
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Expression of iNOS in endothelium-denuded rings of rat aorta assessed
by nitrite accumulation into the Krebs solution
Previous reports described expression of inducible nitric oxide synthase 
(iNOS) in isolated arterial rings following overnight incubation, as indicated by 
depression of vasoconstriction (Wakabayashi et al., 1987; Fleming et al., 
1991b; Szabô et al., 1992). An attempt was made to determine if expression of 
INOS could be assessed by measuring nitrite accumulation into the Krebs 
solution bathing endothelium-denuded rings of rat aorta using the sodium 
iodide/glacial acetic acid reflux system. All rings were denuded of endothelium 
and incubated overnight (18 h) in Krebs solution in the absence and presence 
of drugs as indicated below.
At the end of the overnight (18 h) incubation of rat aortic rings in Krebs 
solution, nitrite accumulation reached 680 ± 90 pmoi, n= 8  and this was 
unaffected if L-arginine (1 mM), the endogenous substrate for NOS (Palmer et 
al., 1987), was included (fig 6.1a). In addition, if the NOS inhibitor, 
N^-nitro-L-arginine methyl ester (l-NAME; 1 mM)(Rees et al., 1990b; McCall et 
al., 1993), was included with L-arginine in the Krebs solution for the overnight 
(18 h) incubation this also had no effect on nitrite accumulation (fig 6 .1 a). 
Furthermore, including endotoxin from Salmonella typhosa (LPS; 100 ng ml-i) 
or polymixin B (30 pg mM), a scavenger of lipopolysaccharide (LPS) 
(Lasfargues et al., 1989), during the overnight (18h) incubation also failed to 
influence the accumulation of nitrite into the Krebs bathing the aortic rings (fig 
6 .1 b).
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Figure 6.1: Effects of overnight (18 h) incubation with (a) L-arginine (L-ARG; 1 
mM) alone and in combination with N^-nitro-L-arginine methyl ester (l-NAME; 
ImM) and (b) endotoxin from Salmonella typhosa (LPS; 100 ng ml-^) and 
polymixin B (PMB; 30 pg mM) on nitrite accumulation into the medium bathing 
endothelium-denuded rings of rat aorta measured by the sodium iodide/glacial 
acetic acid reflux system. Values are given as nitrite accumulation (pmoi). Also 
shown are the levels attained in the absence of drugs (control) as well as the 
background signals obtained from Krebs solution. Each column is the mean of 
4 -1 3  observations with vertical bars representing the s.e. mean.
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Expression of iNOS in endothelium-denuded rinas of rat aorta assessed
by the depression of PE-induced contraction
In the previous section nitrite accumulation into the Krebs bathing 
endothelium-denuded rings of rat aorta incubated at 37°C for 18 h was 
measured. Although nitrite did accumulate into the Krebs solution, there was 
no evidence that it was derived from the L-arginine/NO system. It was 
therefore not possible to conclude if iNOS had indeed been expressed. 
Consequently, a further set of experiments were conducted to determine if 
expression of iNOS could be assessed by measuring the depression in 
phenylephrine (PE)-induced contraction following incubation of endothelium- 
denuded rings of rat aorta.
Depression of PE~induced contraction
Freshly isolated endothelium-denuded rings of rat aorta contracted in a 
concentration-dependent manner to PE (1 nM - 10 pM; fig 6.2 and 6.3). The 
sensitivity and the maximal contraction to PE declined following incubation in 
Krebs solution at 37°C for 18 h.
Attempts were made to determine if this depression of PE-induced contraction 
was due to the production of NO following expression of iNOS in rat aortic 
rings. These experiments involved using drugs known to inhibit the synthesis, 
actions of NO and the expression of iNOS.
Reversal of depression of PE-induced contraction by l-NAME
The concentration-dependent contraction to PE (1 nM - 10 pM) in freshly 
isolated endothelium-denuded rings of rat aorta was unaltered by the addition
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Figure 6.2: Individual traces showing contraction to phenylephrine (PE; 1 nM - 
10 pM) in endothelium-denuded rings of rat aorta and the effects of L-NAME 
(100 pM) on these responses, (a) Freshly isolated rings and (b) rings 
incubated at 37°C for 18 h in Krebs solution.
127
-10  -9
log [PE] M
Figure 6.3: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 1 nM ~ 10 pM) on endothelium-denuded rings of rat aorta: 
freshly isolated rings (•) and rings incubated at 37°C for 18 h in Krebs solution 
(m). Each point is the mean of 6  - 10 observations with vertical bars 
representing the s.e. mean. * P<0.005, indicates a significant difference from 
freshly isolated rings.
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of l-NAME (100 pM), an inhibitor of NOS (McCall et a i, 1993; Rees et ai, 
1990b), to the tissue baths 10 min prior to the addition of PE (fig 6.2 and 6.4). 
However, following an 18 h incubation of endothelium-denuded rings of rat 
aorta, the addition of L-NAME (100 - 1000 pM) to the tissue baths 10 min prior 
to PE resulted in a concentration-dependent reversal of the depression of PE 
(1 nM - 30 pM)-induced contraction (fig 6.2 and 6.4). The depression of PE- 
induced contraction therefore appeared to be due to production of NO from 
L-arginine.
Reversal of depression of PE-induced contraction by methylene blue
Methylene blue (10 pM), an inhibitor of soluble guanylate cyclase (Martin et 
ai, 1985), when added to the tissue baths had no effect on the concentration- 
dependent contraction to PE (1 nM - 10 pM) in freshly isolated endothelium- 
denuded rings of rat aorta (fig 6.5). However, methylene blue (10 pM) 
produced a substantial reversal of the depression of PE (1 nM - 10 pM)- 
induced contraction seen in endothelium-denuded rings of rat aorta following 
incubation at 37°C for 18 h (fig 6.5). The depression of PE-induced contraction 
therefore appeared to be due to activation of soluble guanylate cyclase.
Reversal of depression of PE-induced contraction by haemoglobin
Haemoglobin (30 pM), which binds and inactivates NO (Gibson & Roughton, 
1957; Martin et ai, 1985), when added to the tissue baths had no effect on the 
concentration-dependent contraction to PE (1 nM - 10 pM) in freshly isolated 
endothelium-denuded rings of rat aorta (fig 6 .6 a). However, haemoglobin (10 
and 30 pM) produced a concentration-dependent reversal of the depression of 
PE (1 nM - 10 pM)-induced contraction seen in endothelium-denuded rings of 
rat aorta following incubation at 37°C for 18 h (fig 6 .6 b). The depression of PE- 
induced contraction therefore appeared to be due to the actions of NO.
129
■I
1.8 "
1.6 -
1.4 “
1.2 -
oto 1.0 -ca 0.8 -O) 0.6 ~
0.4 -
0.2 -
0.0 -
1.4 -
ç  1.0i 0-8
D) 0.6
10 -9-10 -9 -8
log [PE] M
-7 -6
og [PE] M
Figure 6.4: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 1 nM - 30 pM) on endothelium-denuded rings of rat aorta: 
control freshly isolated rings (•); (a) freshly isolated rings treated by the 
addition of l-NAME (100 pM) to the tissue baths (▼) and (b) rings incubated at 
37°C for 18 h in Krebs solution (■) and rings incubated at 37°G for 18 h 
followed by the addition of l-NAME (100 pM, a ; 300 pM, ♦ and 1000 pM, o) to 
the tissue baths. Each point is the mean of 4 - 16 observations with vertical 
bars representing the s.e. mean. * and ^  P<0.005, indicate a significant 
difference from freshly isolated rings and from rings incubated at 37°C for 18 
h, respectively. $ P<0.005, indicates a significant difference from freshly 
isolated rings contracted with PE (1 nM -1 pM).
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Figure 6.5: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 1 nM - 10 pM) on endothelium-denuded rings of rat aorta: 
freshly isolated rings (#); freshly isolated rings following the addition of 
methylene blue (10 pM) to the tissue baths (r); rings incubated at 37°C for 18 
h in Krebs solution (■) and rings incubated for 18 h followed by the addition of 
methylene blue (10 pM) to the tissue baths (a). Each point is the mean of 8  - 
1 2  observations with vertical bars representing the s.e. mean. * and ^ 
P<0.005, indicate a significant difference from freshly isolated rings and from 
rings incubated at 37“C for 18 h, respectively.
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Figure 6 .6 ; Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 1 nM - 10 pM) on endothelium-denuded rings of rat aorta: 
freshly isolated rings (•); (a) freshly isolated rings following the addition of 
haemoglobin (30 pM) to the tissue baths (▼) and (b) rings incubated at 37°C 
for 18 h in Krebs solution (■) and rings incubated for 18 h followed by the 
addition of haemoglobin (10 pM, ♦ and 30 pM, ▲) to the tissue baths. Each 
point is the mean of 3 -15 observations with vertical bars representing the s.e. 
mean. * P<0.005, indicates a significant difference from freshly isolated rings 
and ^ P<0.05, indicates a significant difference from rings incubated at 37°C 
for 18 h. j
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sInability of dexamethasone to reverse the depression of PE~induced
contraction
When dexamethasone (1 pM), which is reported to inhibit the expression of 
iNOS (Di Rosa et al., 1990; Knowles et al., 1990b; Rees et al., 1990a), was 
present during the 18 h incubation, the depression of PE (1 nM - 10 pM)- 
induced contraction was unaffected (fig 6.7). Furthermore, the reversal of the 
depression of PE (1 nM -10 pM)-induced contraction produced by the addition 
of l-NAME (1 mM) to the tissue baths was not enhanced if dexamethasone (1 
pM) had been present during the 18 h incubation (fig 6.7).
Reversal of depression of PE-induced contraction bvpolvmlxin B
Polymixin B, which binds and inactivates LPS (Lasfargues et al., 1989), was 
used to determine if the depression of PE (1 nM - 10 pM)-induced contraction 
in aortic rings after overnight incubation resulted from contamination of the 
Krebs solution with bacterial endotoxin (LPS). When polymixin B (30 pg m |i) 
was present during the 18 h incubation it produced a substantial reversal of 
the depression of PE-induced contraction (fig 6 .8 a). The magnitude of this 
reversal was similar to that obtained when the NOS inhibitor, l-NAME (1 mM), 
was added to rings following overnight incubation. However, no further 
reversal of depression was seen when l-NAME (1 mM) was added to rings 
incubated in the presence of polymixin B (30 pg mM; fig 6 .8 b). It was likely 
therefore that contamination by bacterial endotoxin could account for the major 
part of the depression of PE-induced contraction following overnight 
incubation.
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Figure 6.7: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 1 nM - 10 pM) on endothelium-denuded rings of rat aorta: 
freshly isolated rings (•); rings incubated at 37X  for 18 h in Krebs solution (■); 
rings incubated overnight in Krebs solution containing dexamethasone (1 pM; 
▲); rings incubated overnight followed by the addition of l-NAME (1 mM) to the 
tissue baths (▼) and rings incubated overnight with dexamethasone followed 
by the addition of l-NAME (1 mM) to the tissue baths (♦). Each point is the 
mean of 3 - 8  observations with vertical bars representing the s.e. mean. * and 
^  P<0.005, indicate a significant difference from freshly isolated rings and from 
rings incubated at 37°C for 18 h, respectively.
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Figure 6 .8 : Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 1 nM - 10 pM) on endothelium-denuded rings of rat aorta: 
freshly isolated rings (#); rings incubated at 37°C for 18 h in Krebs solution (■) 
and rings incubated in Krebs solution containing polymixin B (30 pg ml-'’ ; t )  
and (b) rings incubated in Krebs solution followed by the addition of l-NAME 
(1 mM) to the tissue bath (♦) and rings incubated in Krebs solution containing 
polymixin B (30 pg mM) followed by the addition of l-NAME (1 mM, ▲) to the 
tissue bath. Each point is the mean of 6  - 1 0  observations with vertical bars 
representing the s.e. mean. * and ^  P<0.005, indicate a significant difference 
from freshly isolated rings and from rings incubated at 37°C for 18 h, 
respectively.
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Effects of LPS on the depression of PE-induced contraction
Having established that contamination by LPS appeared to be responsible for 
the depression of PE-induced contraction in endothelium-denuded rings of rat 
aorta following overnight (18 h) incubation, an attempt was made to determine 
if this depression could be potentiated by adding further exogenous LPS to the 
Krebs solution.
The depression of PE-induced contraction was not enhanced if LPS from S. 
typhosa ( 1 0 0  ng mM) was present throughout the 18 h incubation (fig 6.9). 
This depression was partially prevented if polymixin B (30 pg mM) was present 
together with LPS (100 ng ml-'’) during the 18 h incubation (fig 6.9).
Interactions of superoxide anion with NO produced by iNOS in 
endothelium-denuded rinas of rat aorta
The free radical superoxide anion destroys the vascular activity of NO 
(Gryglewski et al., 1986). We made use of superoxide anion in an attempt to 
determine the locus within the arterial wall where NO was being produced 
following overnight (18 h) incubation of endothelium-denuded rings of rat 
aorta.
One possibility was that expression of iNOS had taken place in non-smooth 
muscle cells in the arterial wall and that the NO released from this cell type
'diffused to the smooth muscle cells producing relaxation. If this hypothesis 
was correct then superoxide anion generated extracellularly would interact
I:!with NO and inactivate it. Furthermore, superoxide dismutase either 
endogenously present or added exogenously to the extracellular space would 
be expected to destroy superoxide anion thus protecting NO.
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Figure 6.9: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 1 nM - 10 pM) on endothelium-denuded rings of rat aorta: 
freshly isolated rings (#); rings incubated at 37"C for 18 h in Krebs solution (■); 
rings incubated for 18 h in Krebs solution containing endotoxin (LPS; 100 ng 
ml-'’ ; A) and rings Incubated for 18 h in Krebs solution containing LPS (100 ng 
mM) and polymixin B (30 pg mM; ♦). Each point is the mean of 6  - 10 
observations with vertical bars representing the s.e. mean. * and ^ P<0.005, 
indicate a significant difference from freshly isolated rings and from rings 
incubated at 37°C for 18 h, respectively.
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An alternative possibility was that expression of iNOS had taken place in the 
smooth muscle cells themselves. In this particular case, superoxide anion 
generated only intracellularly would have the opportunity of destroying NO. 
Furthermore, only endogenous, intracellularly located superoxide dismutase 
would have the opportunity of protecting NO and any enzyme in the 
extracellular space would have no effect.
To test which of these two possibilities was correct, we used two generators of 
superoxide anion; hypoxanthine/xanthine oxidase, which generates the free 
radical only extracellularly (McCord & Fridovich, 1968), and LY 83583, which 
generates the free radical intracellularly (Müisch et al., 1988; Müisch et al., 
1989). Bovine erythrocyte superoxide dismutase was also used as a tool to 
destroy superoxide anion in the extracellular space.
Effects of hypoxanthine/xanthine oxidase on PE-induced contraction
and b). Thus, generation of superoxide anion extracellularly failed to destroy 
the depressant action of NO on PE-induced contraction.
In all experiments involving the use of hypoxanthine/xanthine oxidase, 
catalase ( 1 0 0 0  u mb'’) was present in order to remove any hydrogen peroxide 
generated from superoxide anion. The concentration-dependent contraction to |
PE (1 nM - 10 pM) in freshly isolated endothelium-denuded rings of rat aorta 
was unaltered by the addition of hypoxanthine (100 pM)/xanthine oxidase (16 
mu ml-i) to the tissue baths (fig 6.10a). Following incubation of endothelium- 
denuded rings of rat aorta for 18 h at 37°C, the addition of hypoxanthine (100 
pM or 1000 pM)/xanthine oxidase (16 mu mM) to the tissue baths had no 
effect on the depression of PE (1 nM - 10 pM)-induced contraction (fig 6.10a
I
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Figure 6.10: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 1 nM - 10 pM) on endothelium-denuded rings of rat aorta: 
freshly isolated rings (#) and rings incubated at 37°C for 18 h in Krebs solution 
(■); (a) freshly isolated rings with the addition of hypoxanthine ( 1 0 0  
pM)/xanthine oxidase (16 mu m |i) to the tissue baths (t ) and rings incubated 
for 18 h in Krebs solution followed by the addition of hypoxanthine (100 
pM)/xanthine oxidase (16 mu mM) to the tissue baths (♦) and (b) rings 
incubated for 18 h in Krebs solution followed by the addition of hypoxanthine 
(1000 pM)/xanthine oxidase (16 mu mh'*) to the tissue baths (a ) .  Catalase 
( 1 0 0 0  u ml-’’) was present in all experiments to remove any hydrogen peroxide 
generated. Each point is the mean of 5 - 17 observations with vertical bars 
representing the s.e. mean. * P<0.005, indicates a significant difference from 
freshly isolated rings.
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Reversal of depression of PE-induced contraction bv LY 83583
The concentration-dependent contraction to PE (0.1 nM - 10 pM) in freshly 
isolated endothelium-denuded rings of rat aorta was unaltered by the addition 
of LY 83583 (1 pM) to the tissue baths (fig 6.1 la). In contrast, the addition of 
LY 83583 (0.1 - 1 pM) to the tissue baths following incubation of rings for 18 h 
at 37°C produced a concentration-dependent reversal of the depression of PE 
(0,1 nM -10 pM)-induced contraction (fig 6.11b). Thus, taken together with the 
findings using hypoxanthine/xanthine oxidase, generation of superoxide anion 
intracellularly was necessary to destroy the depressant action of NO on PE- 
induced contraction. It was therefore likely, that NO was being produced and 
acting within the same smooth muscle cells.
Effects of superoxide dismutase on the reversal of depression of PE-induced 
contraction bv LY 83583
If LY 83583 does indeed destroy NO through the intracellular generation of 
superoxide anion then addition of exogenous superoxide dismutase, which 
would be restricted to the extracellular space, should have no effect on this 
action.
Overnight (18 h) incubation of endothelium-denuded rings of rat aorta resulted 
in the depression of PE (0.1 nM - 30 pM)-induced contraction and this was 
unaltered if superoxide dismutase (250 u mb'*) was added to the tissue bath 
prior to PE contraction (fig 6.12).
As before LY 83583 (1 pM), produced a significant reversal of the depression 
of PE (0.1 nM - 10 pM)-induced contraction when added to the tissue baths
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Figure 6.11: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 0.1 nM - 10 pM) on endothelium-denuded rings of rat 
aorta: freshly isolated rings (•); (a) freshly isolated rings treated with LY 83583 
(1 pM; A) and (b) rings incubated at 37X  for 18 h in Krebs solution (■); rings 
incubated for 18 h in Krebs solution followed by the addition of LY 83583 (0.1 
pM, t ; 0.3 pM, A and 1 pM, ♦) to the tissue baths. Each point is the mean of 3 
- 16 observations with vertical bars representing the s.e. mean. * and ^ 
P<0.05, indicate a significant difference from freshly isolated rings and from 
rings incubated at 37°C for 18 h, respectively.
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Figure 6.12: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 0.1 nM - 30 pM) on endothelium-denuded rings of rat 
aorta: freshly isolated rings (•); rings incubated at 37°G for 18 h in Krebs 
solution (■) and rings incubated overnight in Krebs solution followed by the 
addition of superoxide dismutase (250 u mM) to the tissue baths (a ). Each 
point is the mean of 7 -16 observations with vertical bars representing the s.e. 
mean. * P<0.005, indicates a significant difference from freshly isolated rings.
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(fig 6.13). This reversal of depression was completely unaffected by the 
addition of superoxide dismutase (250 u mh’*). Again suggesting that NO was 
being produced and acting within the same smooth muscle cells.
Effects of catalase on the reversal of PE-induced contraction bv LY 83583
Although LY 83683 (1 pM) produced a concentration dependent reversal of 
the depression of PE (1 nM - 10 pM)-induced contraction seen in rings of rat 
aorta following an overnight (18 h) incubation, we found that surprisingly a 
concentration of 3 pM produced a lesser degree of reversal than 1 pM (fig 
6.14a). We investigated if this smaller degree of reversal was a result of the 
accumulation of the relaxant, hydrogen peroxide, by examining the effects of 
catalase. As can be seen in fig 6.14b. However, the addition of catalase (1000 
u mM) to the tissue baths had no effect on the ability of LY 83583 (3 pM) to
reverse the depression of PE (1 nM -10 pM)-induced contraction.
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Figure 6.13: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 0.1 nM - 10 pM) on endothelium-denuded rings of rat 
aorta: freshly isolated rings (•); rings incubated at 37°C for 18 h in Krebs 
solution (■); rings incubated overnight in Krebs solution followed by the 
addition of LY 83583 (1 pM) to the tissue baths (▲) and rings incubated 
overnight in Krebs solution followed by the addition of superoxide dismutase 
(250 u mM) 10 min prior to the addition of LY 83583 (1 pM) to the tissue baths 
(▼). Each point is the mean of 4 - 16 observations with vertical bars 
representing the s.e. mean. * and # P<0.005, indicate a significant difference 
from freshly isolated rings and from rings incubated at 37°C for 18 h, 
respectively.
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Figure 6.14: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 0.1 nM - 10 pM) on endothelium-denuded rings of rat 
aorta: freshly isolated rings (•); rings incubated at 37“C for 18 h in Krebs 
solution (■); rings incubated for 18 h in Krebs solution followed by the addition 
of LY 83583 (3 pM) to the tissue baths (a ); (a) rings incubated for 18 h in 
Krebs solution followed by the addition of LY 83583 (1 pM) to the tissue baths 
(t ) and (b) rings incubated overnight followed by the addition of catalase 
(1000 u mM; ♦) or catalase (1000 u mh^) and LY 83583 (1 pM; A) to the tissue 
baths. Each point is the mean of 3 - 16 observations with vertical bars 
representing the s.e. mean. * and ^  P<0.05, indicate a significant difference 
from freshly isolated rings and from rings incubated at 37°C for 18 h, 
respectively.
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contained internal controls of untreated cells.
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In the previous chapter it was suggested that inducible nitric
oxide synthase (iNOS) could be expressed in rat aortic rings. In this section a 
more detailed investigation of the factors regulating expression of iNOS was 
made using rat aortic smooth muscle cells (RASMC) in culture. In order to 
assess the expression of iNOS, we measured the accumulation of nitrite, the 
major stable breakdown product of NO (Wennmalm et ai, 1992; Ignarro et ai, 
1993), into the medium bathing the cells. All measurements were made using 
the Griess reaction and are expressed as nmol per 1 0 ® cells.
induction of nitrite accumulation into full culture medium bathing 
RASMC
All experiments in this section were conducted on RASMC grown in full culture 
medium, i.e. Dulbecco's Modified Eagle's Medium (DMEM) containing foetal -
calf serum (PCS; 10%), new born serum (NBS; 10%), glutamine (4 mM) and 
penicillin (100 u m|i)/streptomycin (100 pg ml ^. Basal accumulation of nitrite 
into the full culture medium bathing RASMC was remarkably similar between 
experiments (4 - 6.5 nmol. Fig 7.1 - 7.6). Nevertheless, all experiments
Effects of LPS on nitrite accumulation into full culture medium bathing RASMC
Incubation for 24 h with endotoxin (lipopolysaccharide, LPS) from Salmonella 
typhosa at 1 0 0 0  ng mb'* had no effect on nitrite accumulation into the full 
culture medium bathing RASMC (fig 7.1).
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Figure 7.1: Nitrite accumulation (nmol per 10® cells) into the full culture 
medium bathing rat aortic smooth muscle cells following a 24 h incubation with 
lipopolysaccharide from Salmonella typhosa (LPS; 1000 ng mM). Each value 
is the mean of 6  observations with vertical bars representing the s.e. mean.
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Effects of IFN-v on nitrite accumulation into the full culture medium bathing 
RASMC
Incubation for 24 h with the cytokine, murine interferon-y (IFN-y), in the 
concentration range 1 - 1 0 0  u mM, produced a fall in nitrite accumulation into 
the full culture medium bathing RASMC (fig 7.2).
Effects of IL-1a on nitrite accumulation into the full culture medium bathing 
RASMC
Incubation for 24 h with a second cytokine, human interleukin-1 a (IL-la) at 10 
and 40 u mb'* produced a significant decrease in nitrite accumulation into the 
full culture medium bathing RASMC (fig 7.3).
Combined effects of IFN-r and LPS on nitrite accumulation into the full culture 
medium bathing RASMC
In order to investigate potential interactions between IFN-y and LPS on nitrite 
production by RASMC in culture, additional experiments were conducted in 
which cells were exposed to both stimuli.
As previously stated, incubation for 24 h with LPS (1000 ng mb'*) alone had no 
effect on nitrite accumulation into the full culture medium bathing RASMC and 
IFN-y (10 u mb'*) alone produced a slight decrease (fig 7.4). When RASMC 
were treated with both of these stimuli for 24 h no effect was seen on nitrite 
accumulation (fig 7.4).
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Figure 7.2: Nitrite accumulation (nmol per 10® cells) into the full culture 
medium bathing rat aortic smooth muscle cells following a 24 h incubation with 
interferon-y (IFN; 1 - 100 u mM). Each value is the mean of 6  - 12 
observations with vertical bars representing the s.e. mean. *** P<0.005, 
indicates a significant difference from control (c).
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Figure 7.3: Nitrite accumulation (nmol per 10® cells) into the full culture 
medium bathing rat aortic smooth muscle cells following a 24 h incubation with 
interleukin-1 a (ILI; 10 and 40 u mk^). Each value is the mean of 6  
observations with vertical bars representing the s.e. mean. *** P<0.005, 
indicates a significant difference from control (c).
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Figure 7.4: Nitrite accumulation (nmol per 10® cells) into the full culture 
medium bathing rat aortic smooth muscle cells following a 24 h incubation with 
lipopolysaccharide (LPS; 1000 ng mM) and interferon-y (IFN; 10 u ml-i) alone 
and in combination. Each value is the mean of 6  observations with vertical 
bars representing the s.e. mean. *** P<0.005, indicates a significant difference 
from control (c).
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Combined effects of IFN-y and IL -la  on nitrite accumulation into the full culture 
medium bathing RASMC
In order to investigate potential interactions between IFN-y and IL-1a on nitrite 
production by RASMC in culture, additional experiments were conducted in 
which cells were exposed to both stimuli.
As previously stated, incubation for 24 h with IFN-y (10 u mM) alone or with 
IL - la  (10 u ml"'') alone resulted in decreases in nitrite accumulation into the full 
culture medium bathing RASMC. When cells were treated with both of these 
stimuli, the level of nitrite accumulation was similar to that of untreated cells 
(fig 7.5a). However, an increase in nitrite accumulation was produced by the 
combination of IFN-y (10 u mM) and IL - la  (40 u mM), although both stimuli on 
their own decreased nitrite accumulation (fig 7.5b).
Combined effects of LPS and IL-1 a on nitrite accumulation into the full culture 
medium bathing RASMC
In order to investigate potential interactions between LPS and IL-1 a on nitrite 
production by RASMC in culture, additional experiments were conducted in 
which cells were exposed to both stimuli.
As previously stated, incubation for 24 h with IL-1 a (10 u mM) alone 
decreased nitrite accumulation into the full culture medium bathing RASMC 
and LPS (100 ng mM) alone had no effect. When RASMC were treated with 
both of these stimuli, the level of nitrite accumulation was similar to that of 
untreated cells (fig 7.6).
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Figure 7.5; Nitrite accumulation (nmol per 10® cells) into the full culture 
medium bathing rat aortic smooth muscle cells following a 24 h incubation with 
(a) interleukin-1 a (ILI; 10 u mM) and interferon-y (IFN; 10 u mh^) alone and in 
combination and (b) ILI (40 u mM) and IFN (10 u mM) alone and in 
combination. Each value is the mean of 6  observations with vertical bars 
representing the s.e. mean. *** P<0.005 and P<0.005, indicate a 
significant difference from control (c) and from either drug alone, respectively.
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Figure 7.6: Nitrite accumulation (nmol per 10® cells) into the full culture 
medium bathing rat aortic smooth muscle cells following a 24 h incubation with 
interleukin-1 a (ILI; 10 u mM) and lipopolysaccharide (LPS; 100 ng ml-i) alone 
and in combination. Each value is the mean of 6  observations with vertical 
bars representing the s.e. mean. *** P<0.005, indicates a significant difference 
from control (c).
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Effects of serum on nitrite accumulation into the medium bathing RASMC
The above results suggested that agents, i.e. IFN-y, IL-1 a and LPS, known to 
stimulate expression of iNOS in other cell types failed to do so in RASMC 
(Stuehr & Marietta, 1987a; Geller et al., 1993b). When a recent report (Schini 
et a!., 1992) was published showing that serum and two of its constituents, 
platelet-derived growth factor^e and bb and transforming growth factor p i, 
could inhibit the induction process, experiments were conducted to determine 
if this could explain our inability to promote nitrite production by RASMC in full 
culture medium. In order to test this, a series of experiments was conducted 
on RASMC that had been grown in serum-free culture medium (DMEM 
containing bovine serum albumin (0.1%), glutamate (4 mM) and penicillin (100 
u ml-i)/streptomycin (100 pg mM) for 24 h prior to experimentation. After that 
time they were washed and the experiment continued in fresh serum-free 
culture medium.
The basal accumulation of nitrite into the serum-free culture medium during a 
24 h incubation was highly variable amongst different batches of cells (4 - 40 
nmol, fig 7.8 - 7.21). There was, however, little variability within a given batch 
of cells. Consequently, all experiments were conducted with their own internal 
untreated controls.
In contrast to its effect in full culture medium, IFN-y (10 u mM) produced a 
significant increase in nitrite accumulation into the serum-free culture medium 
bathing RASMC following a 48 h incubation (fig 7.7). The presence of FCS 
(10%) or NBS (10%) had no effect on basal nitrite accumulation into the 
medium bathing RASMC during the 48 h incubation, but both FCS and NBS 
significantly inhibited the increase in nitrite accumulation stimulated by
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Figure 7.7: Nitrite accumulation (nmol per 10® cells) into the serum-free culture 
medium bathing rat aortic smooth muscle cells following a 48 h incubation with 
interferon-y (IFN; 10 u ml-i), foetal calf serum (FCS; 10%) alone and in
combination with IFN, and new born calf serum (NBS; 10%) alone and in
combination with IFN. Each value is the mean of 6  observations with vertical
bars representing the s.e. mean. *** P<0.005 and * P<0.05, indicate a
significant difference from control (c) and P<0.005, indicates a significant 
difference from IFN alone.
157
I
_
IFN-y (10 u ml-'*). Thus, the presence of serum was likely to have accounted 
for the inability to stimulate expression of iNOS in RASMC grown in full culture 
medium.
Induction of nitrite accumulation into serum-free culture medium bathing 
RASMC
As a result of our observation that the presence of serum in the culture 
medium inhibits IFN-y-induced increases in nitrite accumulation into the 
medium bathing RASMC, all further experiments were carried out in serum- 
free culture medium.
Effects of LPS on nitrite accumulation into serum-free culture medium bathing 
RASMC
Following a 24 h Incubation with LPS from Salmonella typhosa, in the 
concentration range 1 - 1 0 0 0  ng mM, the level of nitrite accumulation into the 
serum-free culture medium bathing RASMC was no different from control 
unstimulated cells (fig 7.8). Higher concentrations of LPS (1 -100 pg mM) also 
had no effect on nitrite accumulation (fig 7.9). Extremely high concentrations of 
LPS (300 pg ml-i and 1000 pg mb'*) did significantly increase nitrite 
accumulation into the serum-free culture medium bathing RASMC but these 
concentrations clearly produced toxic actions, resulting in detachment of cells 
from the growth surface. The effects of a second type of LPS, i.e. from 
Esherichia coll, were examined and compared with those of S. typhosa. 
Incubation for 24 h with LPS from E. coll in the concentration range 0.1 -1000 
ng mb'* had no consistent effect on nitrite accumulation into the serum-free 
culture medium bathing RASMC, but statistically the concentrations of 10 ng 
mb'* and 1000 ng ml-"* did produce small but significant increases (fig 7.10).
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Figure 7.8: Nitrite accumulation (nmol per 10® cells) into the serum-free culture 
medium bathing rat aortic smooth muscle cells following a 24 h incubation with 
lipopolysaccharide from Salmonella typhosa (LPS; 1 - 1000 ng mM). Each 
value is the mean of 6  observations with vertical bars representing the s.e. 
mean.
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Figure 7.9; Nitrite accumulation (nmol per 10® cells) into the serum-free culture 
medium bathing rat aortic smooth muscle cells following a 24 h incubation with 
lipopolysaccharide from Salmonella typhosa (LPS; 1 - 1000 pg ml-^). Each 
value is the mean of 6  observations with vertical bars representing the s.e. 
mean. * P<0.05 and *** P<0.005, indicate a significant difference from control 
(c), but these concentrations of LPS resulted in detachment of cells indicating 
a toxic action.
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Figure 7.10: Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with lipopolysaccharide from Escherichia coii (LPS; 0.1 - 1000 ng 
m|-i). Each value is the mean of 6  observations with vertical bars representing 
the s.e. mean. ** P<0.01 and *** P<0.005, indicate a significant difference from 
control (c).
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Effects of IFN-y on nitrite accumulation into the serum-free culture medium 
bathing RASMC
Incubation for 24 h with IFN-y in the concentration range 1 - 100 u mM 
produced a concentration-dependent increase in nitrite accumulation into the 
serum-free culture medium bathing RASMC (fig 7.11).
Time course of the effects of IFN-r on nitrite accumulation into the serum-free 
culture medium bathing RASMC
Effects of IL-1 a on nitrite accumulation into serum-free culture medium bathing 
RASMC
Incubation for 24 h with a different cytokine, IL-la, in the concentration range 
1 - 1 0  u mM, produced a concentration-dependent increase in nitrite 
accumulation into the serum-free culture medium bathing RASMC (fig 7.13).
Having established that LPS had no consistent effect on nitrite accumulation 
into the serum-free culture medium bathing RASMC, and that IFN-y and IL-la 
each stimulated an increase, a new series of experiments were conducted to 
determine the effects of combinations of these stimuli.
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A separate experiment was conducted to determine the time course of the 
increase in nitrite production stimulated by IFN-y. The level of nitrite 
accumulation into the serum-free culture medium bathing RASMC produced 
by IFN-y became significantly greater than for unstimulated cells at 9 h and 
levels continued rising faster than for control cells until at least 74 h (fig 7.12). 
For convenience, a time point of 24 h was adopted for all further experiments, 
since at this time a significant increase in nitrite accumulation was obtained.
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Figure 7.11: Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with interferon-y (IFN; 1 - 100 u ml-^). Each value is the mean of 6  
observations with vertical bars representing the s.e. mean. ** P<0.01 and *** 
P<0.005, indicate a significant difference from control (c).
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Figure 7.12; Time course of nitrite accumulation (nmol per 10® cells) into the 
serum-free culture medium bathing rat aortic smooth muscle cells, incubated 
in the absence (control; ^  ) or presence of interferon-y (IFN; 30 u 
mM; ™  ). Each value is the mean of 6  observations with vertical bars 
representing the s.e. mean. * P<0.05 and *** P<0.005, indicate a significant 
difference from control cells at same time point.
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Figure 7.13: Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with interleukin-1 a (IL1; 1 - 10 u mM). Each value is the mean of 6  
observations with vertical bars representing the s.e. mean. *** P<0.005, 
indicates a significant difference from control (c).
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Combined effects of LPS and IFN-von nitrite accumulation into the serum-free
culture medium bathing RASMC
Incubation for 24 h with the combination of a low concentration of IFN-y (10 u 
mM), which itself had no effect on nitrite accumulation, and LPS (100 ng ml-i), 
which in this case significantly decreased nitrite accumulation, produced a 
significant increase in nitrite accumulation into the serum-free culture medium 
bathing RASMC (fig 7.14a). In contrast, if a higher concentration of IFN-y (30 u 
ml'''), which itself significantly increased nitrite accumulation, was used in 
combination with LPS (100 ng ml-''), there was no further increase in nitrite 
accumulation over that seen with IFN-y alone (fig 7.14b). Thus, additivity was 
seen between the effects of LPS and IFN-y but only when sub-threshold 
concentrations of the agents were used.
Combined effects of IFN-y and iL-1 a on nitrite accumulation into the serum- 
free culture medium bathing RASMC
In order to investigate possible interactions between IFN-y and IL-1 a  the 
effects of combinations of both drugs were examined.
Incubation for 24 h with the combination of IFN-y ( 30 u mM), which itself 
stimulated nitrite accumulation, and a sub-threshold concentration of IL-1 a  (1 
u mM), produced no further increase in nitrite accumulation into the serum-free 
culture medium bathing RASMC over that produced by IFN-y alone (fig 7.15a). 
In contrast, when the effective concentration of IFN-y (30 u ml-'') was 
combined with a concentration of IL-1 a  (10 u ml-''), which alone increased 
nitrite accumulation, a larger increase in nitrite accumulation was obtained 
than that induced by either alone (fig 7.15b). Thus, additivity was seen 
between IFN-y and IL-1a but only when both were used at concentrations 
which themselves were effective.
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Figure 7.14; Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with lipopolysaccharide (LPS; 100 ng ml-'' ) or interferon-y (IFN; a, 
10 u ml-i and b, 100 u ml-"') alone and in combination. Each value is the mean 
of 6  observations with vertical bars representing the s.e. mean. *** P<0.005 
and ** P<0.01, indicate a significant difference from control (c) and 
P<0.005, indicates a significant difference from either drug alone.
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Figure 7.15: Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with interferon-y (IFN; 30 u ml-'') and interleukin-1 a (IL1; a, 1 u 
mMand b, 10 u ml-"') alone and in combination. Each value is the mean of 4 - 
5 observations with vertical bars representing the s.e. mean. *** P<0.005 and 
### p<o.005, indicate a significant difference from control (c) and from either 
drug alone, respectively.
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Inhibition of the increase in nitrite accumulation into serum-free culture
medium bathing RASMC stimulated bv cytokines
Having established that the cytokines IFN-y and IL-1 a increased accumulation 
of nitrite into the serum-free culture medium bathing RASMC, a series of 
experiments were conducted to determine if this nitrite was derived from NO 
produced by the L-arginine/NO pathway. These experiments involved the use 
of the inhibitors of NOS, l-NAME and l-NMMA (Gross et al., 1990; Rees et ai, 
1990b; McCall et al., 1993), as well as agents which inhibit the expression of 
iNOS, i.e. the corticosteriod, dexamethasone, and the protein synthesis 
inhibitor, cycloheximide (Di Rosa et al., 1990; Knowles et al., 1990b; Radomski 
et al., 1990b; Rees et al., 1990a).
Effects of Inhibitors of NOS on nitrite acoumulation into the serum-free culture 
medium bathing RASMC
The first Inhibitor of NOS examined in these experiments was l-NAME (Rees 
et al., 1990b; McCall et al., 1993). l-NAME (100 pM) had no effect on basal 
accumulation of nitrite into the serum-free culture medium bathing RASMC 
following a 24 h incubation (fig 7.16). However, L-NAME (100 pM) abolished 
the increase in nitrite accumulation produced by IFN-y (30 u ml-^).
Similarly, l-NAME (100 pM), when present during a 24 h incubation also 
inhibited the increase in nitrite accumulation into the serum-free culture 
medium bathing RASMC produced by the joint stimulus of LPS (1000 ng mM) 
and IFN-y (30 u mM; fig 7.17).
The second inhibitor of NOS examined was l-NMMA (Rees et a!., 1990b; 
McCall et al., 1993), which produced roughly similar results to l-NAME.
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Figure 7.16: Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with interferon-y (IFN; 30 u ml-'') and N^-nitro-L-arginine methyl 
ester (LNAME; 100 pM) alone and in combination. Each value is the mean of 4 
- 5 observations with vertical bars representing the s.e. mean. *** P<0.005 and 
P<0.005, indicate a significant difference from control (c) and from IFN 
alone, respectively.
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Figure 7,17: Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with the joint stimulus of interferon-y (IFN; 30 u ml-'') and 
lipopolysaccharide (LPS; 1000 ng ml-’') alone and in combination with 
N^-nitro-L-arginine methyl ester (LNAME; 100 pM). Each value is the mean of 
6  observations with vertical bars representing the s.e. mean. *** P<0.005 and 
### p<o.005, indicate a significant difference from control and from IFN 
together with LPS, respectively.
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Specifically, l-NMMA (300 pM) produced a small decrease in basal 
accumulation of nitrite into the serum-free culture medium bathing RASMC
incubation (fig 7.20a). However, cycloheximide (1 pg mM) had a tendency to 
reduce the increase in nitrite accumulation produced by IFN-y (30 u m l''). A 
higher concentrations of cycloheximide ( 1 0  pg ml-"') did decrease basal 
accumulation of nitrite as well as inhibit the increase produced by IFN-y (30 u
1 7 2
following a 24 h incubation (fig 7.18). Furthermore, L-NMMA (300 pM) also 
abolished the increase in nitrite accumulation produced by IFN-y (30 u ml-'*).
/fié
Thus, the effects of L-NAME and l-NMMA suggested that the increased 
accumulation of nitrite stimulated by cytokines arose from the L-arginine/NO 
pathway. They also suggest that this pathway was responsible for only a small 
component of the nitrite generated under basal conditions.
Effects of inhibitors of the expression of iNOS on nitrite accumulation into the 
serum-free culture medium bathing RASMC
The first inhibitor of expression of iNOS examined in these experiments was 
dexamethasone (Di Rosa et al., 1990; Knowles et al., 1990b; Rees et al.,
1990a). Dexamethasone (0.1 pM and 1 pM) produced concentration- 
dependent decreases in basal accumulation of nitrite into the serum-free 
culture medium bathing RASMC following a 24 h incubation (fig 7.19). 
Furthermore, dexamethasone (0.1 pM and 1 pM) abolished the increase in 
nitrite accumulation produced by IFN-y (30 u mM).
Roughly similar results were obtained with a second inhibitor of the expression 
of iNOS, the protein synthesis inhibitor, cycloheximide (Radomski et al.,
1990b). Cycloheximide (1 pg ml-'') had no effect on basal accumulation of 
nitrite into the serum-free culture medium bathing RASMC following a 24 h
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Figure 7.18: Nitrite accumulation (nmol per 10® cells) into the serum free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with interferon-y (IFN; 30 u ml-^) and NG-monomethyl-L-arginine 
(LNMMA; 300 pM) alone and in combination. Each value is the mean of 4 
observations with vertical bars representing the s.e. mean. *** P<0.005 and 
### p<o.005, indicate a significant difference from control (c) and from IFN, 
respectively.
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Figure 7.19: Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with interferon-y (IFN; 30 u mM) and dexamethasone (DEX ; 0.1 pM 
or 1 pM) alone and in combination. Each value is the mean of 4 observations 
with vertical bars representing the s.e. mean. *** P<0.005 and P<0.005, 
indicate a significant difference from control (c) and from IFN, respectively.
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Figure 7.20: Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with interferon-y (IFN; 30 u mb'*) and cycloheximide (CY; a, 1 pg 
ml-'* or b, 1 0  pg mM) alone and in combination. Each value is the mean of 4 
observations with vertical bars representing the s.e. mean. *** P<0.005 and 
### p<0.005, indicate a significant difference from control (c) and from IFN, 
respectively.
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ml"''), but this concentration was associated with a toxic action on the ceils, 
namely detachment of cells from the growth surface (fig 7.20b).
Thus, the effects of dexamethasone and cycloheximide are consistent with the 
increased accumulation of nitrite stimulated by IFN-y arising from the 
expression of iNOS. The data also suggest that the extent to which the 
L-arginine/NO pathway contributes to basal nitrite accumulation is smalFbut 
varies from experiment to experiment.
Effects of Dolvmixin B, a scavenger of LPS. on nitrite accumulation into the 
serum-free culture medium bathing RASMC
Although LPS alone failed to stimulate increased accumulation of nitrite into 
the serum-free culture medium bathing RASMC, it was able to potentiate the 
actions of sub-threshold concentrations of IFN-y (fig 7.14a). Experiments were 
therefore conducted to determine if the effect of IFN-y alone was influenced to 
any extent by endotoxin which might be contaminating the culture medium. 
These experiments were conducted using the antibiotic, polymixin B, which 
binds and inactivates bacterial LPS (Lasfargues et ai, 1989).
Incubation for 24 h with polymixin B (1 , 1 0  or 30 u mM) had no effect on the 
basal accumulation of nitrite into the serum-free culture medium bathing 
RASMC (fig 7.21a, b and c). Similarly, polymixin B (1, 10 or 30 u mM) had no 
effect on the increase in nitrite accumulation into the serum-free culture 
medium produced by IFN-y (30 u mM). It was therefore unlikely that 
contamination of the culture medium by LPS played any part in the increase in 
nitrite accumulation produced by IFN-y.
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Figure 7.21: Nitrite accumulation (nmol per 10® cells) into the serum-free 
culture medium bathing rat aortic smooth muscle cells following a 24 h 
incubation with interferon-y (IFN; 30 u ml-i) and polymixin B (PMB; a, 1 pg 
ml-i; b, 1 0  pg mM or c, 30 pg ml-i) alone and in combination. Each value is 
the mean of 6  observations with vertical bars representing the s.e. mean. *** 
P<0.005, indicates a significant difference from control (c).
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In the previous chapter it was established that expression of inducible nitric 
oxide synthase (iNOS) in rat aortic smooth muscle cells (RASMC) stimulated 
by cytokines could be assessed by measuring the accumulation of nitrite, a 
major stable breakdown product of nitric oxide (NO) (Wennmalm et al., 1992; 
Ignarro et al., 1993), into the bathing medium. In this section verification of 
expression of iNOS was sought by measuring the cellular content of cyclic 
GMP, the second messenger by which NO produces its actions in vascular 
smooth muscle (Rapoport & Murad, 1983).
As in the previous chapter, in order to avoid the inhibitory actions of serum on 
expression of iNOS, all experiments were conducted on cells grown for 24 h in 
serum-free culture medium. Thereafter, they were washed and fresh serum- 
free culture medium was added before the experiment was begun.
Effects of LPS on cyclic GMP content of RASMC
In the previous chapter, it was shown that lipopolysaccharide (LPS) from 
Salmonella typhosa had no effect on accumulation of nitrite into the medium 
bathing RASMC except at extremely high concentrations. A similar action of 
LPS was seen when measuring the cyclic GMP content of RASMC. 
Specifically, incubation for 24 h with LPS from S. typhosa, in the concentration 
range 1 - 100 pg ml-i produced no significant change in the cyclic GMP 
content of RASMC in culture (fig 8.1). However, extremely high concentrations 
of LPS (300 pg ml“i and 1000 pg m|-i) did increase the cyclic GMP content of 
RASMC, but this was associated with toxicity, resulting in detachment of the 
cells from the growth surface.
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Figure 8.1: Cyclic GMP content (pmol per 10® cells) of rat aortic smooth 
muscle cells in culture following a 24 h incubation with lipopolysaccharide 
(LPS; 1 - 1000 pg mM). Each value is the mean of 4 observations with vertical 
bars representing the s.e. mean. *** P<0.005, indicates a significant difference 
from control (c), however these concentrations of LPS resulted in detachment 
of cells from the growth surface indicating a toxic action.
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Effects of !L~1 a on cyclic GMP content of RASMC
Incubation for 24 h with interleukin-1 a (IL-1 a) in the concentration range 1 -10 
u produced a concentration-dependent increase in cyclic GMP content of 
RASMC in culture (fig 8.2).
Combined effects of LPS and IFN-von cyclic GMP content of RASMC
l-NAME (100 pM and 3 mM) had no effect on the cyclic GMP content of 
unstimulated RASMC incubated for 24 h (fig 8.4a and b). Also, L-NAME (100 
pM) had no effect on the increase in cyclic GMP content of RASMC stimulated 
by IFN-y (30 u mM; fig 8.4a). However, the higher concentration of 3 mM did 
inhibit the increase in cyclic GMP content of RASMC stimulated by IFN-y (30 u 
m |i; fig 8.4b).
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Incubation for 24 h with interferon-y (IFN-y; 30 u mM) produced a significant 
increase in the cyclic GMP content of RASMC (fig 8.3). When LPS (5 pg mM), 
which alone had no effect, was incubated together with IFN-y (30 u mM), the 
increase in cyclic GMP content was no greater than the increase seen with 
IFN-y (30 u ml'i) alone (fig 8.3). Thus, there was no apparent interaction 
between IFN-y and LPS on the cyclic GMP content of RASMC.
Effects of inhibitors of NOS on cyclic GMP content of RASMC
Having found that the cytokines, IFN-y and IL-1 a  increased the cyclic GMP 
content of RASMC in culture, experiments were conducted using 
N^-nitro-L-arginine methyl ester (l-NAME), an inhibitor of NOS (Rees et al., 
1990b; McCall et a!., 1993), to see if this increase was due to actions of NO 
produced by the L-arginine/NO pathway.
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Figure 8.2: Cyclic GMP content (pmol per 10® cells) of rat aortic smooth 
muscle cells in culture following a 24 h incubation with interleukin-1 a (IL1; 1 - 
10 u mM). Each value is the mean of 4 observations with vertical bars 
representing the s.e. mean. ** P<0.01, indicates a significant difference from 
control (c).
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Figure 8.3: Cyclic GMP content (pmol per 10® cells) of rat aortic smooth 
muscle cells in culture following a 24 h incubation with interferon-y (IFN; 30 u 
mM) and lipopolysaccharide from Salmonella typhosa (LPS; 5 pg mi-i) alone 
and in combination. Each value is the mean of 4 - 6  observations with vertical 
bars representing the s.e. mean. *** P<0.005, indicates a significant difference 
from control (c).
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Figure 8.4: Cyclic GMP content (pmol per 10® cells) of rat aortic smooth 
muscle cells In culture following a 24 h incubation with interferon-y (IFN; 30 u 
mM) and NG-nitro-L-arginine methyl ester (LNAME; a, 100 pM and b, 3 mM) 
alone and in combination. Each value is the mean of 4 - 6  observations with 
vertical bars representing the s.e. mean. * P<0.05 and P<0.01, indicate a 
significant difference from control and from IFN (30 u ml-'') alone, respectively.
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Similarly, the lower concentration of l-NAME (100 pM) did not inhibit the 
increase in cyclic GMP content of RASMC following a 24 h incubation with the 
combined stimulus of LPS (1000 ng ml-i) and IFN-y (30 u ml-i; fig 8.5).
Effects of dexamethasone on cyclic GMP content of RASMC
In order to further investigate the possibility that the increase in cyclic GMP 
content of RASMC in culture stimulated by IFN-y resulted from the actions of 
NO produced by iNOS the effects of dexamethasone were investigated. 
Dexamethasone has previously been shown to inhibit the expression of iNOS 
(Di Rosa et al., 1990; Knowles et al., 1990b; Rees et al., 1990a).
The presence of dexamethasone (1 pM) had no effect on the cyclic GMP 
content of unstimulated RASMC in culture following a 24 h incubation (fig 8 .6 ). 
In contrast, a two hour pre-treatment with dexamethasone did prevent the 
increase in cyclic GMP content of RASMC stimulated by IFN-y (30 u mM).
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Figure 8.5: Cyclic GMP content (pmol per 10® cells) of rat aortic smooth 
muscle cells in culture following a 24 h incubation with the combined stimulus 
of interferon-y (IFN; 30 u ml-i) and lipopolysaccharide (LPS; 1000 ng mM) 
alone and in combination with NG-nitro-L-arginine methyl ester (LNAME; 100 
pM). Each value is the mean of 4 - 6  observations with vertical bars 
representing the s.e. mean. *** P<0.005, indicates a significant difference from 
control (c).
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Figure 8 .6 : Cyclic GMP content (pmol per 10® cells) of rat aortic smooth 
muscle cells in culture following a 24 h incubation with interferon-y (IFN; 30 u 
ml-i) and dexamethasone (DEX; 1 pM) alone and in combination. Each value 
is the mean of 4 observations with vertical bars representing the s.e. mean. *** 
P<0.005 and P<0.005, indicate a significant difference from control (c) 
and from IFN (30 u ml-i ), respectively.
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Effects of modulating 
cytokine activity on the 
depression of 
phenylephrine-induced 
contraction of rat aortic
rings
188
The results of the previous chapters have shown that lipopolysaccharide (LPS) 
alone appeared able to stimulate the expression of inducible nitric oxide 
synthase (iNOS) in the wall of rat isolated endothelium-denuded aortic rings. 
In contrast, LPS was unable to stimulate expression in rat aortic smooth 
muscle cells (RASMC) in culture without the additional presence of a cytokine. 
One possible explanation for this apparent difference is that non-smooth 
muscle cells in the aortic wall could respond to LPS by releasing a cytokine 
which then diffuses to the smooth muscle cells resulting in expression of iNOS. 
This hypothesis was tested by examining the actions of inhibitors of cytokine 
activity. The inhibitors used were pentoxifylline, which inhibits transcription of 
mRNA for tumour necrosis factor-a (TNF-a)(Strieter et a!., 1988; Han et a!., 
1990; Doherty et al., 1991), and a panel of antibodies to the cytokines TNF-a, 
interleukin-1(3 (IL-lp) and interferon-y (IFN-y).
Effects of pentoxifylline on the depression of PE-induced contraction
As indicated previously (chapter 6 ), overnight (18 h) incubation of rat aortic 
rings in Krebs solution at 37°C led to depression of the ability of phenylephrine 
(PE, 0.1 nM - 10 pM) to induce contraction and this was partly reversed 
following addition of the NOS inhibitor, N^-nitro-i-arginine methyl ester (L- 
NAME; 100 or 300 pM)(Rees et a!., 1990b; McCall et ai, 1993), to the tissue 
baths (fig 9.1). When the inhibitor of TNF-a, pentoxifylline (0.1 - 10 pM) was 
present during the overnight (18 h) incubation, the depression of PE-induced 
contraction was completely unaffected (fig 9.1a, b & c). Furthermore, 
pentoxifylline (0.1 - 10 pM) did not significantly alter the ability of l-NAME (100 
pM or 300 pM) to produce a partial reversal of the depression of PE-induced
contraction.
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Figure 9.1: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 0.1 nM - 10 pM) on endothelium-denuded rings of rat 
aorta: freshly isolated rings (•); rings incubated at 37°C for 18 h in Krebs 
solution (■); rings incubated overnight in Krebs solution containing 
pentoxifylline (a; a, 0.1 pM; b, 1 pM and c,10 pM); rings incubated overnight in 
Krebs solution followed by treatment with N^-nitro-i-arginine methyl ester 
(l-NAME; t ; a and c, 300 pM and b, 100 pM); and rings incubated with 
pentoxifylline and then treated with l-NAME (♦; a and c, 300 pM and b, 100 
pM). Each point is the mean of 3 - 16 observations with vertical bars 
representing the s.e. mean. * P<0,05, indicates a significant difference from 
freshly isolated rings and ^  P<0.005 indicates a significant difference from 
rings incubated at 37°C for 18 h and from rings incubated at 37°C in the 
presence of pentoxifylline.
I
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Effects of a monocional antibody to TNF-a on the depression o f PE-
When present throughout an overnight (18 h) incubation of rat aortic rings, a
:
s
I
induced contraction   -
monoclonal antibody to mouse TNF-a (anti-m TNF-a, prepared from rat-
mouse hybrid cells, clone 1VIP6-XT3) used at 10 and 30 pg mh^  had no effect 
on the depression of PE (0.1 nM - 10 pM)-induced contraction (fig 9.2). 
Furthermore, the presence of anti-m TNF-a (10 and 30 pg ml-i) did not 
significantly alter the ability of L-NAME (100 pM) to reverse the depression of 
PE (0.1 nM -10 pM)-induced contraction (fig 9.2).
Effects of a monocional antibody to IL-J6 on the depression of PE- 
induced contraction I
When present throughout an overnight (18 h) incubation of rat aortic rings a 
monoclonal antibody to human IL-1(3 (anti-m IL-ip, prepared from mouse-rat 
hybrid cells, clone P3x63Ag 8.653) used at 10 and 50 pg ml-i had no effect on 
the depression of PE (0.1 nM - 10 pM)-induced contraction (fig 9.3). 
Furthermore, the presence of anti-m IL-1p (10 pg ml-'*) did not significantly 
alter the ability of L-NAME (100 pM) to reverse the depression of PE (0.1 nM - 
10 pM)-induced contraction (fig 9.3a). However, anti-m IL-1p at 50 pg mh  ^ but 
not 10 pg ml-'* appeared to enhance the ability of l-NAME (100 pM) to reverse 
the depression of PE-induced contraction, but only at sub-maximal levels of 
contraction, i.e. in the concentration range of PE from 30 - 300 nM (fig 9.3b).
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Figure 9.2: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 0.1 nM - 10 pM) on endothelium-denuded rings of rat 
aorta: freshly isolated rings (•); rings incubated at 37°C for 18 h in Krebs 
solution (■); rings incubated overnight in Krebs solution followed by treatment 
with l-NAME (300 pM; A); rings incubated overnight in Krebs solution 
containing the monoclonal antibody to tumour necrosis factor-a (v; a, 1 0  pg 
ml-i, and b, 30 pg mM); and rings incubated with the monoclonal antibody to 
tumour necrosis factor-a and then treated with N^-nitro-i-arginine methyl ester 
(l-NAME; ♦). Each point is the mean of 3 - 16 observations with vertical bars 
representing the s.e. mean. * P<0.005, indicates a significant difference from 
freshly isolated rings; ^  P<0.005, indicates a significant difference from rings 
incubated at 37*C for 18 h and from rings incubated in the presence of 
pentoxifylline.
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Figure 9.3: Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 0.1 nM - 10 pM) on endothelium-denuded rings of rat 
aorta: freshly isolated rings (•); rings incubated at 37°C for 18 h in Krebs 
solution (■); rings incubated overnight in Krebs solution followed by treatment 
with N^-nitro-L-arginine methyl ester (l-NAME; 100 pM; v); rings incubated 
overnight in Krebs solution containing the monoclonal antibody to 
interleukin-1 p (a ; a, 1 0  pg ml-i and b, çO pg ml-'); and rings incubated with the 
monoclonal antibody to interleukin-1 (3 and then treated with L-NAME (♦). Each 
point is the mean of 3 -16 observations with vertical bars representing the s.e. 
mean. * P<0.005, indicates a significant difference from freshly isolated rings; 
^ P<0.005, indicates a significant difference from rings incubated at 37°C for 
18 h and from rings incubated in the presence of pentoxifylline; and ^ 
P<0.005, indicates a significant difference from rings incubated at 37°C 
followed by treatment with L-NAME.
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Effects of a monoclonal antibody to IFN -r on the depression of PE-
induced contraction
When present throughout an overnight (18 h) incubation a monoclonal 
antibody to mouse IFN-y (anti-m IFN-y, prepared from rat-mouse hybrid, clone 
XMG1.2) and used at 10 and 30 pg ml-i had no effect on the depression of PE 
(0.1 nM - 10 pM)-induced contraction (fig 9.4). The presence of anti-m IFN-ly 
(10 pg ml"i) did appear, to reduce the ability of L-NAME (100 pM) to reverse 
the depression of PE-induced contraction, in the concentration range of PE 
from 1 to 3 pM (fig 9.4a). However, the ability of l-NAME (100 pM) to reverse 
the depression of PE (0.1 nM -10 pM)-induced contraction was unaffected by 
anti-m IFN-ly at 30 pg mM (fig 9.4b).
!
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Figure 9.4; Concentration-response curves showing the contractile effects of 
phenylephrine (PE; 0.1 nM - 10 pM) on endothelium-denuded rings of rat 
aorta: freshly isolated rings (•); rings incubated at 37°C for 18 h in Krebs 
solution (■); rings incubated overnight in Krebs solution followed by treatment 
with N^-nitro-L-arginine methyl ester (L-NAME; 100 pM; a ); rings incubated 
overnight in Krebs solution containing the monoclonal antibody to interferon-y 
(t ; a, 1 0  pg ml-i and b, 30 pg mM); and rings incubated with the monoclonal 
antibody to interferon-y and then treated with l-NAME (♦). Each point is the 
mean of 3  - 16 observations with vertical bars representing the s.e. mean. * 
P<0.005, indicates a significant difference from freshly isolated rings; ^  
P<0.01, indicates a significant difference from rings incubated at 37°C for 18 h 
and from rings incubated in the presence of pentoxifylline; $ P<0.01, indicates 
a significant difference from rings incubated at 37°C for 18 h in presence of 
pentoxifylline; and ^ P<0.05, indicates a significant difference from rings 
incubated with pentoxifylline and treated with l-NAME.
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In this study an examination and comparison was made of a variety of different 
techniques for the indirect measurement of nitric oxide (NO) production. None 
of the detection systems employed measured native NO as this radical has a 
very short half life of 3 - 50 s (Griffith et al., 1984; McCall & Vallance, 1992). 
The first systems we examined measured nitrite or combined nitrite/nitrate, the 
stable metabolites of NO (Wennmalm et a!., 1992; Ignarro et a!., 1993). The 
systems employed to measure nitrite were the Griess reaction (Green et a!., 
1982), a chemiluminescence detection system using two different reducing 
systems (1,1 '-dimethylferrocene/acetonitrile or sodium iodide/glacial acetic 
acid reflux) (Cox, 1980; Tracey et a!., 1990) and a fluorometric detection 
system (Damiani & Burini, 1986). The Griess reaction and the fluorometric 
detection system measure nitrite directly but the chemiluminescence system 
measures NO, thus making a prior reduction step necessary. Combined 
measurement of the two stable metabolites of NO, nitrite and nitrate, were 
made by the chemiluminescence detection system but in the presence of a 
stronger reducing solution (vanadium chloride/hydrochloric acid) (Braman & 
Hendrix, 1989).
The other detection systems examined, which do not involve measurement of 
the breakdown products of NO, were cyclic GMP content and relaxation of 
blood vessels. Cyclic GMP is the second messenger system employed by NO 
(Rapoport & Murad, 1983). The vasodilator action of NO in blood vessels has 
also been used as a means of bioassaying the amount of this vasodilator 
being produced. For example, many investigators have used cascade 
bioassay systems in which NO produced by endothelium-containing vessels 
(Griffith et a!., 1984) or endothelial cells grown on microcarrier beads (Angus 
et a!., 1986) was detected on endothelium-denuded arteries. Furthermore, the 
endothelium-dependent depression of contraction seen in many blood vessels 
has been used as a means of assessing indirectly basal production of NO
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(Martin et al., 1986). A variant of this last technique was employed in this study 
whereby depression of the contraction induced by phenylephrine (PE) was 
used as a means of assessing production of NO in endothelium-denuded rings 
of rat aorta following expression of inducible nitric oxide synthase (iNOS).
The sensitivity and utility of each of these systems was evaluated using 
different cell and tissue preparations, i.e. J774.2 murine macrophages, bovine 
aortic endothelial cells (BAEC) in culture, rat aortic smooth muscle cells 
(RASMG) in culture and endothelium-denuded rings of rat aorta. These 
preparations were chosen because the literature suggests that each could 
express iNOS and so should produce large quantities of NO.
The second part of this study involved examining in detail the factors 
controlling expression of iNOS in rat aorta and in cultured RASMG.
The Griess Reaction
The Griess reaction is a well established technique for the measurement of 
nitrite, the major in vitro breakdown product of NO (Wennmalm et al., 1992; 
Ignarro et al., 1993). It has been widely used to measure nitrite produced by 
the L-arginine/NO pathway in macrophages (Stuehr & Marietta, 1985; Stuehr & 
Marietta, 1987a; Di Rosa et al., 1990; Gross et al., 1990), endothelial cells 
(Schmidt et al., 1988), vascular smooth muscle cells (Schini et al., 1992) and 
hepatocytes (Geller et al., 1993b). Although this system can only measure 
nitrite, nitrate can additionally be measured by converting it to nitrite by 
passage over a cadmium column (Green et a!., 1981a; Green et al., 1981b). 
This technique was used to show that nitrate was synthesised in man (Green 
et al., 1981a) and in rats (Green et al., 1981b) by measuring the content of the 
urine.
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The Griess reaction involves the formation of a complex between nitroxides 
and sulfaniiic acid which reacts with N-(l-naphthyl) ethylenediamine 
generating a product easily measured spectrophotometrically (Green et al., 
1982). We found that this reaction can easily measure nitrite in biological 
samples, with a threshold sensitivity of 300 pmol and linearity between 300 - 
9000 pmol. Others have stated the threshold sensitivity to be 500 - 1000 pmol 
(Green et al., 1982; Tracey et al., 1990). In addition to its inability to measure 
nitrate, as stated previously, the Griess reaction is also not entirely specific for 
nitrite, as nitrosothiols and nitrosamines also react giving an identical coloured 
product (Downes et al., 1976; Tracey et al., 1990). The presence of these 
agents in biological samples would therefore give 'false' readings. The Griess 
reaction could, however, easily measure large numbers of samples using the 
same batch of reagents, thus permitting speedy, efficient and convenient 
conduction of assay. Another advantage was that once the reagents were 
mixed with the samples, the coloured product was stable for at least 24 h 
when kept at 4°G, and so measurement did not have to be made immediately; 
they could have been made many hours later with no fear of loss of sensitivity.
A number of other problems were associated with this measuring technique. 
These included the fact that the turbidity of the samples could interfere with 
the spectrophotometric measurements. To reduce turbidity samples were spun 
in a microcentrifuge before the Griess reagents were added. Also, the colour 
of the medium resulting from the presence of the pH indicator, phenol red, as 
well as other constituents may affect the measurements, but to compensate 
for these the standard curve was prepared by dissolving sodium nitrite in the 
same culture medium (DMEM) as was used for experimentation.
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Chemiluminescence detection systems
Chemiluminescence systems have been widely used and are reported to be 
more sensitive than the Griess reaction. Another advantage of one of these 
detection systems is its ability to measure both of the major breakdown 
products of NO, i.e. nitrite and nitrate, in the presence of strong reducing 
solutions (Braman & Hendrix, 1989). The reducing solutions tested in this 
study were 1,1 '-dimethylferrocene/acetonitrile (Tracey et al., 1990) and sodium 
iodide/glacial acetic acid (Cox, 1980), both of which reduce nitrite back to NO, 
and vanadium chloride/hydrochloric acid (Braman & Hendrix, 1989), which 
reduces both nitrite and nitrate to NO.
The basis of the mechanism of detection is that NO formed reacts with ozone 
generated within the chemiluminescence analyser to produce N0 ®2 , which is 
highly unstable and spontaneously decomposes to NO2 emitting light. In our 
study, it was this light that was measured by a photomultiplier tube and 
displayed on a computer and a Linseis recorder. The amount of light detected 
was directly proportional to the amount of NO generated from either nitrite 
and/or nitrate.
1.1 '-Dimethylferrocene/acetonitrile system
The first chemiluminescence technique we investigated was the
1.1 '-dimethylferrocene/acetonitrile system. This system was described by 
Termin et al. (1992) who used it to measure nitrite production by harvested 
bovine aortic endothelial cells. The system initially looked attractive as there 
was no need for reflux involving the potentially dangerous boiling acid during 
the reduction of nitrite to NO (Termin et al., 1992). Termin's group report that 
this system was sensitive to nitrite at 50 pmol and above but we found that the 
signals generated from nitrite were small, difficult to discern from the
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background noise and were long in duration. The slow generation of signals 
suggested a slow and inefficient reduction of nitrite to NO. We also found the 
sensitivity of this system to be much lower, with a threshold detection limit of 
nearer 500 pmol, but even then samples were hard to read. Thus, we found 
this system impractical to use.
Sodium iodide/alacial acetic acid reflux system
The second chemiluminescence technique we investigated was the sodium 
iodide/glacial acetic acid reflux system. This system was already well 
established before our study and detects nitrite (Cox, 1980; Palmer et al.,
1987). The system had previously been used to measure nitrite produced by 
porcine aortic endothelial cells (Palmer et al., 1987) and blood platelets 
(Radomski et al., 1987b). In fact it was this system which Palmer et al. (1987) 
originally used to demonstrate that the amount of NO produced by endothelial 
cells was sufficient to account for the biological activity of endothelium-derived 
relaxing factor (EDRF). However, it was also this system that Myers et al. 
(1989) used to claim that the amounts of NO produced by endothelial cells 
were 7 - 10-fold too low to account for the actions of EDRF. Instead, these 
authors suggested that EDRF was more likely to be an S-nitrosothiol than free 
NO (Myers et al., 1989).
One major disadvantage with this system is it involves reflux of boiling acid at 
high temperature (65°C) to reduce nitrite back to NO (Cox, 1980). This is 
clearly a dangerous procedure which requires to be performed in a safety 
cabinet to safeguard the experimenter.
We found that this system produced fast ( 1 - 2  min to peak) signals which 
were easily distinguishable from the background noise and could measure 
nitrite levels as low as 100 pmol, making it 3 times more sensitive than the
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Griess reaction. The sensitivity of this system has, however, been reported to 
vary in the literature. For example, Cox (1980) found a threshold of 300 pmol, 
but Palmer et al. (1987) were able to measure values as low as 70 pmol. The 
latter group, in fact, reported that electronic modification of their commercially 
available detector was necessary to obtain such a high sensitivity. Using our 
system, when the amount of nitrite (100 - 1000 pmol) injected was plotted 
against the peak signal obtained the resulting relationship though reasonably 
proportional was not strictly linear. This was probably due to samples with a 
large volume reducing the temperature of the reflux system thus leading to 
slow generation of NO. Indeed, large sample volumes were clearly seen to 
stop the reducing solution from boiling. Theoretically, under these situations it 
would be expected that measuring the entire area under the curve of the 
signal would provide a more reliable index and indeed this was the case. 
When the amount of nitrite injected was plotted against the area under the 
curve of the signal a good linear relationship was obtained. Consequently,
A major concern using this, as well as other reducing systems, is that they 
lead to the generation of NO not just from nitrite but also from other nitrogen- 
containing compounds, e.g. nitrosothiols and nitrosamines (Myers et al., 
1990). Consequently, a number of compounds and reagents used in our 
experiments were examined to determine if they could interfere with the 
measurement of NO production by cells through the generation of 'false' 
positive signals. These included nitrate, the major in vivo product of NO 
(Wennmalm et al., 1992); L-arginine, the precursor of NO (Palmer et al., 1988) 
and a number of L-arginine analogues that inhibit NOS, l-NOARG and 
l-NMMA (Rees et al., 1990b; Moore et al., 1990). In fact, none of these 
compounds were found to produce a chemiluminescence signal using this 
system.
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measuring the area under the curve vms adopted as the routine means of 
assessing the signals generated by standards and biological samples.
I
The media used for experimentation were also examined. Bicarbonate- and 
HEPES-buffered Krebs solutions, similarly produced no signals using this 
system. However, the culture media and some of the constituents added to 
culture media did produce chemiluminescence signals. Signals were produced 
by Dulbecco's Modified Eagles Medium (DMEM), HEPES-buffered DMEM and 
new born serum (NBS). Serum is known to contain nitrite at 2 - 5 pM and this 
probably accounts entirely for the signals produced by NBS. In our samples,
100 pi NBS produced a signal of 220 ± 33 ppb which is equivalent to ~250 
pmol (i.e. 2.5 pM). However, neither type of DMEM contains nitrite and so 
another constituent must be responsible for producing the chemiluminescence 
signals. We were unable to identify the agents responsible but a full list of 
constituents is shown in table 4.2. These signals due to DMEM, although of 
unknown origin, and NBS, from its nitrite content, were taken as background 
and subtracted from those of biological samples to obtain corrected levels of 
nitrite.
One disadvantage of this system over the Griess reaction was that measuring 
each sample took approximately 10 min, thus making the measurement of 
large sample numbers a long process. Thus, only 30 - 40 samples could be 
assayed conveniently each day compared to 200 using the automated plate 
reader with the Griess reaction. Also, the reducing solution lasted 
approximately 2 days which sometimes made it difficult to measure all the
..
samples from a single experiment using the same batch.
Vanadium chloride/hvdrochloric acid reflux system
The third chemiluminescence technique we investigated was the vanadium 
chloride/hydrochloric acid reflux system which is reported to reduce both nitrite 
and nitrate to NO (Braman & Hendrix, 1989; Bush et al., 1992). Again, like the 
sodium iodide glacial acetic acid system, reflux at high temperature (95°C)
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was required. This system had also been well established before we began 
our study (Braman & Hendrix, 1989; Bush et al., 1992) and had been used 
successfully to measure the nitrite/nitrate content of human blood serum and 
urine (Braman & Hendrix, 1989) as well as to detect NO produced by rat 
cerebellum (Bush et al., 1992).
We found, in common with the sodium iodide/glacial acetic acid system, that 
the vanadium chloride/hydrochloric acid reflux system also produced fast ( 1- 2  
min to peak) signals which were easily distinguishable from the background 
noise. The system, in fact, could not distinguish between nitrite or nitrate and 
similar amounts of these produced identical signals. The assay could measure 
nitrite and/or nitrate levels as low as 200 pmol making it more sensitive than 
the Griess reaction but not as sensitive as the sodium iodide/glacial acetic acid 
reflux system. Other papers report a higher sensitivity of around 100 pmol 
(Braman & Hendrix, 1989; Bush et al., 1992) but again this may be dependent 
on the nature of the individual detectors used. The ability to measure both 
metabolites of NO should potentially make this system more efficient than the 
sodium iodide/glacial acetic acid reflux system. When the amount of nitrite 
and/or nitrate (200 - 1000 pmol) was plotted against the peak signals obtained 
the resulting relationship although roughly proportional was not strictly linear. 
Thus, as with the sodium iodide/glacial acetic acid reflux system, this was 
likely to be due to large sample volumes lowering the temperature and thereby 
slowing the rate of reduction to NO. On the other hand, when the amount of 
nitrite and/or nitrate (200 - 1000 pmol) was plotted against the area under the 
curve of the signals the resulting line was linear.
Although on a theoretical basis this system should be more appropriate for the 
measurement of total oxides of nitrogen formed from NO, it suffered from a 
major drawback. Specifically, a number of compounds and reagents used in 
experiments, i.e. L-arginine, the endogenous substrate for NOS (Palmer et al.,
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1988), and L-arginine analogues, which inhibit NOS, l-NOARG and l-NMMA 
(Moore et al., 1990; Rees et al., 1990b), produced large chemiluminescence 
signais. These signals may have been due to the vanadium 
chloride/hydrochloric acid reflux reducing L-arginine and the L-arginine
analogues with the consequent release of NO from these compounds. 
Alternatively, the reducing conditions may have generated other substances 
from these compounds which reacted with ozone to produce 
chemiluminescence signals. Whatever their origin, these large signals 
produced by L-arginine and the L-arginine analogues severely limited the type 
of experimental sample which could be measured using this system.
The media in which experimentation was conducted were also examined. 
Bicarbonate-buffered Krebs solution produced no signal in this system. Unlike 
Krebs, however, culture media and some of the its constituents produced 
signals using this system. Signals were produced by DMEM, HEPES-buffered 
DMEM, foetal calf serum (PCS) and NBS. Each type of DMEM contained both 
nitrate (7400 pmol) and L-arginine (40000 pmol), thus we would expect larger 
signals if all the nitrate and L-arginine was reduced to NO but this does not 
seem to be the case. The possibility that other constituents of the culture 
media also contributed to the signal was not investigated. PCS and NBS both 
contain nitrite ( 2 - 5  pM) which should give a signal of 400 - 700 ppb but the 
signal generated is much larger so some other component of PCS and NBS 
must be producing a false signal. The signals due to DMEM, PCS and NBS 
were so large, in fact, that the smaller levels of nitrite and/or nitrate generated 
by cells were extremely difficult to discern. These difficulties were minimised, 
however, by ensuring that standards of nitrite and nitrate were made up in 
exactly the same medium as used for experimentation.
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In common with the sodium iodide/glacial acetic acid reflux system, it took 
approximately 10 min to assay each sample, thus making the measurement of
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large sample numbers a long process. Also, the reducing solution lasted 
approximately 2 days, again often making it difficult to assay all samples from 
a single large experiment using the same batch.
Fluorometric detection
The fluorometric detection system for nitrite was described by Damiani & 
Burini (1986). Misko at al. (1993) were the first to introduce this assay in the 
study of NO produced by cells. Specifically, this group used the technique 
successfully to examine inhibition of NO production by aminoguanidine, a 
selective iNOS inhibitor, in macrophages.
The fluorometric detection system is based on the reaction of nitrite with 
2,3-diaminonaphthalene (DAN) in acidic solution to form 
1 -[H]-naphthotriazone, a highly fluorescent compound when placed in alkaline 
conditions (Damiani & Burini, 1986; Misko et a/., 1993). This system could, like 
the Griess reaction and the chemiluminescence system with sodium 
iodide/glacial acetic acid, measure nitrite but not nitrate. In our experiments, 
the relationship between the amount of nitrite in standards and the intensity of 
fluorescence measured at 405 nm when excited at 365 nm was linear. The 
threshold sensitivity was approximately 120 pmol. Damiani & Burini (1986) 
reported a similar threshold sensitivity of 150 pmol. This system was thus 
more sensitive than the Griess reaction and the chemiluminescence detection 
system using vanadium chloride/hydrochloric acid but of an equal sensitivity to 
the chemiluminescence system using sodium iodide/glacial acetic acid.
This system too was not without limitations. For example, the 
1-[H]-naphthotriazone produced is only stable for approximately 10 min, 
rendering this system inappropriate for measuring large numbers of samples.
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Also, the turbidity of samples interfered with the measurements thus samples 
required firstly to be microcentrifuged quickly before assay.
Damiani & Burini (1986) have reported that interference in the measurement of
nitrite can occur in the presence of cations such as calcium (16 pM),
.magnesium (0.03 pM) and iron (0.06 pM) (Damiani & Burini, 1986). Certain
;anions, such as chlorine (1 mM) and sulphate (660 pM), were also reported to
interfere but higher concentrations were required except for sulphide (0.3 pM) 
which causes interference at relatively low concentrations (Damiani & Burini,
1986). Bicarbonate (16 pM) also interferes. In our system certain ions were 
present in the Krebs solution including chlorine as NaCI (118 mM), KOI (4.8 
mM) and CaCl2 (2.4 mM); calcium as CaCl2 (2.4 mM); sulphate as MgSO^ (1.2 
mM); magnesium as MgSO^ (1.2 mM); and bicarbonate as NaHCOg (2.4 mM). 
These ions would cause high background readings thus rendering this system 
hard to employ to measure small changes in nitrite concentrations, but to 
minimise these difficulties standards of nitrite were made up in exactly the 
same medium as used for experimentation.
Cyclic GMP detection
The cyclic GMP assay unlike the previous assays described does not measure 
NO or the breakdown products of NO, i.e. nitrite and nitrate, but measures the 
content of the second messenger system employed by the mediator (Rapoport 
& Murad, 1983). This assay is well characterised and has been used by many 
to demonstrate the activity of NO (Beasley et ai, 1991; Geller et ai, 1993b). It 
has also been used to assess the activity of iNOS in a number of cell types 
such as hepatocytes (Geller et ai, 1993b) and rat vascular smooth muscle 
cells (Beasley et ai, 1991) following activation by endotoxin and cytokines.
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The basis of this assay involves measuring cyclic GMP using a 
radioimmunoassay (RIA) where radioactive and non-radioactive antigen 
compete for a fixed number of binding sites. In our hands, the cyclic GMP 
assay could readily detect 1 fmol cyclic GMP and this agreed with other 
reports (Harper & Brooker, 1975). This assay is highly specific for cyclic GMP 
but it is important to bear in mind that it is not only NO that can activate soluble 
guanylate cyclase; arachidonic acid is reported to activate this enzyme 
(Ignarro & Wood, 1987) and so stimulate increases in cyclic GMP content. 
Furthermore, atrial natnuretic factor (Rapoport, 1986) can activate particulate 
guanylate cyclase leading to elevation of the second messenger. 
Consequently, this system should not be used on its own as an index of NO 
activity. When used, however, in conjunction with another measuring system 
such as the Griess reaction or chemiluminescence it should provide valuable 
supportive information.
Relaxation of blood vessels
Relaxation of blood vessels can also be used as a detection system for NO. 
Such assay systems have been used enormously where NO activity or 
production of nitrite or nitrite/nitrate were too small to be measured. For 
example,mthe first ever report on EDRF Furchgott and Zawadzki (1980) 
showed that placing an endothelium-containing strip of rabbit aorta close to an 
endothelium-denuded strip led to transfer of relaxation activity. Thus, EDRF 
was shown to be a humoral factor. Numerous cascade bioassay systems in 
which NO released from endothelium-containing rings (Griffith et ai., 1984) or 
endothelial cells grown on microcarrier beads was assayed on endothelium- 
denuded vessels have also been described. In addition, work on endothelium- 
containing and “denuded blood vessels from many species has demonstrated 
the existence of basal production of NO. Thus, endothelium-containing vessels 
are often less sensitive to vasoconstrictor agents than their endothelium-
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denuded counterpart because of the tonic vasodilator action of basal NO 
(Allan et at., 1993; Egleme et al., 1984). A variant of this last assay has been 
used successfully to examine the expression of iNOS in blood vessels. Thus, 
following overnight incubation in Krebs solution contaminated with bacterial 
endotoxin (lipopolysaccharide, IPS) a depression of PE-induced tone and 
relaxation to L-arginine in endothelium-denuded rings, indicative of expression 
of iNOS was seen (Rees et al., 1990a).
In this study we used the depression of PE-induced contractions of 
endothelium-denuded rings of rat aorta which occurs after overnight incubation 
(Rees et al., 1990a) as a means of indirectly assessing expression of iNOS. 
By using, L-NAME, a known inhibitor of NOS we were able to determine with 
certainty if this depression of PE-induced contraction resulted from NO 
production following expression of iNOS. This system therefore can be used to 
determine if NO is being produced but it is not able to be used to quantify 
production. Its utility is therefore limited to situations where it might be 
impossible to measure nitrite.
Comparison of measuring systems tested
All of the measuring systems we examined had advantages and limitations. 
The Griess reaction was perhaps the simplest and quickest system to use 
since it permitted assay of hundreds of samples per day especially when the 
automated plate reader was employed. Furthermore, the samples once mixed 
with the Griess reagents were stable for at least 24 h so the assay could be 
read at any point during this time. The chemiluminescence systems were more 
sensitive but each sample took roughly 10 min to read, thus making these 
systems inefficient when large numbers of samples were to be measured. 
Also, the reflux solutions were stable for only 1 - 2  days. The theoretical 
advantage of measuring both products of NO (nitrite and nitrate) using the
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vanadium chloride/hydrochloric acid reflux system was not realised. In 
practice, the large chemiluminescence signals generated from L-arginine and 
its analogues together with the constituents of the culture media employed, 
prevented the use of this system in most experimental situations. The 
fluorometric system was more sensitive than the Griess reaction and less so 
than the chemiluminescence techniques, but samples were only stable for 10 
min or so, again making it awkward to employ when large numbers of samples 
were to be measured. As will be seen later in the Discussion, relaxation of a 
segment of blood vessel provided a good physical sign of NO production from 
iNOS. It was thus, useful for tissue work where levels of nitrite/nitrate were 
below detection limits for even our most sensitive chemiluminescence assays. 
As will also be seen, the measurement of cyclic GMP was good as a 
secondary detection system to show that NO was indeed active, but it 
provided no direct quantitative information on how much was produced. 
Fortunately, in many of our experiments the added sensitivity of the 
chemiluminescence detection systems were not required so it was prudent to 
routinely adopt the fast and reliable Griess reaction as the assay of choice.
Comparison with other measuring systems
A number of systems other than those described above are available for the 
measurement of NO or activity of the L-arginine/NO pathway. These include 
the L-citrulline assay (Rees et al., 1990b; Pollock et al., 1991), 
methaemoglobin spectrophotometry (Kelm & Schrader, 1988; Ignarro et ai, 
1987; Kelm et ai, 1988), electron paramagnetic resonance (EPR) (Arroyo & 
Kohno, 1991; Maples et ai, 1991), gas chromatography (Pai et ai, 1987), 
mass spectroscopy (Gustafsson et ai, 1991) and various NO-sensitive 
microelectrodes (Shibuki, 1990; Malinski & Taha, 1992; Ichimori et ai, 1994).
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The L-citrulline assay in fact measures pHJ-L-citrulline formation, i.e. the by­
product of NO production from pH]-L-arginine (Hibbs et al., 1987). This does 
not give a direct measurement of NO but has been used extensively to 
examine NOS activity in a large number of different cells and tissues (Rees et 
al., 1990b; Pollock et al., 1991; Bush et al., 1992; Yu, 1994).
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Methaemoglobin detection is based on the rapid oxidation of reduced 
haemoglobin to methaemoglobin by NO (Kelm et al., 1988; Kelm & Schrader, 
1988; Ignarro et al., 1987). This is a highly sensitive technique, having a 
threshold sensitivity of around 1 nM and is thus as powerful as the most 
sensitive of the chemiluminescence techniques. Its other major advantage is 
that it measures NO and not one of its breakdown products. Methaemoglobin 
spectrophotometry has in fact been used by Kelm & Schrader (1988) to 
support the view of Palmer et al. (1987) that NO is produced in amounts 
sufficient to account for the actions of EDRF.
NO is a paramagnetic molecule with an unpaired electron. Thus, application of 
a magnetic field of an appropriate strength will promote this electron to a 
higher energy level, and relaxation from this state will produce a characteristic 
spectrum (Maples et al., 1991). In view of the unstable nature of NO, EPR 
detection of NO per se has not been applied to biological experiments. When 
bound to haemoglobin, however, the complex formed is quite stable and 
retains paramagnetic properties. Consequently, detection of the haemoglobin- 
NO complex by EPR has been applied successfully in a number of biological 
situations. Specifically, EPR has been successfully used to demonstrate the 
expression of iNOS in macrophages upon activation with IFN-y, and this was 
inhibited in the presence of l-NMMA (Henry et al., 1991). Interestingly, 
Rubanyi et al. (1991) reported using EPR that EDRF was probably a S- 
nitrosothiol rather than native NO. This was based on their finding that
authentic NO gave a paramagnetic signal when combined with haemoglobin 
but EDRF did not.
Gas chromatography using Varian gas chromatography with a Parapak Q 
column and electron capture was less sensitive than chemiluminescence (Pai 
et al., 1987). In this study the production of NO from nitrite was examined 
using nitrite reductase purified from Achomobacter cycloclastes (Pai et al.,
1987).
Mass spectroscopy has been used to detect NO in the breath of rabbits 
(Gustafsson et al., 1991) and was also used by Palmer in conjunction with a 
cascade bioassay and chemiluminescence to show that NO was derived from 
the precursor, L-arginine (Palmer et al., 1988). The detection limit for mass 
spectroscopy is 9 pmol (Gustafsson et al., 1991) and thus more sensitive than 
chemiluminescence.
Two different microelectrode detection systems for NO have been described. 
The first was able to detect nanomolar levels of NO by measuring the 
oxidation of NO at the electrode tip (Shibuki, 1990; Ichimori et al., 1994). This 
system is highly specific for NO, with nitrite and nitrate producing no 
interference. The inhibitor of NOS, l-NAME, however, causes a significant 
non-specific current when used in conjunction with this form of microelectrode 
(Ichimori et al., 1994) thus reducing its utility. This system has, however, been 
employed to measure acetylcholine (1 pM)-induced release of NO (30 nM) 
from rat aortic rings, which was inhibited by l-NMMA (50 pM)(lchimori et al., 
1994), and on release of NO (28 nM) from rat cerebellum following electrical 
stimulation (Shibuki, 1990). The underlying principle on which the second type 
of microelectrode is based is % metalloporphyrin-catalysed oxidation of NO. 
This technique is even more sensitive, measuring NO at concentrations of 
10-20 M and above (Malinski & Taha, 1992). This is therefore the most
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powerful of all the techniques yet described and can be used to detect NO 
(450 nM) release from individual endothelial cells exposed to bradykinin (2 
nmol). A major advantage of both types of microelectrode is that they detect 
NO per se and not one of its breakdown products. Furthermore, their use can 
give an insight into the kinetics of NO production in real time (Malinski & Taha, 
1992).
Having established the sensitivity of a number of different measuring systems 
we then went on to examine their utility to measure the activity of the 
L-arginine/NO system in a number of different tissues and cell preparations. 
Those studied were J744.2 murine macrophages, BAEC, endothelium- 
denuded rings of rat aorta and RASMG in culture.
Expression of iNOS in J774.2 murine macrophages
In resting macrophages, NOS is not normally present but the inducible form 
can be expressed following stimulation with LPS and cytokines, such as 
interferon-y (IFN-y) (Stuehr & Marietta, 1987a; Stuehr & Marietta, 1987b). In 
our experiments we used J774.2 murine macrophages, and when 10® 
unstimulated cells were incubated in 1 ml of tissue culture medium, 
accumulation of nitrite into the medium reached 5.3 ± 0.3 nmol, which was 
easily measured by the Griess reaction. Others have also successfully used 
the Griess reaction to measure nitrite production by macrophages (Hibbs et 
ai, 1987; Stuehr & Marietta, 1987a; Stuehr & Marietta, 1987b). For 
comparison, we also measured basal nitrite production using 
chemiluminescence with the sodium iodide/glacial acetic acid reflux system 
and found a similar resting level of nitrite (4.5 ± 0.5 nmol). Furthermore, when 
we measured combined nitrite and nitrate production using the vanadium 
chloride/hydrochloric acid reflux system we found a basal level of 5.3 ± 4.7 
nmol. These data, therefore, suggest that the major metabolite of NO formed
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by resting cells is nitrite with only very small levels of nitrate. Such findings are 
in keeping with the literature which suggests that when NO reacts with Og in 
aqueous solution in vitro, nitrite is the major product formed (Ignarro et a!., 
1993; Wennmalm et a!., 1992), Nitrate, would only be expected if NO was 
destroyed by superoxide anion (Beckman et al., 1990) or if it reacted with 
haemoglobin (Wennmalm et al., 1992). Consequently, nitrate has been found 
to be the major product of NO present in plasma in vivo (Wennmalm et al., 
1992).
When the macrophages were stimulated with IFN-y, nitrite and combined 
nitrite/nitrate accumulation during the overnight incubation increased 
significantly in a concentration-dependent manner. Again the Griess reaction, 
the sodium iodide/glacial acetic acid reflux system and the vanadium 
chloride/hydrochloric acid reflux system produced similar results for maximal 
nitrite or nitrite/nitrate production by 100 u mh^  IFN-y (44.4 ± 0.6 nmol, 54.5 ± 
3.5 nmol and 52.5 ± 7.3 nmol, respectively). The data suggested that, as with 
resting cells, the major metabolite of NO produced by activated cells was 
nitrite. Thus, as the major metabolite of both unstimulated and stimulated cells 
was nitrite, all further experiments were performed using the Griess reaction or 
the sodium iodide/glacial acetic acid reflux system only. A second reason for 
not using the vanadium chloride/hydrochloric acid system was that it resulted 
in the production of high background readings when DMEM, FCS, NBS, 
L-arginine and L-arginine analogues were present, thus making precise 
measurement of cellular nitrite/nitrate production difficult. The ability of IFN-y to 
increase nitrite accumulation in our experiments is thus consistent with the 
stimulated expression of iNOS in these cells, as has previously been reported 
for other macrophage cell lines (Stuehr & Marietta, 1987a).
LPS from Salmonella typhosa, like IFN-y, stimulated a concentration- 
dependent increase in nitrite production by J774.2 murine macrophages
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during an overnight incubation. The maximum increase at 1000 ng ml-'* 
was 3-fold. These data are therefore in agreement with a previous report by Di 
Rosa et al. (1990). Moreover, when IPS and IFN-y were used in combination 
we found, as did Stuehr and Marietta (1987a), that these stimuli acted in a 
synergistic manner to increase nitrite production.
Thus, in J774.2 murine macrophages the production of NO could be assessed 
by measuring its major stable product, nitrite, using either the Griess reaction 
or chemiluminescence coupled with the sodium iodide/glacial acetic acid 
reducing system under reflux. No added benefit was derived from the 
combined measurement of nitrite and nitrate using the vanadium 
chloride/hydrochloric acid reflux system as the main metabolite of NO 
produced by J774.2 murine macrophages was nitrite. By far the most 
convenient way to measure accumulation of nitrite into the medium bathing 
cells was using the Griess reaction since large numbers of samples could be 
measured simultaneously. Chemiluminescence, although just as accurate and 
reliable was extremely slow by comparison. Having established that the Griess 
reaction was the most appropriate system for measuring NO production by
J774.2 murine macrophages which produce large quantities of nitrite we then 
wished to examine if we could measure NO production after expression of 
iNOS in BAEC using the more sensitive chemiluminescence detection 
systems.
Attempted expression of iNOS in BAEC
It is well established that NOS is constitutively present in endothelial cells and 
is responsible for production of NO, the EDRF (Müisch & Busse, 1991). It has 
been reported, as for other cells such as macrophages described above, that 
iNOS can also be expressed in endothelial cells from porcine aorta following 
stimulation with LPS and IFN-y (Radomski et a!., 1990b). Also, expression of
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iNOS has been shown In murine brain microvascular endothelial cells after 
stimulation with the cytokines, TNF-a and IFN-y (Gross et al., 1991). Thus, it 
appeared that vascular endothelial cells could be made to express both cNOS 
and INOS.
As outlined in the next section, there is growing evidence that the hypotension 
of septic shock is due to massive production in the blood vessels of NO 
following expression of iNOS (Parker & Adams, 1993). Associated with this 
hypotension is a profound increase in vascular permeability, but the role of NO
and iNOS in this action had not been investigated when our study was
'underway. Such a role was suggested, however, by reports showing that the 
cytokines, interleukin-1 and interleukin-2 (lL-1 and IL-2), which promote 
expression of iNOS, also stimulate massive increases in vascular permeability 
(Campbell et a!., 1992). I therefore undertook a joint project with other 
members of the laboratory to investigate the role of iNOS in the increased 
vascular leakage produced by LPS.
We found that overnight incubation with LPS from Salmonella typhosa 
stimulated a massive increase in albumin transfer across monolayers of BAEC 
grown on polycarbonate membranes (Berman & Martin, 1993a; Berman &
Martin, 1993b; Berman et ai, 1993). This increase in vascular leakage did not, 
however, appear to involve the L-arginine/NO pathway, because l-NMMA and 
l-NOARG, inhibitors of NOS, failed to inhibit the increase in endothelial 
permeability (Berman et al., 1993)
Although it seemed apparent that the increase in endothelial permeability 
produced by LPS did not appear to involve NO, it was still important to 
establish if concomitant iNOS expression had occurred. Using
chemiluminescence coupled with sodium iodide/glacial acetic acid reflux, 
nitrite (27.8 ± 4 nmol 10® cells-'*) was found to accumulate into the medium
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bathing unstimulated cells during an overnight incubation and when combined 
nitrite/nitrate was measured using vanadium chloride/hydrochloric acid reflux 
there was no significant difference in the measurements (31.2 ± 4 nmoMO® 
cells-'*). We found that the presence of LPS in the bathing medium failed to 
increase the accumulation of nitrite or nitrite/nitrate suggesting that iNOS 
expression had not taken place. There may be a species difference between 
bovine and porcine aortic endothelial cells.
Basal production of nitrite by BAEC (27.8 ± 4 nmol) was greater than the basal 
production by J774.2 macrophages (5.3 ± 0.3 nmol) for the same number of 
cells. Surprisingly, we could further conclude that the basal production of nitrite 
by BAEC was not derived from the L-arginine/NO pathway as the inhibitors of 
NOS, l-NAME and L-NMMA (Moore et al., 1990; Rees et al., 1990b), had no 
effect when present during the overnight incubation. The biochemical pathway 
by which basal nitrite production took place was therefore unknown. The 
inhibitor of expression of iNOS, dexamethasone (Di Rosa et al., 1990; 
Knowles et al., 1990b; Rees et ai, 1990a), similarly had no effect on basal 
accumulation of nitrite.
On the basis of these findings it was likely that expression of iNOS was not 
responsible for the increased permeability of the endothelium associated with 
endotoxic shock.
Role of iNOS in septic shock
Septic shock is a devastating systemic inflammatory response which results in 
60 - 90% mortality (Hess et al., 1981). A number of different stimuli cause 
septic shock including Gram-negative bacteraemia, Gram-positive 
bacteraemia, fungi, viruses and parasites (Bone et al., 1987; Ispahani et al., 
1987; Calandra et al., 1988; Glauser et al., 1991). In this study we examined
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the effects of LPS, the active component of Gram-negative bacterial cell walls 
(Glauser ef a/., 1991; Rietschel eta!., 1993).
Exposure to LPS has led to the expression of iNOS in a number of different 
cells in culture including macrophages (Di Rosa et al., 1990) and rat vascular 
smooth muscle cells (Marczin et al., 1993; Szabô et al., 1993a). Expression of 
iNOS has also been demonstrated in vivo in rats, mice and dogs treated with 
LPS (Kilbourn et al., 1990b; Thiemermann & Vane, 1990; Kosaka et ai, 1992).
The increased production of NO results in hypotension and this can be 
reversed by inhibitors of NOS, e.g. l-NMMA (Kilbourn et al., 1990b; 
Thiemermann & Vane, 1990; Meyer et al., 1992). However, l-NMMA has its 
disadvantages as it also inhibits the actions not only of INOS but of cNOS, 
thus preventing endothelial control of blood vessel tone, resulting in Intense 
vasoconstriction and increased vascular resistance which adversely affects 
survival (Nava et al., 1992; Wright et al., 1992). Some of these detrimental 
effects of l-NMMA can be prevented by co-administration of the NO donor 
S-nitroso-N-acetylpenicillamine (Nava et al., 1992; Wright et al., 1992).
Selective inhibitors of iNOS might also be advantageous in the treatment of 
septic shock since they would be unlikely to interfere with the normal 
endothelial function. Certain selective inhibitors of iNOS have been described
3';such as L-canavanine (Misko et al., 1993) and aminoguanidines (Hasan et al.,
1993; Misko et al., 1993) but these have not yet been evaluated for the 
treatment of septic shock.
,1The effects of inhibitors of NOS have been tested on man. l-NMMA and 
L-NAME have been given to patients suffering from septic shock, and both 
inhibitors produced a dose-dependent increase in blood pressure and 
peripheral resistance (Petros et al., 1991). In a larger clinical trial l-NMMA 
produced similar results but was also noted to cause a fall in cardiac output
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i(Petros et ai, 1994). Thus, again selective inhibitors of iNOS require 
evaluation.
In experimental animals, as already stated, LPS induces septic shock-like 
symptoms (Kilbourn et ai, 1990b; Thiemermann & Vane, 1990; Gray et ai,
1991; Kosaka et ai, 1992), however, other compounds have also been shown 
to produce similar effects. These include cytokines, TNF-a, IFN-y, IL-1 and 
IL-2(Kilbourn et ai, 1990a; Hibbs et ai, 1992; Ochoa et ai, 1992; Szabô et ai,
1993c). As with LPS, certain of the septic shock-like symptoms induced by 
these cytokines can be reversed by administration of l-NMMA or l-NAME 
(Kilbourn et ai, 1990a).
The hypotension of septic shock is also associated with a reduction in the 
pressor response to vasoconstrictor agents (Parratt, 1973; Teale & Atkinson,
1992). Depression of contraction to a number of different pressor agents, 
including noradrenaline (Parratt, 1973), vasopressin (Schaller et ai, 1985), 
angiotensin II (Schaller et ai, 1985) and serotonin (Wakabayashi et ai, 1987) 
can still be observed in blood vessels from treated animals ex vivo. 
Furthermore, in order to examine the mechanism underlying 
hyporesponsiveness, many groups have examined the reactivity of vascular 
rings taken from animals treated with LPS. This depression of contraction has
■been shown to be reversed by the inhibitor of NOS, l-NMMA (Julou-Schaeffer 
et ai, 1990). Hypo reactivity to vasoconstrictors can even be produced
following overnight incubation of rings of rat aorta in Krebs solution 
contaminated with LPS (Rees et ai, 1990a). This hyporeactivity is blocked by 
inhibitors of NOS, l-NMMA (Busse & Müisch, 1990), and by inhibitors of 
expression of iNOS, e.g. glucocorticoids (Rees et ai, 1990a), suggesting that 
it is due to expression of iNOS. Agents other than LPS, including IFN-y, 
TNF-a, IL-1 and IL-2, have also been shown to produce a similar 
hyporeactivity to vasoconstrictors (Busse & Müisch, 1990). Again, this
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hyporeactivity was reversed by inhibitors of NOS, l-NAME and l-NMMA 
(Busse & Müisch, 1990) suggesting that it resulted from the production of NO 
by iNOS in the vascular wall.
The data described above provide powerful evidence that the hyporeactivity of 
septic shock is due to the over production of NO in the vascular wall. Although 
expression of iNOS could have taken place in many different cell types in the 
vessel wall, most attention has been focused on the smooth muscle cells. This 
is principally because expression of iNOS is readily achieved in smooth 
muscle cells cultured from blood vessels such as rat aorta (Busse & Müisch, 
1990; Fleming et al., 1991). For example, treatment of vascular smooth 
muscle cells with IL-1, TNF-a, IFN-y and LPS for several hours has led to the 
production of nitrite, indicative of expression of iNOS (Busse & Müisch, 1990; 
Beasley et al., 1991; Kanno et al., 1993; Koide et ai, 1994). In cultured 
smooth muscle cells there is debate as to whether LPS alone can stimulate 
expression of iNOS. Marczin et a i (1993) and Szabô et a i (1993a) report that 
LPS can stimulate expression of iNOS but Sirsjô et a i (1994) dispute this and 
propose that the additional presence of a cytokine is required. We therefore 
wished to examine the factors which lead to expression of iNOS in the 
vascular wall of rat aorta as well as in smooth muscle cells cultured from it.
Expression of iNOS in endothelium-denuded rings of rat aorta
In order to investigate the factors regulating expression of iNOS in the intact 
blood vessel, rat isolated aortic rings were incubated overnight in Krebs 
solution as previously described by Rees et a i (1990a). All rings were 
denuded of endothelium to avoid any effects of cNOS. Our experiments 
showed a clear depression of the contractile actions of PE following incubation 
in Krebs solution at 37°C for 18 h in support of the earlier report (Rees et ai, 
1990a). Also consistent with earlier reports was our finding that a major
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component of this hyporeactivity was abolished following blockade either of 
the synthesis of NO with l-NAME (Fleming et al., 1991a), or its actions with 
methylene blue (Fleming et al., 1993). We also found that haemoglobin, which 
binds and inactivates NO (Gibson & Roughton, 1957; Martin et al., 1985), 
partially reversed this hyporeactivity. Surprisingly, although nitrite 
accumulation was detected by chemiluminescence in the Krebs used to 
incubate the rings, this was completely unaffected by the presence of l-NAME 
throughout the incubation. The source of this nitrite, like that produced by 
BAEC, therefore appeared not to be the L-arginine/NO pathway. Thus, 
production of NO appeared to be the cause of the depression of contraction in 
incubated rings but no evidence of enhanced production of NO could be 
obtained by measurement of its major metabolite nitrite.
Actions of polvmixin B
Our finding that polymixin B, which binds and inactivates bacterial LPS 
(Lasfargues et al., 1989), inhibited the development of hyporeactivity to PE 
supported the previous conclusion that it resulted from the expression of iNOS 
in the vascular wall stimulated by endotoxin contaminating Krebs solution 
(Rees et al., 1990a). The levels of LPS found to be contaminating the Krebs 
solution have been reported to be 9.1 - 18.2 ng mH (Rees et al., 1990a). We 
found that addition of further LPS failed to enhance the degree of depression 
of PE-induced contraction obtained suggesting that the levels already present 
in the Krebs solution were maximal for expression of iNOS. Interestingly, 
although l-NAME and polymixin B each only partially reversed the depression 
of PE-induced contraction following incubation in Krebs solution, the combined 
effect of these two treatments was no greater than with either alone. This 
would suggest that the hyporesponsiveness seen consisted of two 
components; a major component through expression of iNOS and a lesser
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component whose origin is unknown, but may simply represent a decline in 
tissue integrity following prolonged incubation.
Actions of dexamethasone
In contrast to an earlier report (Rees et al., 1990a), we found that 
dexamethasone did not inhibit the depression of PE-induced contraction if it 
was present throughout the overnight incubation. Previous work in our 
laboratory did, however, find that dexamethasone inhibited the lower degree of 
depression of PE-induced contraction seen following incubation of aortic rings 
for 6 - 10 hours (personal communication from S. Eason and K. Mian). The 
reason for this difference is not clear but we speculate that perhaps our 
tissues may have been exposed to higher concentrations of endotoxin than 
those of Rees et al. (1990a) and that dexamethasone was unable to oppose 
this more powerful stimulus.
Actions of suneroxide anion
To further determine if NO was being produced and to examine if the 
expression of iNOS was occurring in the vascular smooth muscle cells or 
another cell type in the cell wall, we examined the effects of superoxide anion 
generating systems.
It is well established that superoxide anion destroys the relaxant activity of NO 
(Gryglewski et al., 1986). Interestingly, we found that the depression of PE- 
induced contraction following overnight incubation was inhibited in a 
concentration-dependent manner by LY 83583 (0.1 - 1 pM), which generates 
superoxide anion both intracellularly and extracellularly (Müisch et al., 1988; 
Müisch et al., 1989), but not by hypoxanthine/xanthine oxidase (McCord & 
Fridovich, 1968), which produces the free radical only extracellularly. These
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actions were thus consistent with NO being produced and then acting within 
the same smooth muscle cell. Also consistent with this conclusion was the 
inability of superoxide dismutase, which inactivates superoxide anion, to 
enhance the depression of PE-induced contraction or to reverse the effects of 
LY 83583, since in view of its large size, superoxide dismutase can only act 
extracellularly. Interestingly, a concentration of 3 pM LY 83583 produced a 
smaller degree of reversal of the depression of PE-induced contraction than 1 
pM. The possibility was considered that this paradoxical action may have 
arisen due to the production of the relaxant, hydrogen peroxide from the 
superoxide anion (Dowell et al., 1993). However, when catalase, which 
inactivates hydrogen peroxide, was added it had no effect on the magnitude of 
the reversal induced by 3 pM LY 83583. Thus, in view of the inability of 
catalase to enter cells we can conclude that reduced ability of LY 83583 at 3 
pM to reverse the depression of PE-induced contraction was not due to the 
extracellular accumulation of hydrogen peroxide. Whether or not this action 
results from the intracellular accumulation of hydrogen peroxide or some other 
unrelated action remains to be determined.
Expression of iNOS in RASMC in culture
In contrast to the agreed actions on isolated vascular rings, there is 
controversy regarding the ability of LPS alone to stimulate expression of iNOS 
in vascular smooth muscle cells in culture. Certain groups have found that 
LPS alone is a sufficient stimulus (Marczin et al., 1993; Szabô et al., 1993a; 
Beasley & Eldridge, 1994; Donald & Struthers, 1995) for expression of iNOS in 
RASMC in culture. Others disagree, reporting that LPS alone has no effect on 
nitrite production or expression of INOS mRNA and that the additional 
presence of a cytokine such as IFN-y is required (Sirsjô et al., 1994). Similar 
results to Sirsjô et al. (1994) were reported for rat pulmonary artery smooth 
muscle cells in culture (Nakayama et al., 1992). There is general agreement,
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however, that certain cytokines including IL-1 and TNF-a reliably stimulate 
expression of iNOS in RASMC In culture (Junquero et al., 1992; Beasley & 
Eldridge, 1994; Perrella et al., 1994). On the basis of these conflicting reports 
on the actions of LPS, we felt that it was important to evaluate the actions of 
this agent, as well as those of cytokines on RASMC in culture.
Expression of iNOS in RASMC in full culture medium
Our initial experiments were conducted in full culture medium containing 
serum but we were unable to express INOS In RASMC, as assessed by 
increases in nitrite production measured using the Griess reaction, using either 
LPS, IFN-y or IL-1 a alone over wide concentration ranges. Combinations of 
IFN-y and LPS or IL-1 a and LPS also failed to increase nitrite accumulation, 
however, the combination of IL-1 a (40 u mM) and IFN-y (100 u mb'*) did 
increase nitrite accumulation by 2-fold. At about the time this work was being 
conducted reports came to light which suggested that serum could inhibit the 
expression of iNOS in RASMC (Junquero et al., 1992; Schini et al., 1992; 
Hirokawa et al., 1994b). These papers went on to report that the presence of 
transforming growth factor-p and platelet-derived growth factor^B and bb in the 
serum were likely to account for the ability of serum to inhibit the expression of 
iNOS. It was therefore likely that the presence of serum in our initial 
experiments prevented the expression of iNOS except with the powerful 
combination of IFN-y and IL-1 a. Consequently, we conducted a series of 
experiments in serum-free culture medium and found that IFN-y alone 
stimulated nitrite accumulation following an overnight incubation, consistent 
with expression of iNOS. We also found that NBS and FCS inhibited the 
increase in nitrite accumulation produced by IFN-y suggesting that serum 
indeed had the ability to block expression of INOS. Thus, all further 
experiments were conducted in serum-free culture medium.
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We found that bacterial LPS alone from either Salmonella typhosa or 
Escherichia coli failed to stimulate expression of iNOS activity in RASMC in 
culture, as assessed either as accumulation of nitrite in the culture medium or 
as an increase in smooth muscle cyclic GMP content, except at exceptionally 
high concentrations (300 and 1000 pg mM). These high concentrations of LPS 
in fact appeared toxic to the cells as they induced detachment from the growth 
surface. They are also around 100000 times those required to express iNOS 
in isolated rings of rat aorta (Rees et al., 1990) and 10000 times that required 
in J774.2 murine macrophages. In contrast, IFN-y or IL-1 a alone were able to 
produce concentration-dependent increases in the accumulation of nitrite and 
in cyclic GMP content of the cells, as previously reported (Busse & Müisch,
1990; Beasley et al., 1991; Kanno et ai, 1993; Koide et ai, 1994). Although,
-alone LPS, except at high concentrations produced no effect, low 
concentrations (100 ng ml '*) could enhance the nitrite accumulation if a low, 
near threshold concentration of IFN-y (10 u ml-*) was used. In contrast, a low 
concentration of LPS (100 ng ml-*) failed to augment the actions of a near- 
maximal concentration of IFN-y (30 u ml *). It seemed therefore that the cells 
were able to respond to LPS but only in the presence of an additive stimulus.
The time course of the expression of iNOS that we found when RASMC were
stimulated with IFN-y was in agreement with other reports (Beasley & Eldridge, 
1994; Buttery et ai, 1994). We found that nitrite accumulation began to rise 
after 6 h and continued increasing until at least 72 h. Such a time course is 
consistent with the need for de novo protein synthesis.
Inhibition of the actions and expression of iNOS in RASMC
We concluded that the enhanced production of nitrite by RASMC stimulated by
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overnight incubation with IFN-y was clearly due to expression of iNOS since it
i
was blocked following treatment with l-NMMA or l-NAME, which inhibit NOS 
(Moore et al., 1990; Rees et al., 1990b). Surprisingly, dexamethasone, which 
failed to block expression in rat aortic rings, inhibited the expression of iNOS in 
RASMC. Cycloheximide, which prevents de novo synthesis of proteins, also 
inhibited the production of nitrite by our RASMC, consistent with its reported 
ability to inhibit expression of iNOS (Di Rosa et al., 1990; Knowles et al., 
1990b; Radomski et al., 1990b; Rees et al., 1990a). We also found that 
polymixin B, which binds and inactivates LPS (Lasfargues et al., 1989), had no 
effect on the accumulation of nitrite stimulated by IFN-y alone which suggested 
that the culture medium, unlike the Krebs solution used to bathe aortic rings, 
was not contaminated with bacterial LPS.
Other agents are known to inhibit expression of iNOS in other cell types, e.g. 
macrophages, and these include IL-4 and IL-10 (Oswald et al., 1992; Liew et 
al., 1991; Chesrown et al., 1994) but the effects of these were not examined 
on RASMC in our study.
Comparison of RASMC in culture and in situ
Clearly, an explanation is required to account for the findings of this study and 
of others (Nakayama et al., 1992; Sirsjô et al., 1994) where LPS alone 
stimulated the expression of iNOS in an isolated blood vessel but not in 
smooth muscle cells in culture. Sirsjô et al. (1994) suggested that the 
differential effects of LPS could either be due to the presence of 
heterogeneous cell types in blood vessels which were absent in homogeneous 
populations of smooth muscle cells in culture or to differences in smooth 
muscle phenotype in the vessel wall and in culture, and both merit 
consideration. For example, one of the many cell types which normally reside 
in the vessel wall could potentially respond to LPS by secreting a cytokine 
which then acted either alone or in concert with LPS leading to expression of
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iNOS in the smooth muscle layer. Of the cell types present, endothelial cells, 
although able to express iNOS in some species (Knowles et al., 1990b; 
Radomski et al., 1990b; Gross et al., 1991), can probably be discounted since 
their complete removal has no effect on the magnitude of the depression of 
vasoconstriction observed following incubation of blood vessels for prolonged 
periods in LPS-containing Krebs solution (Rees et al., 1990a). The presence 
of the endothelium may, however, enhance the sensitivity to LPS as well as 
the rate of onset of hyporeactivity (Fleming et al., 1993). 
Monocyte/macrophages or lymphocytes which are normally present in the 
arterial wall (Joris et al., 1979) appear more likely candidates since they are 
known to respond to endotoxin by secreting cytokines (Flad et al., 1993). This 
possibility is further supported by the findings in animal models that shock-like 
symptoms can be induced by certain cytokines such as IL-1, IL-2 and TNF-a 
(Kilbourn et al., 1990b; Gray et al., 1991; Hibbs et al., 1992; Ochoa et al., 
1992; Szabô et al., 1993c), and that the hypotension induced following 
administration of LPS is inhibited by the receptor antagonist, interleukin-1 
(Szabô et al., 1993a), as well as by antibodies to IL-1 or TNF-a (Thiemermann 
et al., 1993). Consequently, we examined the actions of antibodies to TNF-a, 
IL-ip and IFN-y as well as the inhibitor of the production of TNF-a, 
pentoxifylline, on the depression of PE-induced contraction in rat aortic rings 
obtained following overnight incubation.
Inhibition of TNF~a
TNF-a has been shown to produce shock-like symptoms when injected into 
animals (Tracey et al., 1987) and has also been shown to be released during 
shock induced by LPS (Mathison et al., 1988). Inhibition of TNF-a during 
septic shock has been studied in two main ways. Firstly, an inhibitor of the 
production of TNF-a, pentoxifylline, has been shown to be an effective pre­
treatment and inhibits increases in TNF-a in the plasma of rabbits and rats
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(Mathison et al., 1988; Matuschak et al., 1994). Secondly, pre-treatment of 
rats with a monoclonal antibody to TNF-a has been found to prevent the fall in 
blood pressure induced by LPS (Thiemermann et al., 1993). This latter pre­
treatment also prevented the associated depression in contractile response to 
noradrenaline ex wVo (Thiemermann et al., 1993).
In our experiments we incubated rings overnight in the presence of 
pentoxifylline. We found, however, that this had no effect on the depression of 
PE-induced contraction. Thus, although pentoxifylline may reduce plasma 
TNF-a levels following injection of LPS (Mathison et al., 1988) this cytokine 
does not appear to be responsible for the depression of contractility seen 
following overnight incubation of rat aortic rings.
We also examined the effects of including a monoclonal antibody to TNF-a in 
the Krebs solution throughout the overnight incubation. As with pentoxifylline 
this had no effect on the depression of PE-induced contraction. Thus, we had 
no evidence that TNF-a was involved in the depression of contractility. A 
criticism that could be raised against our experiments, however, is that the 
antibody used was raised against mouse and not rat TNF-a. Antibodies to rat 
TNF-a are not, to our knowledge, available. It is therefore possible that the 
antibody would not cross react with and so would therefore not inhibit rat TNF- 
a. Others have found that antibodies to TNF-a are effective in protecting 
animals when used as a 2 h pre-treatment before the addition of LPS (Beutler 
et al., 1985; Silva et al., 1990; Thiemermann et al., 1993). Silva et al. (1990) 
and Thiemermann et al. (1993) used an antibody to murine TNF-a raised in 
hamsters (TN3.19.12) and this was effective against murine and rat TNF-a. 
Beutler et al. (1985) raised antibodies to murine TNF-a in rabbits. An antibody 
to TNF-a has also been administered to human patients with sepsis syndrome 
(Abraham et al., 1995). Here the antibody appeared to reduce mortality but 
this reduction was not statistically significant. However, these human
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experiments, unlike those described above for animal experiments were 
conducted on patients with existing sepsis and not used as a pre-treatment. 
The effectiveness of the antibody may be under-estimated.
Inhibition o f IFN-y
IFN-y is known to produce shock-like symptoms in animals (Heinzel, 1990; 
Silva & Cohen, 1992). Furthermore, a monoclonal antibody to murine IFN-y 
raised in hamsters (H22) has been reported to produce significant protection 
from LPS-induced septic shock in mice (Evans et ai, 1992). These authors 
showed that it also decreased the expression of iNOS in hepatocytes in those 
animals (Evans et ai, 1992). In our experiments, however, inclusion of a 
monoclonal antibody to IFN-y throughout the overnight incubation of rat aortic 
rings had no effect on the resulting depression of PE-induced contraction. 
Thus, we had no evidence that the depression of PE-induced contraction 
involved the release of IFN-y, although, again, it must be acknowledged that 
an antibody raised against rat and not the mouse form of the cytokine would 
have been ideal.
Inhibition o f IL-1/3
Reports suggest that antagonists of lL-1 can reduce the mortality of endotoxin 
shock in rabbits, suggesting that this cytokine does play a role (Ohisson et ai, 
1990; Ohisson et ai, 1990; Wakabayashi et ai, 1991). We therefore examined 
the effects of a monoclonal antibody to human IL-ip on the depression of PE- 
induced contraction following an overnight incubation of rat aortic rings. The 
antibody, despite being present throughout the overnight Incubation, had no 
effect on the depression of PE-induced contraction. It did, however, 
significantly increase the ability of L-NAME to reverse the depression 
suggesting that lL-ip may be involved at least to a limited extent.
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Overall, however, our combined results using pentoxifylline and a panel of 
antibodies to cytokines have thus failed to provide convincing evidence that 
LPS contaminating the Krebs solution leads to depression of contractility via 
expression of iNOS indirectly via release of a cytokine from a non-smooth 
muscle cell type in the vascular wall.
Phenotypic state of smooth muscle
The alternative proposal (Sirsjô et ai, 1994), I.e. that LPS may only be able to 
simulate expression of iNOS in smooth muscle in the contractile phenotype 
(Chamley-Campbell & Campbell, 1989) present in the arterial wall but not in 
the synthetic phenotype in culture has not been tested and requires further 
evaluation.
Induction of iNOS in vascular smooth muscle cells in culture bv LPS
Another major question that remains to be resolved is why some groups 
(Marczin et a!., 1993; Szabô et al., 1993c) find LPS alone to be sufficient to 
stimulate expression of iNOS in vascular smooth muscle cells in culture while 
others do not (Nakayama et ai, 1992; Sirsjô et ai, 1994 & our study). It is 
possible that this anomaly too may be explained by the presence of 
heterogeneous cell types in the smooth muscle culture systems used in 
different laboratories.
LPS binding protein
Another possible reason for the lack of ability of LPS to stimulate expression of 
iNOS in smooth muscle in culture in our experiments is probably worthy of 
consideration. Specifically, in order to bind to its receptor, GDI4, LPS must 
first form a complex with lipopolysaccharide binding protein (LBP) (Wright et
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al., 1990). This LBP is present in the serum of various animals including 
rabbits, mice and humans (Schumann et al., 1990). The removal of serum in 
our experiments to prevent the inhibitory actions of platelet derived growth 
factor^B and bb and transforming growth factor p would certainly have led to 
the removal of LBP, thus preventing the binding of LPS to its receptor. We did 
in fact find that LPS was possibly effective at high concentrations at which LPS 
can bind to its receptor in the absence of LBP (Mailman et al., 1994). 
Experiments involving the use of serum, I.e. to provide LBP, but lacking 
platelet derived growth factor^B and bb and transforming growth factor p, which 
inhibit iNOS expression would therefore be warranted. Although not attempted 
in our study, such experiments are possible through the use of plasma-derived 
serum, i.e. serum formed from the clotting of plasma following the removal of 
blood platelets (which release platelet derived growth factor and transforming 
growth factor p).
In conclusion, our findings suggest that bacterial LPS alone is a sufficient 
stimulus for expression of iNOS in isolated rings of rat aorta but that for 
cultured RASMC the presence of a cytokine such as IFN-y is required. 
Whether this difference results from the heterogeneous nature of the cell types 
present in the blood vessel or from differences in the phenotypic state of 
smooth muscle in the arterial wall and In culture or from the absence of LPS 
binding protein remains to be determined.
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